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This dissertation is to characterize two evolutionarily conserved but 
uncharacterized mitochondrial proteins using yeast and mammalian cells.  The first 
protein, which we named respiratory supercomplex factor 1 (Rcf1), is required for the 
assembly of respiratory supercomplexes.  Deletion of the RCF1 gene causes 
destabilization of respiratory supercomplexes, impaires respiration and elevates 
mitochondrial oxidative stress.  We also show that HIG2A, a mammalian homolog of 
RCF1, performs the same function in mammalian cells.  Therefore, we suggest that Rcf1 
and HIG2A are members of a conserved protein family that acts to maintain the 
homeostasis of mitochondrial metabolism by promoting respiratory supercomplex 
assembly.  The second protein on which my dissertation research was based, originally 
annotated as mitochondrial sorting of protein 1 (Msp1), performs multiple tasks.  The 
first function is its role in facilitating the removal of tail-anchored (TA) proteins that are 
mislocalized to mitochondria.  Disruption of the guided entry of tail-anchored protein 
(GET) system was shown to cause a subset of TA proteins to mislocalize to 
mitochondria.  The AAA+ ATPase Msp1 can limit the accumulation of mislocalized TA 
proteins on mitochondria.  The human homolog of Msp1, ATAD1, also limits the 
mitochondrial mislocalization of TA proteins in mammalian cells.  Therefore, Msp1 and 
ATAD1 are conserved members of a mitochondrial protein quality control system that
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functions to promote the extraction and degradation of mislocalized TA proteins to 
maintain mitochondrial integrity.  The second role of Msp1 and ATAD1 is in a novel 
vesicular trafficking system from mitochondria to peroxisomes in an ATPase activity-
dependent manner.  Impaired peroxisome biogenesis and mislocalization of peroxins 
(peroxisomal biogenesis factors) to the mitochondria has been observed in cells from 
Zellweger patients.  Overexpression of ATAD1 facilitates the removal of these peroxins 
from mitochondria and the accumulation in vesicle-like structures of unknown character 
and function.  We speculate that these vesicles might sort the peroxins to peroxisomes for 
peroxisomal biogenesis.  Therefore, we propose that Msp1 and ATAD1 participate in a 
novel vesicular trafficking pathway, which is likely associated with protein sorting from 
mitochondria to peroxisomes.  In conclusion, our findings provide a better understanding 
of mitochondrial biology, which further sheds light on the etiology of human 























This dissertation is dedicated to my beloved parents and families  
 




ABSTRACT ....................................................................................................................... iii 
LIST OF FIGURES ......................................................................................................... viii 
LIST OF TABLES ...............................................................................................................x 
ACKNOWLEDGEMENTS ............................................................................................... xi 
Chapters 
1. INTRODUCTION .........................................................................................................1 
 Mitochondria and human diseases ...........................................................................2 
 Rationale of studying uncharacterized mitochondrial proteome .............................3 
 Mitochondrial electron transport chain (ETC) .........................................................6 
 Supra-molecular organization of the electron transport chain .................................9 
 Mitochondrial protein quality control ....................................................................12 
 References ..............................................................................................................14 
 
2. IDENTIFICATION OF A PROTEIN MEDIATING RESPIRATORY  
 SUPERCOMPLEX STABILITY ................................................................................22 
 
 Summary ................................................................................................................23 
 Introduction ............................................................................................................23 
 Results ....................................................................................................................24 
 Discussion ..............................................................................................................31 
 Experimental procedures .......................................................................................33 
 Supplemental information ......................................................................................34 
 Acknowledgements ................................................................................................34 
 References ..............................................................................................................34 
 Supplemental information ......................................................................................36 
 Supplemental experimental procedures .................................................................37 
 Supplemental references ........................................................................................43 
 
3. MSP1/ATAD1 MAINTAINS MITOCHONDRIAL FUNCTION BY 
 FACILITATING THE DEGRADATION OF MISLOCALIZED TAIL-ANCHORED 
 PROTEINS ..................................................................................................................61
 vii 
 Abstract ..................................................................................................................62 
 Introduction ............................................................................................................62 
 Results ....................................................................................................................63 
 Discussion ..............................................................................................................72 
 Materials and methods ...........................................................................................74 
 References ..............................................................................................................77 
 
4. MSP1/ATAD1 PARTICIPATES IN MITOCHONDRIA-TO-PEROXISOME 
TRAFFICKING AND PEROXISOME FUNCTION ..................................................91 
 
 Introduction ............................................................................................................92 
 Results ....................................................................................................................96 
 Discussion ............................................................................................................123 
 Materials and methods .........................................................................................128 
 References ............................................................................................................133 
 















1-1. The electron transport chain .......................................................................................7 
2-1. Rcf1 is a mitochondrial inner membrane protein important for respiration .............24 
2-2. Rcf1 physically interacts with respiratory Complex III and IV ................................25 
2-3. Rcf1 interacts with Complex III and Complex IV independently ............................26 
2-4. Respiratory supercomplexes are impaired in the absence of RCF1 .........................28 
2-5. RCF1 genetically interacts with AAC2 and COX13 to stabilize respiratory 
supercomplexes .........................................................................................................29 
2-6. Increased mitochondrial oxidative stress in the absence of RCF1 ...........................31 
2-7. Mammalian HIG2A is critical for normal respiratory supercomplex organization ..32 
2S.1. RCF1 is evolutionarily conserved and important for respiration, related to  
 Figure 1 .....................................................................................................................44 
2S.2. Rcf1 interacts independently with subunits of Complex III and IV, related to Figure 
3.................................................................................................................................46  
2S.3. Rcf1 plays a role in maintaining the integrity of respiratory supercomplexes, related 
to Figure 4 .................................................................................................................48 
2S.4. RCF1 genetically interacts with Aac2 to stabilize respiratory supercomplexes, 
related to Figure 5 .....................................................................................................51 
2S.5. Deletion of RCF1 is susceptible to oxidative stress, related to Figure 6 ..................53 
2S.6. Hig2A is critical in maintaining respiratory supercomplexes, related to Figure 7 ...55 
3-1. Msp1 is a conserved mitochondrial outer membrane protein ...................................64 
3-2. The msp1Δ mutant exhibits growth defects and severe mitochondria damage when 
combined with the GET mutants ...............................................................................65
 
ix 
3-3. Depletion of ATAD1 causes decreased mitochondrial protein level and 
mitochondrial fragmentation in mammals ................................................................67 
3-4. Yeast Msp1 and human ATAD1 are required to limit the level of mitochondrially 
mislocalized TA proteins Pex15 and PEX26, respectively ......................................69 
3-5. Msp1 physically interacts with the TA protein Gos1 and is required to limit 
mitochondrial Gos1 ...................................................................................................71 
3-6. ATAD1 physically interacts with the TA protein, GOS28, and is required to limit 
the level of mislocalized GOS28 on mitochondria in mammals ..............................73 
3S.1. Yeast Msp1 and human ATAD1 localize to both mitochondria and peroxisomes. 
(Related to Figure 1) .................................................................................................79 
3S.2. The msp1Δ mutant exhibits growth defects and severe mitochondria damage when 
combined with GET mutants. (Related to Figure 2) .................................................80 
3S.3. Depletion of human ATAD1 causes mitochondrial fragmentation in HeLa cells. 
(Related to Figure 3) .................................................................................................81 
3S.4. Msp1 and ATAD1 facilitate the turnover of Pex15 and Pex26, respectively. 
(Related to Figure 4) .................................................................................................82 
3S.5. Msp1 physically interacts with the TA protein Gos1 and is required to limit the 
level of mislocalized Gos1 on mitochondria. (Related to Figure 5) .........................83 
3S.6. Mitochondrial TA proteins are poor substrates of yeast Msp1 .................................84 
3S.7. Expression of the dominant-negative mutant ATAD1-E193Q causes mislocalization 
of GOS28 to the mitochondria. (Related to Figure 6) ..............................................85 
4-1. The Msp1 AAA+ domain is necessary and sufficient for the peroxisomal 
localization ................................................................................................................97 
4-2. Msp1 localizes to vesicle-like puncta .....................................................................105 
4-3. Msp1 traffics from mitochondria to peroxisomes ...................................................108 
4-4. Peroxisomal localization of Msp1 is dependent on Fzo1 .......................................110 
4-5. Msp1/ATAD1 plays a role in maintaining peroxisomal morphology ....................115 
4-6. Msp1/ATAD1 is required for peroxin localization .................................................119 




2S.1. Rcf1-associated proteins upon digitonin and DDM treatment .................................57 
2S.2. Yeast strains used in this study .................................................................................58 
3S.1. List of proteins identified by mass spectrometry ......................................................86 
3S.2. List of yeast strains used in this study ......................................................................90 








Many faculty members, colleagues, families and friends played a critical role in 
helping me to finish my dissertation.  Without their mentorship and support, it would not 
be possible for me to accomplish the most important goal in my career.  I am grateful for 
being surrounded by them and I thank them from the bottom of my heart. 
I would like to express my gratitude to my dissertation advisor, Dr. Jared Rutter, for 
his endless patience and scientific breadth in guiding me in the path of my graduate 
career.  Jared accepted me into his lab without any hesitation and he has mentored me 
based on my own personality.  He had so much faith in me even when I experienced 
some bumpiness in the beginning of my graduate career.  His encouragement and 
criticism have always spurred me to constantly improve myself to become an 
independent scientist.  He was always supportive when I undertook risk in different 
projects.  I am grateful for his generosity, support, encouragement and patience. 
I gratefully thank many faculty members who have helped and encouraged me 
during my graduate career.  Dr. Janet Shaw, Dr. Dennis Winge, Dr. Wesley Sundquist 
and Dr. Don Ayer who served as my committee members have used their expertise in 
guiding me to always stay on the right track.  Scientifically, they always offer brilliant 
ideas and comments to help with the project.  Personally, they give me the best guidance 
to help me thrive in my career.  I also thank Dr. Adam Frost for his scientific insight in
xii 
my project.  Furthermore, it would not have been possible to complete my dissertation 
without all of the successful collaborations with fantastic scientists in our field.  Dr. Noah 
Dephore in Dr. Steven Gygi’s laboratory and Dr. George Umanah in Dr. Ted Dawson’s 
laboratory have put tremendous effort into making my projects better.  I thank them for 
their time and effort. 
I also want to show my appreciation to all my past and current lab members: Jin-Mi 
Heo, Caleb Cardon, Thomas Orsake, Addie Walkup, Eric Taylor, Aline Tonhato, Eric 
Fredrickson, Sarah Fogarty, Amy Hawkins, Chintan Kikani, Jason Nielson, Kristofor 
Olson, John Schell, Wojciech Swiatek, Cameron Waller, Peng Wei, Sarah Nowinski, 
Jonathan Van Vranken, Xiaoying Wu.  A collaborative and cheerful lab environment is 
established by all of them.  I also thank many colleagues across the campus for their 
scientific communication and technical support, especially, Oleh Khalimonchuk, Un Na, 
Sajjan Koirala, Qian Guo, Tammy Nguyen, Huyen Bui, Warren Voth and others.  
Without family, I would not have been able to accomplish this most important task 
in my career.  I am extremely fortunate to be the daughter-of-my-father, Shih-Pao Chen, 
and my mother, A-Mei Kao.  Neither of them received higher education but they have 
always encouraged and supported me to pursue my goals.  Their never-give up attitude 
towards life has shaped me into what I am today.  To me, they are the best parents and 
best mentors.  I also thank my four sisters and the little brother who gave me a perfect 
childhood that established my outgoing personality and ability to work with different 
people.  Most importantly, I want to thank my dearest husband for his love, support and 
understanding.  It was both of our dreams to obtain doctorate degrees and we have now 
xiii 
both accomplished this goal.  During this process, we understood and embraced each 
other.     
Finally, as a foreign student who does not have many family members here, 
friends have served as family to me.  I want to express my appreciation to many friends 
who have supported me outside my scientific life; particularly, Lisha Niu, Ya-Chi Yang, 




































Mitochondria and human diseases 
Mitochondria have two membranes, the outer mitochondrial membrane (OMM) and 
the inner mitochondrial membrane (IMM).  The dual membranes divide this organelle 
into two distinct compartments, the matrix and the inter-membrane space (IMS) (Ernster 
and Schatz, 1981; Frey and Mannella, 2000).  The OMM hosts aqueous channels that are 
made by porin, a highly abundant transporter and by the protein import machinery.  The 
porin channels allow molecules that are smaller than 5 kilodaltons to diffuse freely across 
the OMM.  Thus, the microenvironment of the IMS is thought to be quite similar to the 
cytosol.  In contrast, the IMM is highly specialized, containing a unique lipid molecule, 
cardiolipin, that prevents ions from moving across its interface.  Ions and metabolites 
must therefore be selectively transported across this membrane, in and out of matrix, by 
specific transporters.  Among many reactions that occur in the matrix, is the well-known 
citric acid cycle (also know as tricarboxylic acid cycle, TCA cycle or Krebs cycle).  The 
TCA cycle accounts for oxidation of a large proportion of the carbon compounds in the 
cell.  The electrons produced from these oxidative reactions are passed to the electron 
transport chain (ETC) in the IMM and are eventually used to generate adenosine 
triphosphate (ATP), the energy currency of life.  Hence, mitochondria are commonly 
referred to as “the power house” of the cell.  In addition to catabolism and ATP 
production, mitochondria are also known to participate in diverse cellular processes 
including synthesis of metabolites, redox balance, cell signaling, inflammatory responses 
and cell death.   
Probably due to the multifaceted function of the mitochondria, mitochondrial 
dysfunction has been linked to the pathogenesis of many human diseases, including 
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common metabolic diseases such as diabetes and obesity (Abdul-Ghani and DeFronzo, 
2008).  Because most cellular ATP is produced in mitochondria, high energy-demanding 
tissues or organs such as the heart and muscle are particularly susceptible to 
mitochondrial damage.  Therefore, many forms of muscular or cardiovascular disease are 
associated with the impairment of this organelle; specifically myopathy, ischaemic heart 
disease, cardiomyopathy and atherosclerotic vascular disease (Dominic et al., 2014).  The 
redox capacity of mitochondria also determines the cellular level of reactive oxygen 
species (ROS), which directly impacts the lifespan and aging process of organisms (Dai 
et al., 2014).  It is becoming obvious that mitochondrial dysfunction is an important 
contributor to many forms of neurodegenerative disease, such as Parkinson's disease, 
Huntington's disease, Alzheimer's disease, Amyotrophic lateral sclerosis, Friedreich's 
ataxia and Charcot-Marie-Tooth disease (Chaturvedi and Flint Beal, 2013; Witte et al., 
2014).  Although there have been an increasing number of human diseases that are 
directly or indirectly linked to impaired mitochondria, their underlying molecular 
mechanisms await discovery.  Future work is needed to uncover the molecular 
mechanisms that underly these human diseases, which will enable the development of 
novel therapeutics.  
 
Rationale for studying uncharacterized mitochondrial proteins 
The mitochondria proteome is contributed by two separate genomes, the 
mitochondrial and nuclear genoms.  Mitochondrial DNA (mtDNA) exists in multiple and 
circular copies in the mitochondrial matrix.  Human mtDNA encodes ribosomal RNAs, 
transfer RNAs and only 13 proteins.  The nuclear genome encodes the majority of 
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mitochondrial proteins, which must be transported and imported into mitochondria via 
designated import machinery.  While much is understood about the mitochondrion and its 
functions, much is still unknown and awaits discovery.  Recent advances in organelle 
separation, mass spectrometry and bioinformatic analysis have enabled more precise 
definition of the mitochondrial proteome of different organisms (Elstner et al., 2009; 
Meisinger et al., 2008; Pagliarini et al., 2008; Prokisch et al., 2004; Reinders et al., 2006; 
Schmidt et al., 2010; Sickmann et al., 2003; Wiederhold et al., 2010).  The most 
comprehensive proteomic analyses have identified approximately 850 mitochondrial 
proteins in Saccharomyces cerevisiae (baker’s yeast) and nearly 1100 mitochodnrial 
proteins in mouse.  Remarkably, more than 20% of mitochondrial proteins remain 
uncharacterized, including many that are highly conserved across the eukaryotic 
kingdom.  Their evolutionary conservation implies that these proteins play fundamentally 
important roles in mitochondrial function, and perhaps may be associated with human 
diseases (Bricker et al., 2012; Chen et al., 2011; Chen et al., 2012; Chen et al., 2014; Hao 
et al., 2009; Heo et al., 2010). 
After carefully examining the yeast and human mitochondrial proteomes, we 
identified 29 conserved protein families that are uncharacterized in both yeast and 
humans.  We undertook a systematic and multitiered approach to study these proteins. 
Initially, we use yeast as a model system to categorize these proteins based on their loss-
of-function phenotypes and sub-mitochondrial localization.  Based upon the initial 
results, we select proteins of interest for in-depth biochemical and genetic studies using S. 
cerevisiae, which is a powerful model organism for molecular biochemistry and genetics.  
Finally, we pursue the function of the homolog in higher eukaryotes such as cultured 
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mammalian cells or mouse models.  We have employed this scheme successfully to 
characterize proteins that perform conserved functions in different aspects of 
mitochondrial biology (Bricker et al., 2012; Chen et al., 2011; Chen et al., 2012; Chen et 
al., 2014; Hao et al., 2009; Heo et al., 2010).  In this dissertation, I will describe how we 
have discovered the functions of two conserved mitochondrial proteins, Yml030 and 
Ygr028, in both yeast and mammalian cells.  
 
YML030W 
 Yml030 (Aim31), which we renamed respiratory supercomplex factor 1 or Rcf1 
is encoded by YML030W on yeast chromosome XIII.  Rcf1 is a 159-amino acid 
polypeptide that has two predicted transmembrane domains (TMD), spanning amino 
acids 32-54 and 64-85.  HIG1 domain family members 2A and 1A (HIG2A and HIG1A) 
share sequence homology with Rcf1 and also have unknown mitochondrial functions.  
Our initial characterization showed that deletion of YML030W impairs growth of yeast 
cultivated on nonfermentable carbon sources. 
 
YGR028W 
 Ygr028 (Yta4 or mitochondrial sorting of proteins, Msp1) is encoded by 
YGR028W on yeast chromosome VII.  It is a 362-amino acid polypeptide that contains a 
predicted TMD at the N-terminus and a conserved AAA+ domain (ATPase associated 
with various cellular activities) at the C-terminus.  Msp1 was initially characterized as a 
protein that might participate in protein sorting into mitochondria based on a questionable 
assay (Nakai et al., 1993).  The mammalian homologue of Msp1, ATAD1 (AAA domain 
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containing 1) was previously reported to play a role in recycling the AMPAR receptor 
from the plasma membrane (Zhang et al., 2011).  No other mitochondrial functions have 
been reported prior to my study.  
  
Mitochondrial electron transport chain (ETC) 
The majority of cellular ATP is produced in the mitochondria through oxidative 
phosphorylation (Saraste, 1999).  Mitochondria use amino acids, carbohydrates and fatty 
acids as fuels that are then converted into acetyl CoA.  Through oxidation of the acetyl 
group in acetyl CoA via the TCA cycle in the matrix, the electrons are transferred to and 
carried by NADH and FADH2.  These high-energy electrons are then transferred to the 
ETC in the mitochondrial inner membrane.  As the electrons move between the ETC 
complexes, energy is captured as an electrochemical proton gradient across the IMM, 
which then drives ATP synthesis by ATP synthase, as illustrated in Figure 1.1. 
The ETC is composed of four membrane bound protein complexes (Complex I-IV).  
Complex I (also known as the NADH dehydrogenase complex or NADH-Q 
oxidoreductase) is the largest complex in the ETC (~1 megadaltons).  It is present in the 
majority of eukaryotic organisms, but is absent in S. cerevisiae.  It contains more than 
forty protein subunits, a flavin and eight to nine iron-sulfur (Fe-S) clusters.  Two 
electrons are released from NADH and passed through the flavin and Fe-S clusters to 
reduce ubiquinone (Q).  In parallel, Complex I translocates four protons from the matrix 
to the IMS to establish a proton gradient across the IMM (Brandt, 2006).       
Complex II (also known as succinate dehydrogenase or succinate-coenzyme Q 











Figure 1-1. The electron transport chain   
Electrons derived from NADH and FADH2 are transferred through Complex I and 
Complex II, respectively, to reduce quinone (Q).  Electrons transported via Complex 
III, cytochrome c (Cyt c) and Complex VI are accepted by O2 molecules to form 
water.  The proton gradient established in the intermembrane space is then utilized by 
Complex V to convert ADP into ATP.  	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contains four proteins subunits (SDHA, SDHB, SDHC, SDHD), a covalently bound 
flavin adenine dinucleotide (FAD) cofactor, and three iron-sulfur (Fe-S) clusters.  In the 
TCA cycle, it catalyzes the oxidation of succinate to fumarate and the electrons released 
are transferred through FAD and iron-sulfur clusters to reduce Q.  Mutations affecting all 
the subunits of Complex II are associated with an array of human diseases including 
cancer and neurologic disease (Hoekstra and Bayley, 2013). 
Complex III (also known as cytochrome b-c1 complex or coenzyme Q: cytochrome c 
oxidoreductase) is composed of eleven protein subunits and it exists as a stable dimer in 
the IMM.  Three subunits that have prosthetic groups and participate in electron transfer 
are CYTB, CYTC and Rieske iron-sulfur protein (RIP1).  There are two core proteins, 
CORE1 (or Qcr1 in yeast) and CORE2 (or Qcr2 in yeast) and six accessory proteins that 
maintain the stability and fine-tune the activity of this complex.  The complex catalyzes 
the oxidation of Q and transfers electrons though hemes and the iron-sulfur cluster, 
eventually reducing cytochrome c, a small heme protein that is peripherally attached to 
the IMM.  Concomitantly, Complex III translocates four protons across the IMM to the 
IMS (Berry et al., 2000).   
Complex IV (also known as the cytochrome c oxidase complex) is the terminal 
protein complex of the ETC.  It is composed of fourteen protein subunits, two hemes and 
two copper centers.  COX1 and COX2 are the active subunits and contain all of the metal 
prosthetic sites.  Four electrons are transferred from cytochrome c sequentially and 
passed through heme and copper centers, ultimately reducing one oxygen molecule to 
two water molecules.  Complex IV concomitantly exports four protons across the IMM to 
the IMS (Tsukihara et al., 1996). 
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The electrochemical proton gradient across the IMM that is established by Complexes 
I, II III and IV of the ETC, drives ATP synthesis by ATP synthase (also known as 
Complex V).  It is a multi-subunit protein complex residing in the IMM that acts by 
rotary catalysis.  The enzymatic portion (F1 sector) of the complex protrudes into the 
matrix side and is anchored to the membrane by a “rotor,” which comprises a ring of 
transmembrane proteins (F0 sector).  Protons turn the rotor as they flow down their 
electrochemical gradient through the hydrophilic channel of ATP synthase, while the F1 
sector phosphorylates ADP to generate ATP (Boyer, 1997).         
   
Supra-molecular organization of the ETC 
The random collision model, which suggests that ETC complexes are randomly 
dispersed on the mitochondrial inner membrane, was long the prevailing model. In this 
model, electrons are transported via random collision of two mobile electron carriers, 
ubiquinone and cytochrome c, that diffuse laterally on the inner membrane (Hackenbrock 
et al., 1986).  However, this idea has been challenged in the past decade by another model 
by which the ETC complexes associate into massive supercomplexes through which 
electrons can be transported via direct channeling (Cruciat et al., 2000; Schagger and 
Pfeiffer, 2000, 2001).  
 Biochemical and structural evidence now supports the model that ETC complexes 
are physically associated into a huge energy-converting machine, called the respiratory 
supercomplex or respirasome.  The concept of this superstructure was proposed more 
than fifty years ago, but only in recent decades, multiple laboratories started to revisit this 
old idea by utilizing Blue-Native gel electrophoresis (Blue-Native PAGE).  The 
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association of the ETC subunits into supercomplexes has been observed using Blue-
Native PAGE to analyze multiple in species, including mitochondria from yeast, mouse 
or human cultured cells, rodent tissue, bovine heart and plant mitochondria.  These 
studies typically employed the mild nonionic detergent, digitonin to avoid disassociating 
the complexes (Dudkina et al., 2006; Juszczuk and Rychter, 2009; Krause et al., 2004a; 
Krause et al., 2004b; Reifschneider et al., 2006; Schagger, 2002; Schagger et al., 2004; 
Schagger and Pfeiffer, 2000).  There has been a concern, however, that respiratory 
supercomplexes revealed on Blue-Native PAGE might reflect artifacts caused by the use 
of digitonin.  However, the same higher-order complexes have been using other 
detergents such as TritonX-100, NP-40 and Tween-20 (Acin-Perez et al., 2008).  
Cytochrome c and ubiquinone are also present in these respiratory supercomplexes, 
which further supports the idea that they can exist as functional electron transporting 
units (Acin-Perez et al., 2008).  It appears that respiratory supercomplexes are ancient, as 
respirasome-like structures have also been reported in bacteria (Stroh et al., 2004).   
The structure of the yeast and mammalian mitochondria respiratory superomplex has 
been visualized by electron microscopy (Althoff et al., 2011; Dudkina et al., 2005; 
Dudkina et al., 2011; Heinemeyer et al., 2007; Mileykovskaya et al., 2012; Schafer et al., 
2007).  Kinetic data from flux control analyses suggest that either Complex I-III or 
Complex I-III-IV function together as a single enzyme to control nicotinamide adenine 
dinucleotide (NADH) oxidation in bovine heart and potato tuber mitochondria (Fato et 
al., 1993; Genova et al., 2008).  Furthermore, in vitro isolated respiratory supercomplexes 
are fully active in transferring electrons from NADH to molecular oxygen, suggesting 
that respiratory supercomplexes exist as functional entities (Acin-Perez et al., 2008).      
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S. cerevisiae does not possess Complex I, and the yeast respiratory supercomplex is 
therefore composed of a dimeric Complex III and one or two copies of Complex IV 
(III2VI2 or III2IV) (Heinemeyer et al., 2007).   Fractions of Complex III exist as free 
dimers and Complex IV as monomers.  The partitioning of these two species between 
free and respiratory supercomplexes changes under different growth conditions.  
Complex II usually exists in the free form in yeast, and it is controversial whether it is 
ever a component of the respiratory supercomplex in mammals.  Complex V can homo-
oligomerize to form dimers, but can also present as monomers in both yeast and 
mammalian cells (Arnold et al., 1998; Schagger and Pfeiffer, 2000).  In mammals, the 
composition of the respiratory supercomplex is more complicated due to the presence of 
Complex I.  Most Complex I and III subunits are associated with other complexes to form 
distinct forms of supercomplexes. Once again, different mammalian supercomplex 
assembly appears to be quite dynamic, and respond to the mitochondrial 
microenvironment (e.g., lipid composition and mitochondrial membrane potential) 
(Genova and Lenaz, 2014; Porras and Bai, 2015).  It is unclear, however, how cells adjust 
the compositions of different forms of respiratory supercomplexes.  Prior to my work, the 
only molecules that had been shown to be important for the assembly or stability of 
respiratory supercomplexes were the lipid cardiolipin and the ADP/ATP translocase 
Aac2.  Loss of either of these molecules was found to destabilize supercomplexes in 
yeast (Dienhart and Stuart, 2008; Zhang et al., 2002). 
Functional arguments can help to explain why cells form respiratory supercomplexes.  
First, they provide additional stability to each of the individual complexes. Second, the 
close association of ETC complexes shortens the distance that electrons must travel 
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between complexes. Reactive intermediates are therefore more effectively sequestered 
and the generation of reactive oxygen species is minimized.  In both mice and humans, 
mutation in one complex impairs of the stability and activity of other complexes, 
indicating the interdependency of the ETC complexes, most likely by disrupting direct 
physical associations (Acin-Perez et al., 2004; Diaz et al., 2006; Gil Borlado et al., 2010; 
Vempati et al., 2009).  Moreover, there is also evidence suggesting that dissociation of 
the respiratory supercomplex elevates mitochondrial oxidative stress (Ghelli et al., 2013; 
Lenaz et al., 2010; Maranzana et al., 2013).  This finding places the respiratory 
supercomplex at the heart of the aging process and the pathogenesis of chronic diseases.  
 
Mitochondrial protein quality control 
Mitochondria play critical roles in the determination of cell survival and cell death, 
and damage to this organelle is associated with many human diseases.  This critical 
importance requires cells to employ a multitiered and interconnected quality control (QC) 
system to maintain mitochondrial integrity (Rugarli and Langer, 2012). 
The first line of defense consists of intramitochondrial chaperones and proteases that 
promote the folding of newly imported proteins and enable the degradation of misfolded 
or damaged proteins.  Heat-shock protein 60 and 70 (Hsp60 and Hsp70) are matrix- 
localized chaperons that help the import, fold and assembly of mitochondrial proteins 
(Cheng et al., 1989; Kang et al., 1990; Pellegrino et al., 2013).  Two inner membrane-
associated AAA+ proteases, m-AAA and i-AAA, catalyze the degradation of misfolded 
and damaged proteins in the matrix and intermembrane space compartments, respectively 
(Gerdes et al., 2012; Janska et al., 2013).  Lon and ClpXP are two additional soluble 
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AAA+ proteases that patrol the matrix to maintain protein quality (Truscott et al., 2011; 
Venkatesh et al., 2012).  All of these proteins have AAA+ domains which, in most cases, 
oligomerize to form central channels that unfold protein substrates using the energy 
derived from ATP hydrolysis (Gerdes et al., 2012; Hanson and Whiteheart, 2005).  The 
unfolded polypeptides are subsequently degraded by an associated proteolytic domain 
(Sauer and Baker, 2011).  Cells employ an analogous QC system on the mitochondrial 
outer membrane, which enables the extraction and proteasomal degradation of proteins 
exposed to the cytosol (Taylor and Rutter, 2011).  This system also appears to utilize a 
AAA+ ATPase, Cdc48 in yeast or p97 in mammals, to extract proteins prior to 
proteasome engagement (Heo et al., 2010; Tanaka et al., 2010; Xu et al., 2011).  
Furthermore, the capacity of mitochondrial QC systems can be modulated by a 
specialized transcriptional program, known as the mitochondrial unfolded protein 
response (mtUPR).  Upon mitochondrial stress, the mtUPR can induce transcription of 
mitochondrial proteases and chaperones to fulfill the cellular demands for these activities 
(Haynes and Ron, 2010; Nargund et al., 2012; Zhao et al., 2002).  
When mitochondria depolarize, cells initiate the autophagic degradation of 
mitochondria (mitophagy) as a second line of defense (Ashrafi and Schwarz, 2013; Youle 
and Narendra, 2011).  Mitophagy is a selective process that removes and degrades 
damaged mitochondria.  PTEN-induced kinase (PINK1) and Parkin are key regulators of 
mitophagy in mammalian cells.  PINK1 is a mitochondrial serine/threonine kinase and it 
acts upstream of Parkin, which is a cytoplasmic E3 ubiquitin ligase.  Under normal 
conditions, PINK1 is imported into mitochondria in a membrane potential (ΔΨ)- 
dependent manner and instantly degraded by the PARL protease (Jin et al., 2010).  
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However, when mitochondrial ΔΨ is dissipated, PINK1 import is stalled and PINK1 is 
retained on the outer membrane.  PINK1 then recruits Parkin and phosphorylates it to 
activate Parkin ubiquitin ligase activity (Lazarou et al., 2012; Lazarou et al., 2013).  
Ubiquitination of mitochondrial OMM proteins initiates the autophagic removal of 
defective mitochondria (Sarraf et al., 2013).  Parkin and PINK were recently shown to 
participate in a noncanonical form of mitophagy via a vesicular trafficking pathway that 
degrades mitochondria subjected to oxidative stress (McLelland et al., 2014). 
Mitochondria are very dynamic organelles, which undergo constant fission and fusion.  It 
is clear that both fusion and fission are critical for sequestering damaged mitochondria 
prior to engagement with lysosomes (Twig et al., 2008).  In animals, neurons seem to be 
particularly sensitive to the presence of damaged mitochondria and to defects in the 
mitochondrial QC system.  Mutations in PINK1 and Parkin cause familial Parkinson’s 
disease (Kitada et al., 1998; Valente et al., 2004).  Beyond that, an increasing number of 
neurodegenerative diseases, including spastic paraplegia, spinocerebellar ataxia, 
Alzheimer’s disease and peripheral neurophathies, are linked to defective mitochondrial 
quality control systems (Rugarli and Langer, 2012).   
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The complexes of the electron transport chain asso-
ciate into large macromolecular assemblies, which
are believed to facilitate efficient electron flow. We
have identified a conserved mitochondrial protein,
named respiratory supercomplex factor 1 (Rcf1—
Yml030w), that is required for the normal assembly
of respiratory supercomplexes. We demonstrate
that Rcf1 stably and independently associates with
both Complex III and Complex IV of the electron
transport chain. Deletion of the RCF1 gene caused
impaired respiration, probably as a result of destabi-
lization of respiratory supercomplexes. Consistent
with the hypothetical function of these respiratory
assemblies, loss ofRCF1 caused elevatedmitochon-
drial oxidative stress and damage. Finally, we show
that knockdown of HIG2A, a mammalian homolog
of RCF1, causes impaired supercomplex formation.
We suggest that Rcf1 is a member of an evolution-
arily conserved protein family that acts to promote
respiratory supercomplex assembly and activity.
INTRODUCTION
Mitochondria are unique and complex organelles that perform
essential functions in many aspects of cell biology. It is not
surprising, therefore, that mitochondrial dysfunction is associ-
ated with many forms of human disease. This includes relatively
common disorders, such as cancer (Kroemer and Pouyssegur,
2008), diabetes (Patti and Corvera, 2010), and neurodegenera-
tive disease (Lessing and Bonini, 2009). Beyond these common
disorders, which are all age-related, mitochondrial dysfunction
has been associated with the aging process itself. Manipulation
of mitochondrial function, including by modulation of mitochon-
drial oxidative stress andmitochondrial DNA (mtDNA) mutability,
has striking effects on longevity (Schriner et al., 2005; Trifunovic
et al., 2004).
The intimate connection between oxidative stress, mitochon-
drial dysfunction, and age-related disorders is thought to derive
from the physical proximity of the electron transport chain (ETC)
and the mtDNA. The ETC is the major source of reactive oxygen
species (ROS) in most cells. This ROS load is then in immediate
proximity to the mtDNA, which is highly sensitive to mutagenic
insult. Mutated mtDNA is then postulated to be a causal factor
in further ETC dysfunction, leading to a vicious cycle of ROS
production (Wallace, 2005). The challenge for the ETC is to
conduct reactive electrons via soluble carriers, through three
distinct multiprotein complexes, to oxygen. When this conduc-
tion process is disturbed, the risk of ROS production increases.
Because this oxidative stress/ETC/aging axis is of such rele-
vance to human disease, it is of great importance to understand
the mechanisms that have evolved to prevent inappropriate
ROS production. One biochemical phenomenon that has been
postulated to control ETC malfunction and prevent mitochon-
drial ROS production is the assembly of the individual ETC
complexes into massive conduction machines called respiratory
supercomplexes (Cruciat et al., 2000; Lenaz and Genova, 2009).
The clear importance of mitochondria has led to extensive
efforts to define the mitochondrial proteome in many species.
The best current inventory of mammalian mitochondrial-resident
proteins consists of 1,098 proteins (Pagliarini et al., 2008).
Surprisingly, nearly 300 of these proteins are largely or com-
pletely unstudied (Pagliarini et al., 2008). Included among this
number are many that are conserved throughout the eukaryotic
kingdom. Such conservation implies that they perform a function
that is of fundamental importance for cell viability. As a result, we
initiated a project to identify the functions of a subset of these
highly and evolutionarily conserved but uncharacterized mito-
chondrial proteins. We previously described the function of
SDH5/SDHAF2, which is required for assembly of ETC Complex
II and is mutated in multiple families afflicted with the paragan-
glioma tumor syndrome (Bayley et al., 2010; Hao et al., 2009).
We also described Vms1, which plays an important role in
stress-responsive recruitment of the ubiquitin-proteasome
machinery to mitochondria for protein degradation (Heo et al.,
2010).
Herein, we describe the function of Rcf1, which we show is
a stable component of ETC supercomplexes and is required
for their normal stability. In Saccharomyces cerevisiae, ETC
supercomplexes are assemblies in the mitochondrial inner
membrane that contain, among other proteins, both cytochrome
bc1 complex (Complex III) and cytochrome c oxidase complex
(Complex IV) and perhaps Complex II as well (Stuart, 2008).
In mammals, supercomplexes often also contain Complex I




(Acı´n-Pe´rez et al., 2008; Wittig and Scha¨gger, 2009). These huge
macromolecular assemblies are believed to enable more effi-
cient electron flow between complexes and to promote complex
stability (Suthammarak et al., 2010). This efficiency is believed to
reduce electron loss from ETC and ROS generation (Genova
et al., 2008). Not surprisingly, we show that the rcf1D mutant,
which exhibits decreased supercomplex assembly, has
increased mitochondrial oxidative damage. We also show that
knockdown of HIG2A, one of the mammalian orthologs of
RCF1, impairs supercomplex assembly in mouse cells. We,
therefore, speculate that the RCF1 gene family plays an evolu-
tionarily conserved role in maintaining mitochondrial function
through the optimal assembly of electron transport chain
Figure 1. Rcf1 Is a Mitochondrial Inner
Membrane Protein Important for Respira-
tion
(A) The rcf1D mutant expressing Rcf1-GFP and
MtRFP grown to log phase in SD medium was
imaged by fluorescence microscopy.
(B) Intact mitochondria, hypotonic-swollen mito-
plasts, and Triton X-100–solubilized mitochondria
of a strain expressing Rcf1-His6/HA3 were treated
either with (+) or without (!) Proteinase K and
analyzed by immunoblot with the whole-cell lysate
(WCL) and postmitochondrial supernatant
(PMS). Cox2, Mge1, Cyb2, and Fzo1 are inner
membrane, matrix, intermembrane space, and
outer membrane proteins, respectively.
(C) Soluble (S) and pellet (P) fractions from alkali
and high-salt extracted mitochondria expressing
Rcf1-His6/HA3 were analyzed by immunoblot.
Cyb2 is a soluble intermembrane space protein;
Cox4 is an inner membrane-associated protein;
Cox2 is an integral inner membrane protein; and
Por1 is an integral outer membrane protein.
(D) Five-fold serial dilutions of the indicated strains
harboring an empty vector (EV) or a plasmid ex-
pressing Rcf1-His6/HA3 were spotted on plates
and incubated at 30"C and 37"C.
(E) WT and rcf1D mutant strains of the BY4741
background were grown in glucose, lactate, or
glycerol to log phase and the rate of oxygen con-
sumption was measured. Data shown is repre-
sentative of three independent experiments and
mean + SD is shown. *p < 0.05; **p < 0.01.
See also Figure S1.
complexes. Thereby, it might be a
component of the cellular system to
delay ROS-induced and age-associated
degeneration.
RESULTS
Rcf1 Is an Integral Mitochondrial
Inner Membrane Protein Required
for Normal Respiration
Using the yeast S. cerevisiae as the
primary model system, we first verified
mitochondrial localization of the Rcf1
(Yml030w/Aim31) protein using two
complementary methods. First, we generated a strain express-
ing an Rcf1-GFP fusion protein from the native promoter, which
is fully functional as assessed by suppression of the rcf1D
phenotype (data not shown). This strain was cotransformed
with a plasmid expressing a mitochondria-targeted red fluores-
cent protein (MtRFP). As seen in Figure 1A, we observed
complete overlap between the mitochondrial RFP signal and
the Rcf1-GFP signal. Under no conditions did we find extramito-
chondrial GFP fluorescence.
In parallel, we also biochemically examined the localization of
an Rcf1 fusion protein with a dual His6/HA3-tag at its C terminus.
This fusion protein, which is expressed from the native promoter,
was also demonstrated to be fully functional (see Figure 1D).
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Upon biochemical fractionation, Rcf1- His6/HA3 was detected in
the whole-cell lysate, but was essentially absent from the post-
mitochondrial supernatant (Figure 1B). The purifiedmitochondria
fraction was subjected to either proteinase K digestion with or
without swelling to rupture the outer membrane (mitoplasts) or
with Triton X-100 to rupture all membranes. Rcf1 was partially
degraded in mitoplasts and was completely degraded upon
Triton X-100 treatment. This pattern is similar to that observed
for Cox2, which is an integral protein of the mitochondrial inner
membrane (Figure 1B). Independently, we found that this same
Rcf1 fusion protein was stably associated with mitochondrial
membranes even following high salt and bicarbonate extraction
(Figure 1C). This is consistent with the bioinformatic prediction
that Rcf1 and its relatives have two transmembrane domains
and are therefore likely to be integral membrane proteins (Fig-
ure S1A available online). Taken together, these results suggest
that Rcf1 is an integral protein of the mitochondrial inner
membrane, as was found for one of the mammalian orthologs
of RCF1 (Wang et al., 2006).
To begin to understand the role of Rcf1 in mitochondrial func-
tion, we generated an rcf1D mutant and subjected it to growth
assays in comparison to a wild-type (WT) strain. The rcf1D
Figure 2. Rcf1 Physically Interacts with Respira-
tory Complex III and IV
(A) Mitochondria from an EV-containing WT strain or an
rcf1D mutant strain expressing Rcf1-His6/HA3 were sub-
jected to two-step purification. The final eluate was
analyzed by silver staining. Discrete bands were excised
and the protein identity was determined by mass spec-
trometry as indicated in the text.
(B) Digitonin-solubilized mitochondria extracted from
yeast strains either expressing Rcf1-His6/HA3 (+) or not (!)
were immunoprecipitated using anti-HA antibody. One
percent of the mitochondrial lysate and the final eluate
were immunoblotted using anti-Cor1&Qcr2, Cyt1, Cox1,
Cox2, Cox3, Cox4, and HA antibodies. * indicates IgG light
chain.
(C) Rcf1-His6/HA3 was purified from digitonin and DDM-
solubilized mitochondria, respectively. The final eluate
was visualized by silver stain, and protein identities were
determined by mass spectrometry. Cox3 is indicated
based on SDS-PAGE/western blot because it was not
detected by mass spectrometry.
(D) Mitochondria extracted from a strain harboring
a plasmid expressing Rcf1 or Rcf1-His6/HA3 were solu-
bilized by digitonin or DDM and subjected to BN-PAGE/
western blot. Rcf1, Complex III, and Complex IV were
immunoblotted by anti-HA, Cor1&Qcr 2, and Cox2 anti-
bodies, respectively.
mutant exhibited impaired growth on all nonfer-
mentable carbon sources tested, including
acetate (Figure 1D). This phenotype was exac-
erbated when the experiment was conducted
at 37"C (Figure 1D, bottom), consistent with a
destabilization of proteins or protein complexes
in the rcf1D mutant. This slow-growth pheno-
type on nonfermentable carbon sources is
consistent with a partial failure in respiration in
the rcf1Dmutant. To directly assess respiration,
we measured oxygen consumption in the WT and rcf1D mutant
strains. The rcf1D mutant had roughly 30% of WT oxygen
consumption on glucose medium and substantial respiratory
defects on lactate and glycerol medium (Figures 1E and S1B).
Together, these results demonstrate that Rcf1 is an integral
protein of the mitochondrial inner membrane that is required
for normal respiratory activity.
Rcf1 Stably Associates with Complex III and Complex IV
of the Electron Transport Chain
To determine the biochemical mechanism that underlies the
role of Rcf1 in mitochondrial respiration, we identified proteins
associated with Rcf1-His6/HA3 expressed at endogenous levels.
After two-step purification, we observed at least nine discrete
bands, which were absent in the empty vector negative control,
in the sample from the Rcf1-His6/HA3 strain (Figure 2A). These
bands primarily contained subunits of either Complex III or
Complex IV from the electron transport chain (Figure 2A and
Table S1). We also observed the ATP/ADP carrier, Aac2, which
was previously shown to associate with electron transport chain
complexes (Dienhart and Stuart, 2008). Bands containing Dld1,
Sdh1, and Jid1 were also observed. Copurification of multiple
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components of both Complex III and Complex IV with Rcf1 was
confirmed using immunoprecipitation of the Rcf1-His6/HA3
fusion protein (Figure 2B). Note that we observed a clear interac-
tion with Cox3. Perhaps due to its sequence and chemical
properties, Cox3 was not detected by mass spectrometry of
the Rcf1 eluate (Table S1).
It is well known that Complex III and Complex IV physically
associate with one another, forming respiratory supercomplexes
(Scha¨gger and Pfeiffer, 2000; Wittig and Scha¨gger, 2009).
Therefore, it was not surprising that those two complexes
simultaneously copurify with Rcf1. To further explore the interre-
lationships between Rcf1, Complex III, and Complex IV, we
repeated the Rcf1-His6/HA3 purification experiment using both
digitonin-solubilized and dodecylmaltoside (DDM)-solubilized
mitochondria. Although we again observed the same set of
Complex III and Complex IV subunits in the digitonin sample,
the Complex III subunits did not copurify with Rcf1-His6/HA3 in
the DDM-solubilized sample (Figure 2C). Digitonin has been
shown to be mild enough to maintain Complex III/Complex IV
associations in III2/IV and III2/IV2 supercomplexes, whereas
Figure 3. Rcf1 Interacts with Complex III and
Complex IV Independently
(A) Rcf1 was immunoprecipitated using anti-HA anti-
bodies from the digitonin-solubilized mitochondria of the
indicated strains harboring either with (+) or without (!)
a plasmid expressing Rcf1-His6/HA3. Both 1% crude
lysate and final eluate were immunoblotted using anti-
Cor1&Qcr2, Cyt1, Cox1, Cox2, Cox3, Cox4, HA, and Por1
antibodies, respectively. Asterisk on the anti-Por1 blot
indicates the Cox2 signal from a previous exposure;
arrowhead on the anti-Cox3 blot indicates IgG light chain.
(B) Mitochondria from the indicated strains were analyzed
as in (A).
See also Figure S2.
DDM disrupts these interactions. This pattern
of associations in the two detergents was
confirmed by mass spectrometry of the entire
eluate from the purifications. All complex IV
subunits were observed in both digitonin and
DDM, but Complex III subunits were associated
only with Rcf1 in digitonin (Table S1). This
implies that the interaction of Rcf1 with
Complex IV is likely to be more stable than the
interaction with Complex III. Interestingly,
Complex II subunits also were detected in
the Rcf1 eluate, albeit at apparently lower
stoichiometry (Table S1). These observations
were also confirmed using blue native-PAGE
(BN-PAGE) electrophoresis. In DDM-solubilized
mitochondrial lysates, Rcf1-His6/HA3 migrated
in a complex of similar mobility to monomeric
Complex IV, as exemplified by Cox2 (Figure 2D,
lane 3). In digitonin, however, Rcf1-His6/HA3
primarily migrated at the position of the III2/ IV2
heterotetrameric supercomplex (Figure 2D,
lane 4). These data indicate that Rcf1 maintains
strong association with Complex IV in either
detergent condition but loses the association with Complex III
in DDM.
This pattern of associations between Rcf1 and the ETC com-
plexes suggested two possibilities. One possible interpretation
is that Rcf1 associates directly with Complex IV and the
copurification with Complex III is indirect, occurring via the
Complex III/Complex IV interaction. The other possibility is that
Rcf1 interacts with both complexes independently, perhaps
even serving as a contact point between the two complexes.
To systematically address this question, we monitored the
association between Rcf1 and Complex III subunits (Cor1,
Qcr2, and Cyt1) and between Rcf1 and Complex IV subunits
(Cox1, Cox2, Cox3, and Cox4) in mutants that lead to the
loss of either Complex III or Complex IV (Figure 3A). The
copurification of Complex IV with Rcf1 in DDM conditions
was recapitulated in this assay. A qcr7D mutant causes severe
failure of Complex III assembly and Rcf1 shows no association
with Cor1 or Qcr2 in this mutant (Figures 3A, lane 11, and 3B,
lane 20), even though both Cor1 and Qcr2 are present in
the mitochondrial lysate (Figures 3A, lane 3, and 3B, lane 10).
Cell Metabolism
Respiratory Supercomplex Assembly Factor




Interestingly, deletion of QCR7 does not destroy the interaction
between Rcf1 and Cyt1, raising the possibility that Rcf1 might
be associated more closely with Cyt1 than Cor1 or Qcr2. As
expected, deletion ofCYT1 also leads to the loss of Rcf1 interac-
tion with Cor1 and Qcr2 (Figure 3A, lane 12). In both of these
mutants, however, the Rcf1 interactions with Cox1, Cox2,
Cox3, and Cox4 were maintained. For Cox1, Cox2, and Cox4,
Rcf1 interactions were compromised but remained significantly
above background. Interestingly, the Rcf1/Cox3 interaction
was not negatively affected by either the qcr7D or cyt1D muta-
tions, suggesting that it might be more proximal to the Rcf1
interaction site than Cox1, Cox2, or Cox4. These data demon-
strate that Rcf1 interacts stably with Complex IV even in the
absence of association with Complex III.
Themore interesting question, however, is whether Rcf1main-
tains an association with Complex III in the absence of Complex
IV. To address this question, we monitored association between
Rcf1 and Complex III subunits in four different mutants lacking
properly assembled Complex IV. They each lead to distinct
defects in the expression, translation, or assembly of different
Complex IV subunits. Deletion of COX11, which encodes
a Cox1 assembly factor, causes impaired synthesis of Cox1
(Barrientos et al., 2004; Horng et al., 2004). Pet494 and Mss51
are translational activators of COX3 and COX1, respectively,
and their deletion causes loss of their respective target (Cos-
tanzo and Fox, 1986; Perez-Martinez et al., 2003). Cox6 is a
Complex IV subunit that might play a role in oxygen sensing
and is indispensible for the stability and activity of Complex IV
(Wright et al., 1995). None of these mutants has intact, properly
assembled Complex IV. In all cases, however, Cor1, Qcr2, and
Cyt1 copurified with Rcf1, albeit at a reduced level compared
to the WT strain (Figure 3A, lanes 13–16). As observed earlier,
we again saw that Cox3 maintained an association with Rcf1
when other Complex IV subunits did not. In spite of this, deple-
tion of Cox3 by mutation of PET494 did not prevent the associ-
ation of Rcf1 with Complex III subunits (Figure 3A, lane 15).
Even after a stringent two-step purification, the same results
were obtained for the WT, qcr7D, and cox11D strains (Figures
S2A and S2B).
The recent publication of higher resolution structures of
respiratory supercomplexes (Althoff et al., 2011; Dudkina et al.,
2011) has provided some insight into the more intimate relation-
ship between Rcf1 and Cox3. These structures show that Cox3,
Cox7, and Cox13 comprise the majority of the interface with
Complex III. As shown above, loss of Cox3 failed to abolish the
ability of Rcf1 to coprecipitate Complex III subunits (Figure 3B,
lane 17). Additionally, neither loss of Cox7 or Cox13 abrogated
the Rcf1/Complex III interaction (Figure 3B, lanes 18 and 19).
Unlike the other Complex IV mutants, the cox13D mutant had
no deleterious effect on the Rcf1 interaction with either Complex
III subunits (Cor1, Qcr2, and Cyt1) or Complex IV subunits (Cox2
and Cox3). Therefore, even the loss of those proteins that are
likely to be most intimately associated with Rcf1 within Complex
IV doesn’t abolish the Rcf1 interactionwith Cor1, Qcr2, andCyt1.
Although it is possible that subcomplexes of Complex IV remain
in any one of these mutants and could mediate the interaction
between Rcf1 and Complex III, it is unlikely that the same sub-
complex bearing that bridging activity is found in each of these
many mutants. We therefore conclude that Rcf1 has the rather
unusual property of interacting directly with components of
Complex III and Complex IV, independent of association with
the other.
Rcf1 Promotes the Stability of Complex III/Complex IV
Supercomplexes
If Rcf1 interacts directly with both Complex III and Complex IV
and, therefore, serves as a point of contact between the two
complexes, it is possible that an rcf1D mutant might exhibit
defects in their association. BN-PAGE analysis was conducted
on theWT and rcf1Dmutant grown in raffinosemedium to induce
mitochondrial biogenesis. As assessed by a-Cor1/Qcr2 immu-
noblot, Complex III migration in the WT strain was almost
completely as the Complex III2/Complex IV2 tetramer (Figure 4A,
left). A small amount of the III2/IV complex was observed, but we
detected no free Complex III. Complex III in the rcf1D mutant,
however, showed a loss of association with Complex IV. There
was a shift from the fully assembled III2/IV2 complex toward
the III2/IV complex and some free III2 dimer was detected.
Examination of Complex IV (Cox3 immunoblot) showed a similar
loss of the III2/IV2 complex and an increase in the III2/IV complex
and free Complex IV in the rcf1D mutant (Figure 4A, middle).
A similar phenotype was observed for the rcf1D mutant in
stationary phase cultures grown in glucose (Figure S3A). Again,
we observed a shift from the fully assembled III2/IV2 complex
toward the III2/IV and III2 complexes. We detected free Complex
IV in the WT strain that was decreased in the rcf1D mutant,
raising the possibility that Complex IV might be less stable to
BN-PAGE analysis under some conditions in the absence of
Rcf1. This appears to not be general, however, because we
observed increased free Complex IV in the rcf1D mutant grown
in raffinose medium (Figure 4A). The migration of Complex V
was unaffected by loss of Rcf1 (Figure S3A). In both raffinose
and glucose cultures, these effects on supercomplex organiza-
tion occurred in the absence of any substantial effect on the
steady-state levels of Complex III or Complex IV subunits
(Figures 4B and S3B). Although the rcf1D mutant may exhibit
a defect in Complex IV assembly or stability, these data strongly
suggest that there is a specific defect in theComplex III/Complex
IV association.
Measurement of complex activity following BN-PAGE was
consistent with these results. As expected, Complex V/ATP syn-
thase exhibited normal activity in the rcf1Dmutant (Figures S3C
and S4C). Total Complex IV activity was decreased in the rcf1D
mutant, and this impairment was due primarily to a loss of activity
in the III2/IV2 complex (Figures S3C and S4C). The loss of
Complex IV activity could be due to an intrinsic defect in
Complex IV or to loss of association with Complex III, which
has been shown to result in Complex IV defects in mammalian
systems (Acı´n-Pe´rez et al., 2008; Gil Borlado et al., 2010). Quan-
titative assays confirmed these results and also showed that
Complex III activity is unaffected by deletion ofRCF1 (Figure 4C).
We also noticed a slight but reproducible defect in the activity of
Complex II in the rcf1D mutant (Figure S3C), possibly indicating
that the interactions between Rcf1 and Complex II subunits
(Table S1) have functional importance.
Rcf1 doesn’t appear to be a stoichiometric constituent of
the Complex III/Complex IV supercomplex. When we immuno-
precipitate Rcf1, we coprecipitate a smaller amount of both
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Complex III subunits (Cor1, Qcr2, and Cyt1) and Complex IV
subunits (Cox1, Cox2, Cox3, and Cox4) than when we
immunoprecipitate a typical Complex IV subunit, Cox4 (Fig-
ure S3D). Based on that and its apparent function, we
reasoned that overexpression of Rcf1 might increase the
amount of respiratory supercomplexes. As seen in Figure 4D,
expression of Rcf1 from a multicopy 2m plasmid caused
a subtle shift in the Complex IV migration pattern in cells grown
in raffinose. Free Complex IV was lost and both the III2IV and
III2IV2 complexes were increased in abundance, indicating
that increased Rcf1 dosage can promote supercomplex
formation. Although subtle, this effect is reproducible under
distinct growth conditions—stationary phase in glucose
medium (Figure S3E).
Figure 4. Respiratory Supercomplexes Are
Impaired in the Absence of RCF1
(A) Mitochondria from WT and the rcf1D mutant
grown to log phase in synthetic raffinose medium
were analyzed by BN-PAGE/western blot.
Complex III and Complex IV were immunoblotted
by anti-Cor1&Qcr2 and Cox3 antibodies, respec-
tively. Asterisk indicates the position of free
Complex IV monomer. Porin serves as a control.
(B) The mitochondria from (A) were subjected to
SDS-PAGE and immunoblotted using Cox1,
Cox2, Cox3, Cor1&Qcr2, Cyt1, Rip1, and Sdh2
antibodies. Por1 and Mge1 are loading controls.
(C) Enzymatic activities of Complex III, Complex
IV, and Complex V were measured in lysates of the
WT and rcf1D mutant grown in synthetic raffinose
media to log phase. Each was measured in three
independent cultures and data shown is mean +
SD. *p < 0.05.
(D)Mitochondria from theWT strain with or without
a 2m-based plasmid overexpressing Rcf1 grown
in raffinose medium to log phase were analyzed
by BN-PAGE/Western blot. Complex III, Complex
IV and porin complex were immunoblotted
by anti-Cor1&Qcr2, Cox3 and Por1 antibodies,
respectively.
See also Figure S3.
RCF1 Genetically Interacts with
AAC2 and COX13 to Stabilize
Respiratory Supercomplexes
Two other molecules have been shown
previously to be important for the
assembly of respiratory supercomplexes:
the lipid cardiolipin and the ADP/ATP
translocase Aac2. Loss of either of these
molecules was found to destabilize
supercomplexes (Dienhart and Stuart,
2008; Zhang et al., 2002). We wanted
to examine the genetic relationship
between RCF1, AAC2, and the gene en-
coding cardiolipin synthase CRD1, which
is required for cardiolipin synthesis.
Therefore, we constructed strains lacking
these three genes in all possible combi-
nations and examined their growth under
different conditions. The aac2D strain ex-
hibited a complete inability to grow on nonfermentable carbon
sources, making it impossible to use such medium to examine
respiratory growth (Figure S4A). As an alternative, we examined
the survival of these strains in stationary phase, which is also an
indicator of respiratory capability (Gray et al., 2004).When grown
at 30!C to log phase, all mutants exhibited normal survival
(Figure 5A, left panel). Even at day 4 of stationary phase, the
three single mutants and the crd1D rcf1D double mutant showed
no loss of viability. However, both of the other double mutants
showed a substantial defect in survival and the triple-mutant
was even more severely affected (Figure 5A, right). When grown
at 37!C, the same general pattern was evident, but the syner-
gistic growth defects were more pronounced. These data
demonstrated that loss of the RCF1 and CRD1 genes does not
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result in a synergistic or even an additive phenotype. One
possible explanation is that these two genes act in the same
pathway to promote respiration, a conclusion that is supported
by biochemical data described below. On the other hand, loss
of AAC2 causes a synergistic survival defect with both the
rcf1D and crd1D mutants, a result that is consistent with Aac2
acting in parallel with both Rcf1 and Crd1 to promote supercom-
plex assembly or stability. Both Aac2 and cardiolipin have sig-
nificant roles outside of supercomplex stabilization, which
makes it difficult to draw mechanistic conclusions from genetic
interactions.
To directly assess the assembly and stability of respiratory
supercomplexes in these mutants, we subjected the same
strains to BN-PAGE analysis after growth in raffinose. As
Figure 5. RCF1 Genetically Interacts with AAC2 and COX13 to Stabilize Respiratory Supercomplexes
(A and B) The indicated strains were grown in YPAD media to log or stationary phase as indicated were spotted on YPAD plates and incubated at 30!C
(A) or 37!C (B).
(C) Mitochondria from the indicated strains grown in raffinose medium to log phase were analyzed by BN-PAGE/western blot. Complex III, Complex IV, and porin
complex were immunoblotted by anti-Cor1&Qcr2, Cox3, and Por1 antibodies, respectively. III2* indicates a Complex III intermediate.
(D) The indicated strains were spotted on SD and SGlycerol/ethanol plates and incubated at 30!C. (E) Mitochondria from the indicated strains grown in 1%
glucose medium for 1 day were analyzed by BN-PAGE/western blot. Complex III, Complex IV, and Complex V were immunoblotted by anti-Cor1&Qcr2, Cox2,
and Atp2 antibodies, respectively. III2* indicates a Complex III intermediate.
See also Figure S4.
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observed before, the rcf1D mutant showed depletion of the
III2/IV2 complex, as determined both by Complex III and
Complex IV immunoblot (Figure 5C, lanes 2 and 10). The
aac2D mutant exhibited a very similar phenotype (Figure 5C,
lanes 4 and 12). The crd1D single mutant showed a stronger
defect, with an almost complete absence of the III2/IV2 complex
and a significant amount of the III2 and IV species (Figure 5C,
lanes 3 and 11). As seen in the growth assays, the crd1D rcf1D
double mutant showed no additive phenotype and was nearly
identical to the crd1D single mutant (Figure 5C, lanes 5 and
13). The aac2D rcf1D double mutant on the other hand showed
a more substantial loss of the III2/IV2 complex than either single
mutant (Figure 5C, lanes 6 and 14). There was a clear synthetic
phenotype in the aac2D crd1Ddoublemutant, which had a nearly
complete loss of all supercomplexes (Figure 5C, lanes 7 and 15).
Although deletion of AAC2 and CRD1 caused a decrease in the
steady-state levels of some Complex IV subunits, deletion of
RCF1 caused no effect on any Complex III or Complex IV
subunits, even in the context of double mutants that had
a synthetic effect on supercomplex organization (Figure S4B).
Similar phenotypes were also observed in BN-PAGE analysis
of these strains, whichwere grown to stationary phase in glucose
(Figure S4C). Another factor that occupies the predicted inter-
face between Complex III and Complex IV is Cox13. In isolation,
the cox13D mutant exhibits WT growth on both glucose and
glycerol/ethanol plates (Figure 5D). The cox13D rcf1D double
mutant, however, has a more dramatic growth phenotype than
the rcf1D singlemutant when grown under respiratory conditions
(Figure 5D). This growth phenotype is accompanied by a severe
loss of higher-order respiratory supercomplexes, as determined
by BN-PAGE analysis on the strain grown in different conditions.
The cox13D single mutant shows depletion of the III2/IV2
complex similar to that observed in the rcf1Dmutant (Figure 5E).
The cox13D rcf1D double mutant, however, shows almost
a complete loss of the intact III2/IV2 supercomplex and a marked
shift to lower order complexes.
Increased Mitochondrial Oxidative Stress in the rcf1D
Mutant
The physiological importance of mitochondrial ETC supercom-
plexes has not been precisely defined. It has been speculated,
however, that the assembly of individual complexes into super-
complexes enables more efficient electron flow and decreases
the risk of electron stalling. One predicted physiological manifes-
tation of reduced electron stalling would be decreased genera-
tion of reactive oxygen species (ROS) by the ETC. As a means
of assessing the level of oxidative damage in the mitochondrial
matrix of the rcf1D mutant, we measured the activity of aconi-
tase. This mitochondrial enzyme is highly susceptible to inacti-
vation by ROS, due to oxidation of an exposed Fe/S cluster.
Therefore, aconitase activity is a measure of the in vivo burden
of oxidative stress and damage in the mitochondrial matrix (Cris-
cuolo et al., 2005; Gardner et al., 1995). In log phase cultures, we
observed an !20% decrease in aconitase activity in the rcf1D
mutant, compared to an !60% decrease in activity in a mutant
lacking the mitochondrial Mn2+-dependent superoxide dismu-
tase, Sod2 (Figure 6A). In stationary phase cultures, which are
subject to enhanced respiratory activity and elevated oxidative
stress, the aconitase activity was more severely affected in
both mutants. We previously showed that overexpression of
RCF1 caused a modest stabilization of higher-order supercom-
plex structures. RCF1 overexpression also caused a nearly
2-fold increase in aconitase activity (Figure 6B). As described
previously, additional loss of COX13 confers a synergistic
growth and supercomplex assembly phenotype upon the rcf1D
mutant strain. The cox13D rcf1D double mutant also exhibited
a more profound loss of aconitase activity relative to either of
the two single mutants (Figure 6C).
We also monitored the susceptibility of WT and mutant strains
to exogenous hydrogen peroxide. Mutants with higher in vivo
production of ROS are typically more sensitive to this exogenous
stress. Compared to WT, the dose-dependent lethality in
response to hydrogen peroxide is exacerbated in the rcf1D
mutant (Figure 6D). In addition, we alsomeasured the expression
of the endogenous ROS defense system, as exemplified by the
mitochondria-specific superoxide dismutase Sod2. The rcf1D
mutant has elevated Sod2 protein levels relative to the WT
control (Figure 6E), which is consistent with this mutant having
elevated endogenous oxidative stress, particularly in mitochon-
dria. We hypothesize that this increased oxidative damage and
sensitivity result from accelerated ROS production by the
electron transport chain. This ETC dysfunction is a predictable
result of impaired assembly of individual complexes into super-
complexes, which promotes reliable, solid-state electron
transmission. As another manifestation of ETC dysfunction, the
rcf1Dmutant exhibited impaired maximal respiration in the pres-
ence of CCCP, which causes dissipation of the mitochondrial
membrane potential and a compensatory acceleration of respi-
ration in WT cells (Figure S5; compare to Figure 1E). The
impaired stimulated respiration in the rcf1Dmutant was accom-
panied by markedly increased sensitivity to CCCP-induced cell
death (Figure 6F).
The HIG2AMammalian Homolog of RCF1 Plays a Role
in Supercomplex Stability
As previously described, our selection ofRCF1 for detailed study
was based partially upon evolutionary conservation among
eukaryotes. We were interested to determine whether the role
we discovered for Rcf1 in supercomplex organization might
also extend to RCF1 orthologs in other species. The mouse
and human genomes contain five homologs of RCF1, which
are subdivided into two classes that are defined by the two
genes with the broadest expression pattern, HIG1A and HIG2A
(Figure S1A). HIG1A was originally described as being strongly
inducible by hypoxia in a HIF-1-dependent manner (Denko
et al., 2000; Kasper and Brindle, 2006). To determine whether
either HIG1A or HIG2A were required for normal supercomplex
assembly or stability in mammalian cells, we transfected cells
with siRNAs targeted to these two genes. Knockdown of
HIG1A (Figure S6B) had no effect on the pattern of supercom-
plex assembly (Figure S6A), which is more complicated in
mammalian cells due to the presence of Complex I and the
stable incorporation of both Complex II and Complex V (Acı´n-
Pe´rez et al., 2008). On the other hand, knockdown ofHIG2A (Fig-
ure 7B) caused a depletion of all higher order supercomplexes
that contain Complex IV, particularly the I+II+III+IV (#3), I+III+IV
(#4), and III+IV (#6) species (Figure 7A) (Acı´n-Pe´rez et al.,
2008). Supercomplex species that do not contain Complex IV,
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such as the two I+III+V complexes (#1 and #5), were either unaf-
fected or slightly increased uponHIG2A depletion (Figure 7A). To
more rigorously evaluate a role for HIG2A and its encoded
protein in supercomplex stability, we generated three additional
siRNAs targeted to HIG2A, two of which caused significant
depletion of the HIG2A mRNA; the other did not (Figure 7D).
The two additional efficacious siRNAs (Si2 and Si3) caused an
identical phenotype to that observed for Si1 (Figure 7C). Specif-
ically, we again observed a loss of supercomplex species con-
taining Complex IV and either unaffected or increased levels of
Complex IV-independent species. At longer exposure of the
anti-Cox1 immunoblot, we also saw a profound depletion of
the #2 I+II+III+IV species in Si2- and Si3-treated cells (Figure 7C,
panel 5). We observed a slight reduction in the amount of free,
fully assembled Complex IV and a slight increase in an incom-
plete Complex IV (IV*). Although these results demonstrate
a role for HIG2A in C2C12 myoblast cells, it is possible that the
four additional mammalian HIG family members serve a related
function in different cell types or different conditions. Deter-
mining their precise roles and contributions in Complex IV and
supercomplex assembly and stability requires additional study.
Figure 6. Increased Mitochondrial Oxidative
Stress in the Absence of RCF1
(A) Cell lysates of the indicated strains grown in SD media
for 0.5 and 2.5 days were subjected to aconitase activity
assay and immunoblotted with anti-Aco1 antibody. Aco-
nitase activity was determined specifically by normalizing
the NADP reduction rate to Aco1 protein-band intensity.
sod2D was used as a control. Mean ± SD of three inde-
pendent cultures is shown. **p < 0.01; ***p < 0.0005.
(B) The WT strain harboring either EV or a 2m-based
plasmid overexpressing Rcf1 were grown for 1 day in 1%
glucose and analyzed as in (A). Mean ± SD of three inde-
pendent cultures is shown. *p < 0.05.
(C) The indicated strains were harvested after being
grown in SD media for 0.5 day and analyzed as in (A).
Mean ± SD of three independent cultures is shown. *, p <
0.05; **p < 0.01.
(D) Log phase cultures (0.5 day) of the WT and rcf1D
mutant were pretreated with H2O2 for 2 hr, spotted on
synthetic glucose medium, and incubated at 30!C.
(E) Log phase cultures (0.5 day) of the indicated strains
were harvested and immunoblotted for Sod2, which was
normalized to Por1 intensity. Mean ± SD of six indepen-
dent cultures is shown. **p < 0.01.
(F) WT and the rcf1D mutant strains of the BY4741 back-
ground were grown to log phase in glucose media and an
equal number of cells were plated on media containing
the indicated concentration of CCCP. Number of colonies
was counted after 48 hr. Mean ± SD of three independent
cultures is shown. *p < 0.05.
See also Figure S5.
DISCUSSION
Based on the data presented herein, we
conclude that Rcf1 is a component of respira-
tory supercomplexes and is required for their
normal stability. We also conclude that although
Rcf1 is not essential for basal mitochondrial
function, but is essential for optimally efficient
ETC function and respiration. Evidence that supports these
conclusions is detailed below.
First, Rcf1 directly interacts with respiratory supercomplexes.
When we purified Rcf1, we copurified stoichiometric amounts
of both Complex III and Complex IV, the major components of
S. cerevisiae ETC supercomplexes. We considered the alterna-
tive explanation that Rcf1 is a previously unidentified component
of Complex IV. The association with Complex III could be indi-
rect, occurring only as a consequence of the interaction between
Complex III and Complex IV. The fact that extraction of mito-
chondria with the relatively harsh detergent DDM causes the
loss of Rcf1/Complex III association could be seen as supporting
this view. However, none of the seven distinct COX mutants
that we have analyzed, six of which exhibit failed assembly of
Complex IV and the destruction of many of its subunits, have
lost the association of Rcf1 with Complex III subunits. Interac-
tions of Rcf1 with Cor1, Qcr2, and Cyc1 are maintained in spite
of the fact that Rcf1 has lost all detectable interaction with
Cox1, Cox2, Cox3, Cox4, and, presumably, other Complex IV
subunits for which we do not have usable antibodies. Similarly,
loss of the Complex III subunit Cyt1 leads to a complete failure
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of Rcf1 to interact with central Complex III subunits Cor1 and
Qcr2, although interactions with Complex IV subunits are
maintained.
In general, although mutations impairing either Complex III or
IV assembly do not eliminate the interaction of Rcf1 with the
other Complex, the interactions are significantly weakened.
One exception to this is the Complex IV subunit, Cox3. The
qcr7D and cyt1D (Complex III) mutations eliminate the interac-
tion of Rcf1 with the core Cor1 and Qcr2 subunits of Complex
III. They also greatly impair the Rcf1 interaction with Complex
IV subunits Cox1, Cox4, and, to a lesser extent, Cox2. The
Rcf1 interaction with Cox3, however, is essentially unaffected.
The Rcf1/Cox3 interaction also seems to be unusually persistent
in the face of Complex IV destruction. The cox11D,mss51D, and
cox6D (all Complex IV) mutations each eliminate the interaction
of Rcf1 with Cox1, Cox2, and Cox4, but the interaction with
Cox3 is maintained, albeit at a reduced level. In spite of this
seemingly special relationship between Cox3 and Rcf1, loss of
Pet494, which completely blocks the expression of Cox3, does
not destroy the interaction of Rcf1 with Complex III.
The data demonstrating an intimate association between
Rcf1 and Cox3 has been confusing until recently. If Rcf1 inter-
acts independently with both Complex III and Complex IV,
Figure 7. Mammalian HIG2A is Critical
for Normal Respiratory Supercomplex
Organization
(A) Mitochondria extracted from C2C12 cells
transfected with either scrambled (scr) or HIG2A-
targeted siRNA (si1) were solubilized in 2%
digitonin and resolved by BN-PAGE, followed
by immunoblotting with the indicated antibodies.
Respiratory complex species are indicated fol-
lowing the convention of (Acı´n-Pe´rez et al., 2008),
specifically: 1 (I+III+V); 2 (I+II+III+IV); 3 (I+II+III+IV);
4 (I+III+IV); 5 (I+III+V); 6 (III+IV); 7 (III+IV)*.
(B) HIG2A mRNA level normalized to ACTIN
was measured from cells in (A) using quantitative
RT-PCR.
(C) Mitochondria extracted from C2C12 cells
transfected with scrambled (scr) or one of three
unique HIG2A-targeted siRNA (si2, 3, 4) were
treated as in (A). A longer exposure of the anti-
Cox1 immunoblot is shown to enable visualization
of the supercomplexes #1, 2, and 4. Note that si4
is not efficacious in HIG2A knockdown.
(D) HIG2A mRNA level normalized to ACTIN
was measured from cells in (C) using quantitative
RT-PCR.
See also Figure S6.
it must occupy a position close to the
interface between them in the respiratory
supercomplex. The structure of the
III2/IV2 supercomplex from S. cerevisiae,
however, suggested that Cox3 was situ-
ated on the face of Complex IV that was
opposite to the Complex III interaction
site (Heinemeyer et al., 2007). This model
was based on low-resolution data, and
the rotational orientation of Complex IV
was quite speculative. Recently, much higher-resolution elec-
tron microscopy reconstructions of the bovine I/III2/IV super-
complex were completed and published (Althoff et al., 2011;
Dudkina et al., 2011). These data clearly show the Complex IV
orientation to be rotated relative to Complex III, placing Cox3
at the site of the Complex III/Complex IV interface. Interestingly,
the docking of the crystal structures of Complex III and Complex
IV into the EMmodel demonstrated a clear gap between the two
complexes, particularly in the juxtamembrane region (Dudkina
et al., 2011). Based on its small size and two transmembrane
domains, this is the region that should be occupied by Rcf1. It
is possible that in addition to cardiolipin, which was postulated
to occupy this position, Rcf1 fills this space and stabilizes the
Complex III/Complex IV interaction.
Second, RCF1 has a robust genetic interaction with AAC2,
which has been implicated previously in stabilizing ETC super-
complexes (Dienhart and Stuart, 2008). In assays of stationary
phase survival, RCF1 and AAC2 exhibited a profound synthetic
phenotype, particularly at elevated temperature. Such a growth
phenotype is potentially due to destabilization of supercom-
plexes, as we showed using blue native-PAGE. AAC2 has
a nearly identical relationship with CRD1, which encodes cardi-
olipin synthase and is necessary for the synthesis of this lipid.
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Like Aac2, cardiolipin has also been implicated in the stability of
respiratory supercomplexes. There was no additivity, on the
other hand, between RCF1 and CRD1. Although we don’t yet
know how these molecules interrelate in their stabilization of
supercomplexes, these varied genetic interactions imply that
they don’t all function identically or independently.
We also observed a strong genetic interaction between RCF1
and COX13. The Cox13 protein is predicted to occupy the inter-
face between Complex III and Complex IV. Our data shows
amodest loss of the III2/IV2 supercomplexes in the cox13D single
mutant, which is dramatically exacerbated in the cox13D rcf1D
double mutant. This synergistic loss of supercomplexes is
accompanied by a synthetic growth defect and accelerated gen-
eration of oxidative stress, as determined by loss of aconitase
activity. These phenotypes are consistent with the proposed
role of Rcf1 in supercomplex stabilization and with the proposed
role of supercomplexes in prevention of oxidant production.
Finally, loss of Rcf1 leads to a loss of the fully assembled
III2/IV2 supercomplexes and an increase in lower order struc-
tures. The majority of Complex III and IV appears to assume
the III2/IV assemblage but a significant amount of both
complexes dissociate completely from the other. It is important
to note that this effect seems to be specific because assembly
of the other OXPHOS complexes is not impaired. HIG2A, one
of the mammalian homologs of RCF1, appears to play a similar
role in mouse cells. Treatment with any of three siRNAs that
deplete the HIG2A mRNA causes a reduction of all Complex
IV-containing respiratory supercomplexes.
Although we have not explored this possibility to date, it is
likely that the extent and nature of respiratory supercomplexes
is tightly regulated and responsive to environmental conditions.
For example, we predict that nutrient availability, oxygen
concentration, and ATP demand are all likely stimuli for the
adjustment of supercomplex status. This could be accomplished
through transcriptional or posttranscriptional regulation of RCF1
or its homologs in other species. HIG1A, the mouse ortholog of
RCF1whose depletion had no effect on supercomplex organiza-
tion in C2C12 cells, is robustly induced by hypoxia (Denko et al.,
2000). Perhaps HIG1A plays a more prominent role under
hypoxia or in different cells. Indeed, it has been shown to protect
pancreatic b-cells from apoptosis in response to a variety of
stimuli (Wang et al., 2006). Due to its relatively simple supercom-
plex content, S. cerevisiae has only one interaction that can be
targeted for regulation, between Complex III and Complex IV.
In mammals, however, a much more complicated pattern exists.
Complexes I, II, III, IV, and V are all components of respiratory
supercomplexes, and their inclusion and stoichiometry is vari-
able (Acı´n-Pe´rez et al., 2008). The makeup of these complexes
is a likely target of metabolic regulation.
We certainly do not fully understand the consequences of
the loss of supercomplex formation. We do observe, however,
that there is a substantial reduction in respiratory activity, as
measured by total oxygen consumption in the rcf1D mutant.
Perhaps of more interest, it appears that the rcf1D mutant also
has elevated oxidative stress and damage in the mitochondrial
matrix. This was determined by the loss of aconitase activity,
hypersensitivity to exogenous hydrogen peroxide, and an upre-
gulation of the endogenous oxidative stress defenses. These are
common phenotypes among strains that combat an elevated
level of endogenous oxidative stress. One of the factors that
have kept us from an understanding of the effects of supercom-
plex assembly and disassembly is an inability to genetically
manipulate supercomplex formation without disrupting other
mitochondrial functions. As best we can determine, RCF1 dele-
tion causes a specific defect in supercomplex formation in
yeast and HIG2A silencing does the same in mouse cells. These
will be valuable tools in understanding the role and importance
of the assembly of these intricate machines.
EXPERIMENTAL PROCEDURES
Assessment of Submitochondrial Localization
These experiments were performed following a protocol adapted from (Bol-
dogh and Pon, 2007). Mitochondria were incubated in the isotonic SH buffer
or hypertonic H buffer (20 mM HEPES-KOH) with and without 1% Triton
X-100. Protease K was added and incubated on ice for 20–30 min, and diges-
tion was stopped by adding PMSF. Samples were denatured in 6X Laemmli
buffer and resolved by 12% SDS-PAGE, followed by immunoblot. To assess
the solubility of Rcf1, intact mitochondria were extracted by 100 mM
Na2CO3 and 1 M KCl for 20 min on ice. Supernatant was isolated by centri-
fuging samples at 100,000 3 g for 20 min (MLA-130, Beckman Coulter) and
precipitated in 15% TCA. The precipitated supernatant fraction and insoluble
membrane fraction were solubilized in 1X Laemmli buffer, and resolved by
12% SDS-PAGE, followed by immunoblot.
Two-Step Rcf1-His6/HA3 Purification
Crude mitochondria isolated from strains grown in synthetic glycerol/ethanol
medium were solubilized in 0.8% digitonin or dodecylmaltoside (DDM) for
1 hr at 4!C. For the first step of the purification, cleared mitochondria lysate
was incubated with equilibrated Ni-NTA beads for 1 hr at 4!C. Beads were
washed 5 times with buffer containing 20 mM imidazole. Protein was eluted
by 250 mM imidazole. For the second step of the purification, final eluates of
the first purification were mixed with anti-HA antibody conjugated agarose
(Sigma) for 1 hr at 4!C. Agarose was washed 5 times and eluted by 1 mg/ml
HA peptide. Eighty percent of the final precipitate was dissolved in Laemmli
buffer and resolved by SDS-PAGE, followed by silver stain. Protein bands
excised from the gel and the rest of 20% of the final precipitate were analyzed
by mass spectrometry.
Blue-Native Polyacrylamide Gel Electrophoresis (BN-PAGE)
BN-PAGE was performed as described previously (Wittig et al., 2006). Yeast
mitochondria were solubilized in 1% digitonin or DDM and mammalian mito-
chondria were solubilized in 2% digitonin. Lysate was resolved on a 3%–
13% gradient native gel using a PROTEAN! II xi Cell gel running system
(Bio-rad). Western blot was performed as the regular procedure using a
Trans-Blot transfer cell (Bio-rad). Membrane was blocked in 5% nonfat
milk/TBS and probed with antibodies as indicated.
Solution ETC Complex Activity Assay
These experiments were performed following a protocol adapted from (Magri
et al., 2010). Ubiqinol:cytochrome c oxidoreductase (Complex III) activity was
determined by measuring the rate of cytochrome c reduction by ubiquinol at
550 nm. Complex III specific activity was calculated by deducing the rate of
cytochrome c reduction of a parallel reaction with antimycin A. Cytochrome
c oxidase (Complex IV) activity was determined by measuring the rate of cyto-
chrome c oxidation. Complex IV-specific activity was verified by adding KCN
into the reaction mixture. ATP synthase (Complex V) activity was determined
by measuring the rate of NADH oxidation. ATP synthase specific activity
was verified by adding oligomycin to stop the reaction. The specific Complex
V activity was calculated by deducing the rate of NADH oxidation in the pres-
ence of oligomycin.
Isolation of Mammalian Mitochondria
The procedure was adapted from (Bozidis et al., 2007). C2C12 cells were
washed twice with PBS, scraped from dishes, and pelleted. Roughly 150 mg
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cell pellet was resuspended in 2 ml of ice-cold MTE buffer. Cells were lysed by
sonication (continuous pulse on power setting of 3.5) 3 times for 10 s each. Cell
debris and nuclei were pelleted at 1,400 3 g for 10 min. Crude mitochondria
were recovered from the supernatant fraction by centrifuging at 10,000 3 g
for 10 min. Mitochondrial pellet was rinsed with MTE and resuspended in it.
Protein concentration was determined by Bradford assay.
Statistics
Data are presented as the means ± standard deviation (SD). Statistical signif-
icance was evaluated by the Student’s t test. *, p < 0.05; **, p < 0.01; ***, p <
0.0005.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
Figures S1–S6, and Tables S1 and S2 and can be found with this article online
at doi:10.1016/j.cmet.2012.02.006.
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Supplemental Experimental Procedures 
Yeast Strains and Growth Conditions 
Saccharomyces cerevisiae (W303a MATa, his3 leu2 met15 trp1 ura3) was used as the 
wild-type strain in most experiments in this study, with BY4741 also being used 
in isolated experiments as indicated.  Each mutant strain was derived from a 
W303 diploid strain using a standard PCR-based homologous recombination 
method.  Each haploid strain was generated by sporulation and tetrad dissection.  
The genotypes of all yeast strains used in this study are listed in Table 1.  Yeast 
transformation was performed by the standard TE/LiAc method and the 
transformed cells were recovered and grown in synthetic complete dextrose (SD) 
medium lacking the appropriate amino acid(s) for selection purposes.  Medium 
used in this study includes standard YP and synthetic minimal medium 
supplemented with 1 or 2% dextrose, 2% raffinose, 3% glycerol and 2% ethanol 
or 2% acetate. 
Plasmid Construction 
The plasmids expressing C-terminal His6/HA3 or GFP tagged Rcf1 were 
generated by PCR amplification of the RCF1 (NM_001182388) flanked with its 
upstream 500-bp promoter region.  This fragment was ligated into a pRS416-
based vector containing a C-terminal His6/HA3 or GFP tag.  The plasmid 
expressing C-terminal HA tagged Cox4 was constructed as Rcf1. The plasmid for 
RCF1 overexpression was generated by amplifying the RCF1 gene flanked by the 
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endogenous promoter and terminator and ligating into a pRS426 vector.  The 
sequence of each fragment was confirmed by DNA sequencing. 
Fluorescence Microscopy 
The rcf1ǻ mutant strain transformed with plasmids expressing GFP-Rcf1 and 
MtRFP was grown in SD medium overnight.  Cells were diluted in fresh medium 
to 0.1 OD and grown at 30°C for 6 hours.  Images were captured using a Zeiss 
Axioplan 2 Imaging microscope (Carl Zeiss). 
Isolation of Yeast Mitochondria 
Yeast cells were harvested at early log phase, unless indicated otherwise.  
Preparation of crude mitochondria was as described previously(Boldogh and 
Pon, 2007).  Cell pellet was washed once with ddH2O and resuspended in TD 
buffer (100 mM Tris-SO4, pH 9.4 and 100 mM DTT) for 15 min at 30°C.  
Spheroplasts were obtained by incubating cells in SP buffer  (1.2 M Sorbitol and 
20 mM potassium phosphate, pH 7.4) supplemented with 0.3 mg/ml lyticase for 
1 hour at 30°C to remove the cell wall.  Spheroplasts were gently washed once 
and homogenized in ice-cold SEH buffer (0.6 M sorbitol, 20 mM Hepes-KOH, pH 
7.4, 2 mM MgCl2, 1 mM EGTA, and 1mM PMSF) using a Dounce homogenizer 
applied with 30-40 strokes.  Crude mitochondria were further purified by 
differential centrifugation.  Protein concentration was determined using 





Crude mitochondria extracted from each strain were solubilized in 0.7-0.8% 
digitonin for 1 hour at 4°C.  Cleared mitochondria lysate was mixed with anti-
HA antibody conjugated agarose for 2 hours at 4°C.  Agarose was washed 5 
times for 5 minutes each with the buffer supplemented with 0.1% digitonin.  
Laemmli buffer was added to the agarose to elute protein.  Final eluate and 1% of 
the mitochondria lysate were resolved by 15% SDS-PAGE followed by 
immunoblot. 
Oxygen Consumption Assay 
For BY4741 strains, wild-type and rcf1  mutant strains were diluted 1:100 from a 
log-phase culture into YP media containing the glucose, lactate and glycerol, and 
grown to OD600 about 0.5.  Cells were harvested and resuspended in fresh media 
at 108 cells/ml and rate of oxygen consumption was measure by an oxygen 
electrode (Hansetech).  For the measurement of OCR upon uncoupler treatment, 
CCCP was added to final concentration of 1 ȝM to cells in YPD media and OCR 
was measured as described. 
For W303 strain, indicated yeast strains were harvested at early log phase and 
washed once with ddH2O.  Four OD units of each culture were resuspended in 
3% glycerol and oxygen consumption was measured using a 5300A Biological 
Oxygen Monitor (Yellow Springs Instrument Co.).  The rate of consumption was 
determined using the linear region of the O2 concentration curve.  
Oxygen consumption.  
	   
40	  
Steady-State Protein Analysis 
 A certain amount of crude mitochondria were pelleted and resuspended in 1X 
Laemmli buffer to final concentration 1 ȝg/ȝl.  Samples were incubated at 37°C 
for 30-60 min and centrifuged at maximum speed using a tabletop 
microcentrifuge for 2 min.  Supernatant was resolved in 12% SDS-PAGE 
followed by immunoblot. 
In-Gel Activity Assay of OXPHOS Complexes 
All the assays were performed following a protocol adapted from (Wittig et al., 
2007).Gel strips excised from the BN-PAGE were washed once with ddH2O.  For 
Complex II activity, the gel strip was soaked in assay buffer (50 mM potassium 
phosphate, pH 7.4, 90 mM succinate, 4.5 mM EDTA, 10 mM KCN) for 10 minutes 
and activity was stained by 2 mg/ml nitroblue tetrazolium and 0.2 mM 
phenazine methosulfate.  Blue-Purple formazans were formed and the gel strip 
was scanned.  For Complex IV activity, the gel strip was soaked in 50 mM 
potassium phosphate, pH 7.4 for 10 minutes and overlaid with 1 mg/ml 
diaminobenzidine and 1 mg/ml cytochrome c.  Yellow-brown precipitates were 
produced after incubating gel strips at 30°C for 20 minutes and scanned.  For 
Complex V activity, the gel strip was equilibrated in assay buffer (37 mM Tris, 
270 mM Glycine, pH 8.3 and 14 mM MgSO4,) for 10 minutes and overlaid with 8 
mM ATP and 0.2 % lead nitrate. White colored precipitates were produced and 




Yeast cells grown in SD medium were washed once with ddH2O and 
resuspended in lysis buffer (50 mM Tris-HCl, 50 mM KCl, 2 mM sodium citrate 
dihydrate, 10% glycerol, 1 mM PMSF, and 7 mM E-mercaptoethanol), and stored 
at –80°C for at least 2 hours.  After thawing on ice, cells were homogenized by 
vortexing with glass beads and cleared lysate was collected by centrifugation.  
Aconitase activity was measured by coupling with NADP+-dependent isocitrate 
dehydrogenase activity.  30 Pl of crude lysate was mixed with 150 Pl of reaction 
mixture (1 M Tris-Cl pH 8.0, 10 mM MgCl2, 10 mM NADP+, 0.32 units of NADP+-
dependent Isocitrate Dehydrogenase), and 10 Pl of 50 mM citrate.  The reaction 
mixture was recorded at 340nm for 2 minutes (15 sec intervals).  Aconitase -
specific activity was calculated by normalizing the activity with the Aconitase 
protein band intensity. 
Hydrogen Peroxide Sensitivity Assay 
Overnight cultures of the yeast strains indicated were diluted in fresh SD 
medium to 0.1 OD and grown for 0.5 day to 1 OD unit.  Culture was aliquoted 
into 3 tubes, mixed with 0, 2.5 or 5 mM H2O2 and incubated at 30°C for 2 hours.  
Cells were harvested, washed once and resuspended in sterilized ddH2O.  Cell 
intensity was measure at 600nm and 5-fold serial dilutions starting from 0.5 OD 




CCCP Sensitivity Assay 
 Wild-type and rcf1  strains of the BY 4741 background were grown to log phase 
in YPD and harvested.  Three hundred cells were plated on YPD plates 
containing the indicated amount of CCCP and incubated at 30°C.  Colonies were 
counted after 48 hr. 
Mammalian Cell Culture 
C2C12 myoblasts (ATCC CRL-1772) were maintained in DMEM with 10% FBS, 2 
mM Glutamax, and 1% Primocin solution (v/v Invivogen).  All knockdowns 
were performed by treating cells with 20 nM total siRNA, using the 
Lipofectamine RNAiMax transfection reagent, according to the manufacturer’s 
instructions (Invitrogen).  The All-Stars non-targeting siRNA (Qiagen) was used 
as the control for siRNAs targeting HIG1A (NM_019814) and HIG2A 
(NM_025933), which were designed with the Dharmacon siDesign Center tool 
(http://www.dharmacon.com/designcenter/DesignCenterPage.aspx). 
Sequences of the sense strands of targeting siRNAs, which include a 3’ tt DNA 
overhang, are as follows. HIG1A: (#1) CCAAAUUGUUAGUGACUGAtt and (#2) 
GGUCUAAGUUUAUUCGGAAtt.  HIG2A: (#1) 
CCAGAGGGCUUUAAGGAAAtt, (#2) UCUUAAAGCGCCAUGGAAAtt,  (#3)  
GUGAGGAAGUGGCCGAUUUtt, and (#4) AGGAAAAGUUUAUUCGCAAtt.  
Cells were subjected to knockdown on day zero, again on day 3, and analyzed on 
day 6.  Total RNA was isolated with the RNeasy Mini Kit (Qiagen) and reverse 
transcribed to cDNA using the High Capacity cDNA Reverse Transcription Kit 
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(Applied Biosystems).  Quantitative PCR (qPCR) was performed on cDNA with 



























Figure S1. RCF1 Is Evolutionarily Conserved and Important for Respiration, 
Related to Figure 1 
(A) Protein sequence alignment of the yeast Rcf1 and human Hig1A and Hig2A.  
Predicted transmembrane domains are indicated.  Yeast Rcf1 is depicted only 
through residue 96 although it has additional C-terminal residues. 
(B) Rate of oxygen consumption of the wild-type and rcf1ǻ mutant strains (W303 
background) grown in glucose media was measured.  Data shown is 
representative of three independent experiments and mean + standard deviation 
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Figure 2. Rcf1 Interacts Independently with Subunits of Complex III and IV, 
Related to Figure 3 
(A) Rcf1-His6/HA3 was subjected to two-step purification by Ni-NTA beads and 
anti-HA antibody conjugated agarose from wild-type and the indicated mutant 
strains.  Rcf1-His6/HA3 was eluted by HA peptide under native conditions and 
subjected to TCA precipitation.  Five percent of crude lysate and the final eluate 
were immunoblotted by anti-Cor1&Qcr2, Cyt1, Cox2, Cox3 and HA antibodies.  
(B) Steady-state OXPHOS subunits were detected using mitochondria extracted 














Figure S3. Rcf1 Plays a Role in Maintaining the Integrity of Respiratory 
Supercomplexes, Related to Figure 4 
(A) Mitochondria extracted from the wild-type and rcf1Ǎ mutant grown in 1% 
dextrose synthetic media to stationary phase were solubilized in 1% digitonin 
and resolved by BN-PAGE.  Complex II, Complex III and Complex IV were 
immunoblotted by anti-Sdh1, Rip1 and Cox2 antibodies, respectively.  Complex 
V immunoblotted by anti-Atp2 antibody is shown as a loading control.  
(B) Crude mitochondria isolated from wild-type and the rcf1ǻ mutant strains of 
(A) was resolved on SDS-PAGE and immunoblotted by Complex IV antibodies 
against Cox1, Cox2 and Cox3; Complex III antibodies against Cor1&Qcr2, Cyt1 
and Rip1; and Complex II antibody against Sdh2.  Por1 and Mge1 were shown as 
loading controls.  
(C) The enzymatic activities of Complex II, IV, and V (ATP synthase) were 
assayed by in-gel activity assay of the WT and rcf1' mitochondria harvested 
from yeast cells grown in 1% dextrose synthetic media to stationary phase.  
(D) Mitochondria from strains expressing EV, Rcf1-HA or Cox4-HA in place of 
the endogenous gene were solubilized in 0.8% digitonin and 
immunoprecipitated by anti-HA antibodies.  Both 1% mitochondrial lysate and 
the final eluate were analyzed by immunoblot.  Arrowheads indicate HA-tagged 




(E) Mitochondria harvested from the wild-type strain harboring either EV or a 2ȝ 
plasmid overexpressing Rcf1 grown to early stationary phase were solubilized in 
1% digitonin and resolved by BN-PAGE.  Complex III, Complex IV and porin 
complex were immunoblotted by anti-Cor1&Qcr2, Cox3 and Por1 antibodies, 










Figure S4.  RCF1 Genetically Interacts with Aac2 to Stabilize Respiratory 
Supercomplexes, Related to Figure 5 
(A) The wild-type and mutant strains were grown in YPAD medium to log phase 
and 5-fold serial dilutions of each culture were spotted on a synthetic 
glycerol/ethanol plate and incubated at 30°C for 3 days.  
(B) Steady-state OXPHOS subunits were immunodetected from the wild-type 
and rcf1' mutant strains grown in synthetic raffinose media as in Figure 5C.  
(C) The wild type and mutant strains were grown in YPAD medium for 3 days to 
reach stationary phase.  Purified mitochondria from these strains were 
solubilized by 1% digitonin and resolved by BN-PAGE.  Complex III, Complex 
IV and Complex V were immunoblotted by anti-Cor1&Qcr2, Cox3 and Atp2 














Figure S5. Deletion of RCF1 Is Susceptible to Oxidative Stress, Related to 
Figure 6  
Rate of oxygen consumption of the wild-type and rcf1ǻ of the BY4741 
background was measure in the presence of 1 PM CCCP. Mean ± SD of three 













Figure S6. Hig2A Is Critical in Maintaining Respiratory  Supercomplexes, 
Related to Figure 7 
(A) Mitochondria extracted from C2C12 cells transfected with either scrambled 
(scr) or HIG1A-targeted siRNA were solubilized in 2% digitonin and resolved by 
BN-PAGE, followed by immunoblotting with anti-Qcr2 to detect Complex III.  
Respiratory complex species are indicated following the convention of (Acin-
Perez et al., 2008), specifically: 1 (I+III+V); 2 (I+II+III+IV); 3 (I+II+III+IV); 4 
(I+III+IV); 5 (I+III+V); 6 (III+IV); 7 (III+IV)*. (B) HIG1A and HIG2A mRNA level 

















Table S2. Yeast Strains Used in This Study 
 
Strains Genotype Source 
WT (W303) Mat A his3 leu2 lys2 met15 trp1 ura3 David Stillman 
rcf1ǻ Mat A his3 leu2 lys2 met15 trp1 ura3 
rcf1::kanMX4 
This study 
crd1ǻ Mat A his3 leu2 lys2 met15 trp1 ura3 
crd1::kanMX4 
This study 
aac2ǻ Mat A his3 leu2 lys2 met15 trp1 ura3 
aac2::natMX4 
     This study 
rcf1ǻcrd1ǻ Mat A his3 leu2 lys2 met15 trp1 ura3 
rcf1::hphMX4 crd1::kanMX4 
This study 
rcf1ǻaac2ǻ Mat A his3 leu2 lys2 met15 trp1 ura3 
rcf1::hphMX4 aac2::natMX4 
This study 
rcf1ǻcrd1ǻaac2ǻ Mat A his3 leu2 lys2 met15 trp1 ura3 
rcf1::hphMX4 crd1::kanMX4 aac2::natMX4 
This study 
qcr7ǻ Mat A his3 leu2 lys2 met15 trp1 ura3 
qcr7::natMX4 
This study 
cox11ǻ Mat A his3 leu2 lys2 met15 trp1 ura3 
cox11::kanMX4 
This study 
cyt1ǻ Mat A his3 leu2 lys2 met15 trp1 ura3 
cyt1::kanMX4 
This study 
pet494ǻ Mat A his3 leu2 lys2 met15 trp1 ura3 
pet494::kanMX4 
This study 
mss51ǻ Mat A his3 leu2 lys2 met15 trp1 ura3 
mss51::kanMX4 
This study 
cox6ǻ Mat A his3 leu2 lys2 met15 trp1 ura3 
cox6::hphMX4 
Jin-Mi Heo 
sod2ǻ Mat A his3 leu2 lys2 met15 trp1 ura3 
sod2::kanMX4 
This study 
cox13ǻ Mat A his3 leu2 lys2 met15 trp1 ura3 
cox13::kanMX4 
This study 
rcf1 cox13  Mat A his3 leu2 lys2 met15 trp1 ura3 
cox13::kanMX4 rcf1::hphMX4 
This study 
cox4ǻ Mat A his3 leu2 lys2 met15 trp1 ura3 
Cox4::kanMX4 
This study 
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Msp1/ATAD1 maintains mitochondrial function
by facilitating the degradation of mislocalized
tail-anchored proteins
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Abstract
The majority of ER-targeted tail-anchored (TA) proteins are
inserted into membranes by the Guided Entry of Tail-anchored
protein (GET) system. Disruption of this system causes a subset of
TA proteins to mislocalize to mitochondria. We show that the AAA+
ATPase Msp1 limits the accumulation of mislocalized TA proteins
on mitochondria. Deletion of MSP1 causes the Pex15 and Gos1 TA
proteins to accumulate on mitochondria when the GET system is
impaired. Likely as a result of failing to extract mislocalized TA
proteins, yeast with combined mutation of the MSP1 gene and the
GET system exhibit strong synergistic growth defects and severe
mitochondrial damage, including loss of mitochondrial DNA and
protein and aberrant mitochondrial morphology. Like yeast Msp1,
human ATAD1 limits the mitochondrial mislocalization of PEX26
and GOS28, orthologs of Pex15 and Gos1, respectively. GOS28
protein level is also increased in ATAD1!/! mouse tissues. There-
fore, we propose that yeast Msp1 and mammalian ATAD1 are
conserved members of the mitochondrial protein quality control
system that might promote the extraction and degradation of
mislocalized TA proteins to maintain mitochondrial integrity.
Keywords AAA+ ATPase; Guided Entry of Tail-anchored protein; mitochondrial
protein quality control; tail-anchored proteins
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Introduction
Tail-anchored (TA) proteins are a distinct subset of membrane
proteins, which are uniquely characterized by a single transmem-
brane domain (TMD) at the C-terminus with the majority of the
protein extending into the cytoplasm. They play critical roles in a
variety of cellular processes including intracellular trafficking (e.g.,
all SNARE proteins), protein translocation and maturation (e.g.,
Sec61b, Tom5, Tom6, Tom7, and Tom22), apoptosis (e.g., Bcl2
family), organelle ultrastructure (e.g., Fis1), and metabolism (e.g.,
CPT1, Cyb5) (Wattenberg & Lithgow, 2001; Borgese et al, 2003). The
majority of TA proteins are targeted to two distinct membrane
systems: the mitochondrial outer membrane and the ER membrane
from where TA proteins can be subsequently sorted to the nuclear
envelope, Golgi complex, peroxisome, vacuole/lysosome, and
plasma membrane, probably by vesicle-mediated trafficking (Kutay
et al, 1995).
The topology of TA proteins precludes them from being targeted
by the canonical co-translational signal recognition particle pathway
that is used by the vast majority of membrane proteins (Kutay et al,
1995; Steel et al, 2002; Yabal et al, 2003; Brambillasca et al, 2005).
Instead, a post-translational targeting system, GET (Guided Entry of
Tail-anchored proteins), or TRC (TMD Recognition Complex) in
Saccharomyces cerevisiae (yeast) or mammals, respectively, chaper-
ones newly synthesized TA proteins and mediates their insertion
into the ER membrane (Stefanovic & Hegde, 2007; Schuldiner et al,
2008; Hegde & Keenan, 2011; Denic, 2012). The mechanism
whereby TA proteins are targeted and inserted into mitochondria
has not yet been determined. In yeast, the GET system starts with
capture of the nascent TA protein by the pre-targeting subcomplex
composed of Get4, Get5, and Sgt2 (Jonikas et al, 2009; Wang et al,
2010). Via interaction with Get4, Get3 binds the cargo protein
complex and binds the TA protein by directly associating with the
TMD (Chartron et al, 2010; Wang et al, 2010). Through docking of
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Get3 onto the ER membrane receptor, a Get1/Get2 heterodimer, the
TA protein is then released and properly inserted (Schuldiner et al,
2008; Wang et al, 2010; Mariappan et al, 2011). However, the fidel-
ity of protein targeting is not perfect, and when it is impaired by
mutation (e.g., of the GET system), TA proteins mislocalize to the
cytosol or mitochondria (e.g., peroxisomal Pex15 and ER Ubc6)
(Schuldiner et al, 2008; Jonikas et al, 2009). To this end, a protein
quality control system has evolved to clear TA protein aggregates
from the cytosol (Hessa et al, 2011). We hypothesized that a parallel
system evolved to clear TA proteins that have mislocalized to the
mitochondria and constituted a threat to mitochondrial function.
The mitochondrion is a complex organelle that performs func-
tions that are fundamental to many aspects of cell biology. There-
fore, failure or dysregulation of this organelle is associated with
many forms of human disease. This includes cancer (Kroemer &
Pouyssegur, 2008), diabetes (Patti & Corvera, 2010), neurodegenera-
tive disease (Lessing & Bonini, 2009), and others (Lopez-Armada
et al, 2013; Lopez-Otin et al, 2013). This critical importance necessi-
tates that cells employ a multi-tiered quality control system to main-
tain the integrity of mitochondria (Rugarli & Langer, 2012). One line
of defense consists of intra-mitochondrial proteases that enable the
degradation of misfolded or damaged proteins. Among them, two
AAA+ (ATPase Associated with various cellular Activities) prote-
ases, m-AAA and i-AAA, enforce protein quality in the matrix and
inter-membrane space compartments, respectively (Gerdes et al,
2012; Janska et al, 2013). They are characterized by a AAA+
domain that, in most cases, oligomerizes to form a channel to
unfold protein substrates using the energy derived from ATP hydro-
lysis. Unfolded polypeptides are subsequently degraded by an asso-
ciated proteolytic domain (Sauer & Baker, 2011). Mutations
affecting these proteases cause a plethora of phenotypes in yeast,
including respiratory deficiency, loss of mitochondrial DNA
(mtDNA), altered mitochondrial morphology, and decreased chro-
nological lifespan (Thorsness et al, 1993; Campbell et al, 1994;
Janska et al, 2013). Cells employ a related quality control system on
the mitochondrial outer membrane, which enables the extraction
and proteasomal degradation of proteins exposed to the cytosol
(Taylor & Rutter, 2011). This system appears to also utilize the
AAA+ ATPase, Cdc48 in yeast or p97 in mammals, for protein
extraction prior to engagement of the proteasome (Heo et al, 2010;
Tanaka et al, 2010; Xu et al, 2011). When mitochondria depolarize,
cells initiate the autophagic degradation of mitochondria or mito-
phagy as a second line of defense (Youle & Narendra, 2011; Ashrafi
& Schwarz, 2013). In animals, neurons seem to be particularly
sensitive to the presence of damaged mitochondria. An increasing
number of neurodegenerative diseases, including spastic paraplegia,
spinocerebellar ataxia, Parkinson’s disease, Alzheimer’s disease,
and peripheral neuropathies, are linked with defective mitochon-
drial quality control systems (Rugarli & Langer, 2012).
As a result of our ongoing project to functionally annotate the
mitochondrial proteome (Hao et al, 2009; Heo et al, 2010; Bricker
et al, 2012; Chen et al, 2012), we here describe the previously
unknown function of Ygr028 (or Msp1) in yeast and ATAD1 (also
known as Thorase) in mammals, which are mitochondrial members
of the AAA+ family of proteins (Zhang et al, 2011). Our data suggest
that they are components of the mitochondrial protein quality
control system and play a crucial role in degrading TA proteins that
escape from the GET system to mislocalize to mitochondria.
Depletion of Msp1 in yeast or ATAD1 in human cells and mice leads
to ectopic accumulation of a subset of TA proteins that mislocalize to
mitochondria. We also showed that Msp1 and ATAD1 physically
interact with these same mislocalized TA proteins. Finally, loss of
this system causes severe mitochondria damage including respira-
tory deficiency, loss of mitochondria, and altered mitochondrial
morphology. As a result, we hypothesize that Msp1 and ATAD1 are
novel mitochondrial protein quality control components that might
extract and facilitate the degradation of mislocalized TA proteins
from the mitochondria.
Results
Msp1 is an evolutionarily conserved mitochondrial outer
membrane protein
Protein sequence alignment and domain prediction of yeast Msp1,
fly CG5395, mouse ATAD1, and human ATAD1 suggested that they
all contain a transmembrane domain near the N-terminus and a
highly conserved AAA+ domain toward the C-terminus (Fig 1A).
Because yeast Msp1 was previously annotated as a mitochondrial
protein (Nakai et al, 1993), we first confirmed its mitochondrial
localization. We generated a yeast strain co-expressing a fully func-
tional Msp1-GFP fusion protein from the native MSP1 promoter and
mitochondrial RFP (Mito-RFP) (see Supplementary Fig S2A; the
construct fully complements the growth phenotype of the get3D
msp1D mutant strain, which will be discussed in the next section
and Fig 2). As shown in Fig 1B, we observed a nearly complete
overlap of RFP and GFP, demonstrating mitochondrial localization
of Msp1-GFP. We also observed extra-mitochondrial GFP puncta
(marked by arrows), however, which we showed to be peroxisomes
based on co-localization with an RFP protein fused with a peroxi-
somal targeting sequence (SKL) (Supplementary Fig S1A).
To determine in which mitochondrial compartment Msp1
resides, we performed a biochemical fractionation experiment using
a strain expressing a fully functional Msp1-His6-HA3 fusion protein
from the native MSP1 promoter (see Supplementary Fig S2A). Msp1
was absent from the post-mitochondria supernatant, but present in
purified mitochondria. When we subjected intact, hypotonically
swollen or Triton X-100 lysed mitochondria to Proteinase K diges-
tion, Msp1 was completely degraded in all three situations, like the
mitochondrial outer membrane protein Fzo1 (Fig 1C). Furthermore,
similar to Om45 and Por1, both integral mitochondrial membrane
proteins, neither high salt nor alkaline carbonate extracted Msp1
from mitochondria, suggesting that it is an integral mitochondrial
outer membrane protein (Fig 1D).
To confirm that the mitochondrial localization of this protein
family is conserved in higher eukaryotes, we established a number
of human cell lines that stably express human ATAD1 (hATAD1)
as a C-terminal GFP fusion. As shown in Fig 1E and Supplementary
Fig S1B, the GFP signal overlapped with the mitochondrial fluores-
cent dye, Mitotracker Red. Consistent with yeast Msp1, we also
observed that hATAD1-GFP localized to extra-mitochondrial puncta,
which were verified to be peroxisomes by co-localization with a
peroxisomal RFP marker (Supplementary Fig S1C). We also
observed some cytoplasmic localization of ATAD1 (Supplementary
Fig S1B and C). Taken together, the aforementioned data indicate
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that yeast Msp1 and human ATAD1 localize to multiple cellular
compartments. Specifically, yeast Msp1 resides on the mitochondrial
outer membrane, probably anchored via the N-terminal TMD, with
the majority of the protein including the AAA+ domain exposed to
cytosol. While Msp1 and hATAD1 might have important peroxi-
somal (or cytoplasmic for ATAD1) functions, this study will primar-
ily focus on their roles in mitochondria.
The msp1D mutant exhibits synthetic growth and mitochondrial
defects in combination with GET mutants
We generated yeast mutants lacking MSP1, which did not show
any significant growth phenotype in regular laboratory growth
conditions (Fig 2A). Two independent synthetic genetic array exper-
iments, however, both suggested that an msp1D mutant exhibits a
strong negative genetic interaction with get2D or get3D mutants
(lacking critical components of the GET system), indicating that the
growth of the double-mutant strain is more severely compromised
than predicted from the phenotypes of the single knockouts
(Costanzo et al, 2010; Hoppins et al, 2011). To verify these data, we
generated get2D msp1D and get3D msp1D double-deletion strains
and found that both double mutants showed more severe growth
phenotypes than the single mutants when grown on glucose at
30°C, which was exacerbated at 37°C (Fig 2A, top panel). Both
double mutants completely failed to grow on glycerol medium,
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Figure 1. Msp1 is a conserved mitochondrial outer membrane protein.
A Protein sequence alignment and domain prediction of yeast, fly, mouse, and human homologs (SDSC Biology Workbench). The transmembrane domain (TMD) is
marked by a dashed cyan box (dashed because the endpoints of the TMD are not clearly defined), and the AAA+ domain is marked by a yellow box. Glutamate 193 is
indicated by an asterisk (*).
B Representative images of the msp1D mutant expressing Msp1-GFP and Mito-RFP. Yeast were grown to early log phase at 30°C in synthetic glucose (SD) medium and
visualized by fluorescence microscopy. Peroxisomal Msp1-GFP signal is marked by arrows.
C Intact, hypotonically swollen and Triton X-100-solubilized mitochondria of the msp1D mutant expressing Msp1-His6/HA3 were treated with (+) or without (!)
Proteinase K and analyzed by immunoblot with whole-cell lysate (WCL) and post-mitochondrial supernatant (PMS). Mge1, Cyb2, and Fzo1 are matrix, intermembrane
space (IMS), and outer membrane proteins (OMM), respectively.
D Soluble (S) and pellet fraction (P) of the KCl- or Na2CO3-treated mitochondria purified from the strain described in (C) were analyzed by immunoblot. Cyb2 is a
peripherally attached mitochondrial inner membrane protein; Por1 and Om45 are both integral outer membrane proteins. The asterisk (*) indicates a non-specific band.
E Human dermal fibroblasts (HDFs) stably expressing ATAD1-GFP were stained with Mitotracker Red and visualized by florescence microscopy.
Source data are available online for this figure.
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Figure 2. The msp1D mutant exhibits growth defects and severe mitochondria damage when combined with the GET mutants.
A Five-fold dilutions of the indicated yeast strains grown in SD medium were spotted on SD or synthetic glycerol plates (SGly) and incubated at 30 or 37°C.
B Whole-cell lysates of log-phase cultures harvested from synthetic raffinose medium were analyzed by immunoblot. Both mitochondrial and nuclear DNA-encoded
mitochondrial proteins were immunoblotted. Pgk1 is a cytoplasmic control protein.
C The parental haploids and two independent diploids were streaked on SD and SGly plates and cultured at 30°C. The sdh5D strain is a control representing a
respiratory deficient rho+ strain.
D Representative images of the indicated yeast strains expressing the mito-RFP construct, grown in SD medium to log phase and visualized by fluorescence microscopy.
Areas of atypical mitochondrial swelling are indicated by arrows (see also Supplementary Fig S2E). The RFP image intensity was adjusted to be similar for
visualization purposes. Unadjusted images from similar exposure times are shown in Supplementary Fig S2F.
Source data are available online for this figure.
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all of the single mutants exhibited wild-type growth (Fig 2A, top
panel). These growth phenotypes are fully rescued by plasmid
expression of the native or C-terminally tagged Msp1 protein, but
not by expression of the N-terminally tagged Msp1 protein (which
presumably fails to localize to mitochondria) or Msp1E193Q, which is
predicted to lack ATPase activity (Supplementary Fig S2A and B). In
fact, expression of the Msp1E193Q causes dominant-negative growth
impairment when expressed in a get3D mutant (Supplementary Fig
S2B). Given the functions of Get2 and Get3, it is reasonable to spec-
ulate that MSP1 might have a similar genetic relationship with other
GET genes including GET1, GET4, GET5, and SGT2. As expected, the
synthetic growth phenotype of the get1D msp1D mutant is identical
to that of the get2D msp1D and get3D msp1D double mutants
(Fig 2A, top panel). The get4D msp1D, get5D msp1D, and msp1D
sgt2D mutants exhibited modest synthetic growth defects, particu-
larly on glycerol medium (Fig 2A, bottom panel). This is consistent
with the published observations that Get1, Get2, and Get3 are more
central players in the GET system, while Get4, Get5, and Sgt2 play a
more auxiliary role (Jonikas et al, 2009).
The complete failure of get1D msp1D, get2D msp1D, and get3D
msp1D mutants to grow on glycerol medium suggested that mito-
chondrial function might be impaired. To explore a potential mito-
chondrial phenotype further, we extracted whole-cell lysates from
the wild-type (WT) and single and double mutants and immunob-
lotted for proteins that localize to different mitochondrial compart-
ments (Fig 2B). We observed that the get1D msp1D, get2D msp1D,
and get3D msp1D mutants were completely devoid of the mtDNA-
encoded proteins, Cox2 and Cox3, and were severely depleted of
all nuclear-encoded mitochondrial proteins examined, Atp2, Sdh1,
Sdh2, Por1, and Om45 (Lane 4, 6, and 8). The other three double-
mutant strains exhibited a partial depletion of some proteins,
particularly those encoded by mtDNA (Lane 10, 12 and 14). The
respiratory growth defect of the get1D msp1D, get2D msp1D, and
get3D msp1D strains was also irreversible as transformation of an
Msp1-expressing plasmid failed to restore the growth phenotype
(Supplementary Fig S2C). We suspected that these double mutants
might have lost their mitochondrial DNA and become rho0. To
directly test this, we employed a classic cross-complementation
test and found that the strains lacking MSP1 and one of the GET
genes failed to complement the growth phenotype of a rho0 tester
strain on glycerol medium (Fig 2C). These data demonstrate that
the get1D msp1D, get2D msp1D, and get3D msp1D strains lack
functional mtDNA. While mtDNA depletion could explain the
loss of mtDNA-encoded proteins, it causes a much less severe
depletion of nuclear-encoded mitochondrial proteins (Supplementary
Fig S2D).
Finally, we directly visualized mitochondria by expressing Mito-
RFP in the WT and single- and double-mutant strains (Fig 2D). In
addition to the expected observation that the mitochondrial RFP
signal in the get1D msp1D, get2D msp1D, and get3D msp1D strains
was much weaker than WT or the single mutants (Supplementary
Fig S2F), we also found that they exhibited severely altered mito-
chondrial morphology. Again, the severity of the morphological
changes cannot be explained by the lack of mtDNA, which has
only modest effects on mitochondrial morphology (Supplementary
Fig S2E). The get4D msp1D, get5D msp1D, and msp1D sgt2D
strains did not have overt morphological changes, but did have
some areas of apparent atypical mitochondrial swelling (marked
by arrows, Fig 2D and Supplementary Fig S2G). In summary, we
have found that the combined impairment of Msp1 and the GET
system causes severe mitochondrial damage, including depletion
of resident proteins, loss of the mitochondrial genome, and aber-
rant morphology.
Depletion of mammalian ATAD1 causes mitochondrial damage
Because a large fraction of human ATAD1 localizes to mitochondria,
we wanted to assess whether this mitochondrial function is also
conserved in higher eukaryotes. We tested whether depletion of
ATAD1 compromises mitochondrial function. First, we performed
immunoblots on lysates from brain, which was previously shown to
highly express ATAD1, of the WT and ATAD1!/! mice (Fig 3A and B)
(Zhang et al, 2011). We observed a significant decrease of many
mitochondrial proteins in the ATAD1!/! brain of both female and
male mice. The diminished mitochondrial content is further
supported by the decreased basal and mitochondrial respiratory
capacity of the mouse embryonic fibroblasts (MEFs) lacking ATAD1
(Fig 3C). Second, we also directly visualized mitochondrial
morphology of ATAD1!/! MEFs. While WT MEFs exhibit tubular
mitochondria, we observed that the mitochondria of ATAD1!/!
MEFs were severely fragmented (Fig 3D). The same mitochondrial
fragmentation was observed in ATAD1 knockdown HeLa cells
(Supplementary Fig S3). Therefore, we conclude that mammalian
ATAD1, similar to yeast Msp1, plays an important role in mitochon-
drial function.
As a complementary test of the conservation of the mitochondrial
function of the Msp1 protein family, we expressed human ATAD1
and Drosophila melanogaster CG5395 under control of the yeast
ADH1 promoter and found that they either partially or fully rescued
the growth phenotype of the get3D msp1D mutant, respectively
(Fig 3E). The glycerol growth defect was also particularly
suppressed, suggesting that the mitochondrial role of this protein
family spans across the eukaryotic kingdom.
Msp1/hATAD1 is required to minimize the level of the TA protein
Pex15/PEX26 mislocalized to mitochondria
Potential mechanisms that might underlie the severe mitochondrial
defects caused by combined loss of Msp1 and the GET system were
not clear. One potential connection, however, was the previous
observation that disruption of the GET system causes some TA
proteins to aggregate in the cytoplasm and others to mislocalize to
mitochondria (Schuldiner et al, 2008; Jonikas et al, 2009). Perhaps,
loss of Msp1 causes mitochondria to be particularly sensitive to the
damaging effects of TA protein mislocalization to mitochondria
found upon impairment of the GET system. Considering that Msp1
is part of the AAA+ protein family that, in most cases, extracts,
disassembles, or unfolds protein substrates, we hypothesized that
Msp1 might extract TA proteins that mislocalize to mitochondria
upon loss of the GET system. We tested this hypothesis for Pex15, a
peroxisomal TA protein that mislocalizes to mitochondria upon
disruption of the GET system (Schuldiner et al, 2008; Jonikas et al,
2009). Surprisingly, msp1D single mutants displayed significant
mitochondrial localization of a GFP-Pex15 fusion, nearly identical to
previous observations with the get3D single mutant (Fig 4A)
(Schuldiner et al, 2008; Jonikas et al, 2009). Much of the Pex15
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Figure 3. Depletion of ATAD1 causes decreased mitochondrial protein level and mitochondrial fragmentation in mammals.
A Immunoblots of whole-brain lysates obtained from the wild-type (WT) and ATAD1!/! knockout (KO) mice. PDH, pyruvate dehydrogenase; HXK1 and 2, hexokinase 1
and 2.
B The optical densitometry quantification of (A). The values represent the mean " SEM (n = 3, *P < 0.05, **P < 0.005, ***P < 0.001, one-way ANOVA, Tukey’s multiple
comparison tests).
C Oxygen consumption rate (OCR) of the WT and ATAD1!/! mouse embryonic fibroblasts (MEFs). The data were normalized to the amount of protein in each well and
represent % control. **P < 0.005, ***P < 0.001.
D Representative images of the mitochondrial morphology of the WT and ATAD1!/! MEFs. The cells were transfected with Mito-RFP (red), stained with DAPI (blue), and
visualized.
E Five-fold dilutions of the indicated strains harboring empty vector (EV), yeast Msp1, human ATAD1 or fly CG5395 construct cultured overnight in SD-Ura medium were
spotted on SD-Ura or SGly-Ura plates and incubated at 30 or 37°C.
Source data are available online for this figure.
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protein continues to be targeted to peroxisomes in the single-mutant
strains (Supplementary Fig S4A). In the get3D msp1D mutant, we
observed more complete co-localization of the GFP and RFP signals,
which can only be seen with greatly extended exposure time due to
the diminished mitochondrial content in this mutant (Fig 4A; see
also Fig 2B and D). We also performed the converse experiment by
overexpressing Msp1 in the get3D mutant expressing GFP-Pex15
and observed complete depletion of mislocalized Pex15 from the
mitochondria (Fig 4B).
We tested the possibility that Msp1 binds and perhaps extracts
mislocalized Pex15. Given that the wild-type Msp1 protein may
associate with substrates transiently, we performed co-immuno-
precipitation experiments using yeast strains expressing a ‘substrate
trap’ E193Q mutant (asterisk in Fig 1A), which is predicted to bind
substrates but fail to release them efficiently (Weibezahn et al,
2003; Hanson & Whiteheart, 2005). Consistent with this notion,
exogenous expression of Msp1E193Q was unable to rescue the growth
defect of the get3D msp1D mutant; moreover, it induced a dominant-
negative phenotype in the get3D single mutant (Supplementary
Fig S2B). As shown in Fig 4C, we observed that when Pex15 was
overexpressed, it stably interacted with Msp1E193 particularly in the
get4D mutant background. Note that we consistently observed
higher accumulation of Msp1E193Q in spite of it being expressed
under the endogenous MSP1 promoter. This possibly also contrib-
utes to the apparent interaction affinity relative to wild-type Msp1.
It is also noteworthy that Pex15 exhibits elevated accumulation in
the get4D mutant expressing the dominant-negative Msp1E193Q,
possibly related to mislocalization and stabilization on mitochondria
(Fig 4C–input panel).
If the severe phenotype of the get3D msp1D double mutant is due
to accumulation of mislocalized TA proteins in the mitochondrial
outer membrane, overexpression of proteins like Pex15 should exac-
erbate this phenotype. To test this, we compared growth upon over-
expression of GFP-Pex15 from the GAL1 promoter. While the get3D
msp1D mutant exhibited impaired growth on its own, the GAL1::
PEX15 construct caused a complete loss of growth on galactose
medium (Fig 4D). One possible mechanism whereby Msp1 might
maintain a low level of mislocalized TA proteins is to extract them
and facilitate their degradation. We tested the half-life of GFP-Pex15
utilizing the stringent glucose repression of new transcription from
the GAL1 promoter. We first noticed that the steady-state level of
Pex15 was increased in the msp1D mutant compared to WT
(t = 0 min, Supplementary Fig S4B). Furthermore, the time-course
of Pex15 degradation was significantly slower in the msp1D mutant
(Supplementary Fig S4B and C) most likely due to impaired extrac-
tion and degradation of mitochondrial Pex15. To more rigorously
test whether Msp1 limits mitochondrial Pex15 by facilitating its
degradation, we measured the half-life of Pex15 in the get3D mutant
expressing either the wild-type Msp1 or mutant Msp1E193Q (Fig 4E,
Supplementary Fig S4D and E). Therefore, in both cases, Pex15 is
strongly mislocalized to mitochondria (t = 0 min, Supplementary
Fig S4D). Pex15 is significantly more stable in the strain expressing
Msp1E193Q (Fig 4E and Supplementary Fig S4E). When we visual-
ized the localization of GFP-Pex15 throughout the time-course, we
observed that mitochondrial Pex15 was degraded faster in the get3D
mutant expressing the wild-type Msp1 compared to the Msp1E193Q,
which still retained significant mitochondrial Pex15 after 180 min
(Supplementary Fig S4D). Taken together, these results suggest that
Msp1 is required to minimize the abundance of the Pex15 TA
protein on mitochondria, most likely by promoting its extraction
and degradation.
We also tested whether hATAD1 functions similarly to protect
mammalian mitochondria from the mislocalization of PEX26, the
human ortholog of Pex15. We established a human hepatocellular
carcinoma (HepG2) cell line stably expressing GFP-PEX26 and
repeatedly observed very modest mitochondrial GFP localization in
a minority of cells (Fig 4F-top; marked by arrows). Knockdown of
ATAD1 with three distinct siRNAs (Fig 4G), however, greatly
increased the overlap of GFP-PEX26 and Mitotracker Red (Fig 4F).
We also observed that the overall intensity of the mitochondrial
GFP signal was significantly enhanced, consistent with increased
steady-state level of PEX26 in the whole-cell lysates from multiple
cell lines (Fig 4F and Supplementary Fig S4F). Taken together, both
yeast Msp1 and human ATAD1 protein are important to minimize
the mitochondrial mislocalization of the TA proteins, Pex15, and
PEX26, respectively.
Figure 4. Yeast Msp1 and human ATAD1 are required to limit the level of mitochondrially mislocalized TA proteins Pex15 and PEX26, respectively.
A Representative images of GFP-Pex15 localization. The indicated yeast strains expressing GFP-Pex15 from the GAL1 promoter and plasmid-borne Mito-RFP were grown
overnight in SD medium, switched to galactose induction medium for 6 h, and visualized by fluorescence microscopy. The get3D msp1D images (1,000 ms) were
exposed 5 times longer than the WT, msp1D, and get3D images (200 ms).
B The WT and get3D strain expressing GFP-Pex15 from the GAL1 promoter and the plasmid-borne Mito-RFP were transformed with either EV or a Msp1 overexpressing
construct (Msp1(2l)) and subjected to the same procedure as described in (A).
C Pex15 co-immunoprecipitates with the ‘trap mutant’ Msp1E193Q. Msp1 was immunoprecipitated by anti-HA antibodies from digitonin-solubilized mitochondria that
were extracted from the indicated strains overexpressing GFP-Pex15 from the GAL1 promoter and empty vector (!), wild-type Msp1 (WT) or Msp1E193Q (E193Q). Pex15
expression was induced in galactose medium for 6 h. 4% of the crude lysates, and final eluates were immunoblotted with anti-HA and GFP. Om45 is a mitochondrial
outer membrane protein and is used as a loading control.
D Five-fold dilutions of the indicated strains expressing Pex15 from the native PEX15 promoter or GAL1 promoter (PGAL1::GFP–PEX15) were grown overnight in SD
medium, spotted on SD or synthetic galactose (SGal) plates, and cultured at 30°C.
E The get3D strain co-expressing GFP-Pex15 from the GAL1 promoter and wild-type Msp1 or Msp1E193Q was pulsed in galactose medium for 5 h to induce GFP-Pex15
accumulation and chased in glucose medium to shut off transcription. Whole-cell lysates were prepared from cells harvested every 45 min and analyzed by
immunoblot. Por1 is the loading control.
F HepG2 cells stably expressing GFP-PEX26 were treated with scrambled siRNA (scr) or siRNAs (#1–3) targeting human ATAD1 for 6 days, stained with Mitotracker Red,
and visualized by fluorescence microscopy with equivalent exposure times.
G Whole-cell lysates of cells from (F) were analyzed by immunoblot using the indicated antibodies. QCR2 is a mitochondrial protein and is used as a loading control.
Source data are available online for this figure.
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Msp1/hATAD1 physically interacts with and is required
to prevent TA protein Gos1/GOS28 misaccumulation
on mitochondria
To identify bona fide substrates of Msp1, we performed a two-step
purification using a yeast strain expressing Msp1-His6/HA3 tag from
the MSP1 promoter. We expressed the wild-type or E193Q mutant
Msp1 in both the WT and get3D strains and purified Msp1 by two-
step purification. In examining potential substrates, we aimed to
look for proteins that fulfill two criteria. First, they are purified more
efficiently by the ‘trap mutant’ Msp1E193Q than by the wild-type
protein. Second, they exhibit stronger association with Msp1 in the
get3D mutant strain than in the WT strain. As shown in Supplemen-
tary Table S1, Gos1 meets both criteria and is one of the most abun-
dant proteins detected by mass spectrometry. Importantly, it is also
a TA protein and functions as a v-SNARE in Golgi vesicular traffick-
ing (McNew et al, 1998). We first verified this result by conducting
a directed co-immunoprecipitation experiment. We expressed GFP-
Gos1 and Msp1-HA fusion proteins under their endogenous promot-
ers and performed an anti-HA immunoprecipitation from crude
mitochondrial lysate. As seen in Fig 5A, GFP-Gos1 showed a stable
association with Msp1E193Q. We also observed a stronger GFP-Gos1
purification with Msp1E193Q in the get3D and get4D mutants
compared to a strain with a functional GET system (WT). Note that
Msp1E193Q consistently accumulated at a higher level compared to
the wild-type protein (Fig 5A – input panel; also see Fig 4C – input
panel). Similar to Pex15, the steady-state level of Gos1 was higher
in the get3D and get4D mutant strains expressing the dominant-
negative Msp1E193Q mutant (Input panel, Fig 5A). To test Gos1
localization, we expressed GFP-Gos1 under the endogenous GOS1
promoter and observed a partial overlap of GFP-Gos1 signal with
Mito-RFP in both the get4D msp1D mutant strain and in the get3D
mutant expressing the dominant-negative Msp1E193Q (Fig 5B and
Supplementary Fig S5A).
To test whether Msp1 facilitates the degradation of mislocalized
Gos1, we used the GAL1 promoter-based transcriptional shut-off
system to test its half-life. Overexpression of Gos1 from the GAL1
promoter leads to its mislocalization to the mitochondria of the
get3D mutant (T = 0 min, Fig 5D). The time-course of Gos1 degra-
dation in the get3D mutant expressing dominant-negative Msp1E193Q
is significantly slower than the get3D mutant, which expresses
endogenous wild-type Msp1 (Fig 5C). We also visualized the
localization of GFP-Gos1 throughout the time course. We observed
that mitochondrial Gos1 was degraded faster in the get4D mutant
compared to the strain expressing Msp1E193Q, which still retained
significant mitochondrial Gos1 after 180 min (Fig 5D).
To further address whether misaccumulation of Gos1 contributes
to the mitochondrial damage in the get3D msp1D mutant, we
attempted to delete GOS1 and test for rescue of the growth pheno-
type. Unfortunately, loss of Gos1 in our W303-1a strain background
causes lethality (Supplementary Fig S5B). Instead, we reasoned that
overexpression of Gos1 might overload mitochondria and exacer-
bate the growth phenotype caused by loss of Msp1 and/or the GET
system. As shown in Fig 5E, overexpression of Gos1 either caused
or exacerbated growth phenotypes in get1D, get2D, and get3D single
mutants. The double mutants containing those deletions combined
with an msp1D mutation already exhibited such severe growth
defects that Gos1 had no additional consequence. However, the
get4D msp1D, get5D msp1D, and msp1D sgt2D double mutants,
which maintained much more mitochondrial function (See Fig 2),
were markedly impaired by Gos1 overexpression, particularly in
glycerol growth (Fig 5E). The effect of Gos1 overexpression is
specific as overexpression of Sbh1, an endoplasmic reticulum TA
protein that does not mislocalize to mitochondria, did not exacer-
bate the growth phenotypes (Supplementary Fig S5C) (Schuldiner
et al, 2008).
In addition to Gos1, we also observed that Tom5, a native mito-
chondrial TA protein, was strongly purified by Msp1E193Q in the
wild-type and the get3D mutant strain (Supplementary Table S1).
This observation raised the possibility that Msp1 might not only
bind to non-native, mislocalized mitochondrial TA proteins but also
to native proteins. To test this hypothesis, we tagged Tom5 and all
other mitochondrial TA proteins, Tom6, Tom7, Tom22, Fis1, Gem,
and Fmp32 with a GFP at their N-termini and performed co-immu-
noprecipitation experiments (Supplementary Fig S6A). We observed
no interaction between Tom5, Tom6, Fis1, Gem1, or Fmp32 and
either wild-type Msp1 or the Msp1E193Q mutant. Tom7 and Tom22
showed an interaction, but it was with both the wild-type and
mutant Msp1 protein. More importantly, we observed no significant
delay in the rate of degradation of any of these native mitochondrial
TA proteins in the msp1D mutant (Supplementary Fig S6B). Further-
more, overexpression of TOM5, TOM6, or TOM7 did not exacerbate
the growth phenotype of the msp1D mutant strain (Supplementary
Fig S6C). Therefore, it appears that none of the native mitochondrial
TA proteins are efficient substrates of Msp1, at least in the condi-
tions in which we conducted these experiments.
Figure 5. Msp1 physically interacts with the TA protein Gos1 and is required to limit mitochondrial Gos1.
A Gos1 co-immunoprecipitates with the ‘trap mutant’ Msp1. Msp1 was immunoprecipitated by anti-HA antibody from digotonin-solubilized mitochondria that were
extracted from the indicated strains expressing GFP-Gos1 from the native GOS1 promoter and empty vector (!), wild-type Msp1 (+) or Msp1E193Q (E193Q). 4% of the
crude lysates and final eluates were immunoblotted with anti-HA, GFP, and Om45 antibodies. Om45 is a control mitochondrial outer membrane protein.
B The indicated strains expressing GFP-Gos1 from the native promoter and Mito-RFP were grown in SD medium to early log phase and visualized by fluorescence
microscopy.
C The get3D strain expressing GFP-Gos1 from the GAL1 promoter was transformed with EV or Msp1E193Q, grown in galactose medium for 5 h to induce Gos1 expression
and then switched to glucose medium to shut off transcription. Cells were harvested every 30 min thereafter, and the whole-cell lysates were analyzed by
immunoblot.
D Representative images of the GAL1 promoter-based transcriptional shut-off experiment as described in (C) except that the indicated strains were co-transformed with
Mito-RFP to visualize mitochondria.
E Five-fold dilutions of the indicated strains harboring either empty vector (!) or Gos1 overexpression 2 l vector (+) were spotted on SD or SGly plates and incubated
at 30 or 37°C.
Source data are available online for this figure.
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Based on our observations with Gos1, we performed two experi-
ments to test whether GOS28, the mammalian ortholog of yeast
Gos1, is subjected to mitochondrial misaccumulation, which is
prevented by ATAD1. First, to test whether GOS28 misaccumulates
on mitochondria upon ATAD1 depletion, we established a human
dermal fibroblast (HDF) cell line stably expressing a GFP-human
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GOS28 fusion protein and subjected it to knockdown with control
and ATAD1 siRNAs. In control siRNA (scr)-treated cells or cells
treated with si#4 that fails to knockdown ATAD1 (Fig 6B), the
majority of the GFP signal was localized to the peri-nuclear Golgi
apparatus and had no overlap with Mitotracker Red (Fig 6A).
However, when ATAD1 was knocked down by si#1, 2, or 3
(Fig 6B), we clearly observed a partial redistribution of GFP-GOS28
to overlap with Mitotracker Red (Fig 6A). Second, to directly test
whether GOS28 physically interacts with ATAD1, we assessed co-
immunoprecipitation using crude mitochondrial extract from HepG2
cells stably expressing GFP-GOS28 and empty vector, wild-type
ATAD1 or a substrate trap mutant ATAD1 (ATAD1E193Q). Only the
ATAD1E193Q mutant purified detectable amounts of GOS28 (Fig 6C).
Note that the steady-state GOS28 level was reproducibly elevated in
cells expressing the ATAD1E193Q (Fig 6C, lane 3), which is likely
caused by its dominant-negative activity. This is consistent with the
observation that expression of ATAD1E193Q causes ectopic accumu-
lation of GFP-GOS28 on the mitochondria (Supplementary Fig S7A).
Most importantly, we further observed increased steady-state abun-
dance of endogenous GOS28 in multiple ATAD1!/! mouse tissues,
including brain, liver, and heart (Fig 6D and Supplementary Fig
S7B). We therefore conclude that Gos1 and GOS28 are bona fide
substrates of yeast Msp1 and mammalian ATAD1, respectively.
Discussion
Based on the data presented herein, we conclude that yeast Msp1
and human ATAD1 belong to an evolutionarily and functionally
conserved protein family. We demonstrate that they play a role in
quality control of mitochondrial outer membrane proteins. Specifi-
cally, Msp1 or ATAD1 prevents a subset of TA proteins (yeast–
Pex15 and Gos1; mammals–PEX26 and GOS28) that escape from the
GET or TRC system from inappropriately accumulating on the
mitochondria, likely by extracting them and facilitating their cyto-
plasmic degradation. The physiological consequences of combined
impairment of Msp1 and the GET system include loss of mtDNA,
loss of mitochondrial resident proteins, and severely altered mito-
chondrial morphology. The principal evidence supporting this
model is enumerated below.
First, we have found that the targeting and insertion systems for
TA proteins are quite imprecise. This necessitates quality control
systems to manage the burden of TA proteins that are mislocalized
to other cellular compartments. In mammals, the cytoplasmic Bag6
protein not only participates in chaperoning TA proteins to the ER
for insertion, but also mediates ubiquitination of proteins that are
inappropriately released from ribosomes (Mariappan et al, 2010;
Hessa et al, 2011). We suggest that the Msp1 protein family repre-
sents a similar protein quality control system for the mitochondria.
This system is necessitated by the fact that, even when the GET or
TRC system is fully functional, TA proteins can escape and mislocal-
ize to mitochondria. This is demonstrated by our observation that
deletion of Msp1 alone caused ectopic accumulation of Pex15 protein
on yeast mitochondria (Fig 4A). This is also true for both PEX26 and
GOS28 when ATAD1 protein was depleted in multiple human cell
lines (Figs 4G and 6A and Supplementary Fig S7A). For reasons that
remain unclear, the mitochondrial membrane appears to be a recep-
tive host for TA proteins that fail to target their native membrane. It
is possible that this is because the mitochondrial outer membrane
appears to be one of the only two organelles where TA proteins are
directly targeted and inserted. Previous reports and our data (Fig 4A)
clearly show that genetic impairment of the GET system causes
mislocalization of a subset of TA proteins on the mitochondria
(Schuldiner et al, 2008; Jonikas et al, 2009). Therefore, we suggest
that cells have evolved a protein quality control system residing on
mitochondria to handle this burden of mislocalized TA proteins.
Second, Msp1 physically interacts with mislocalized TA proteins.
Our two-step purification identified the TA protein Gos1 as a possi-
ble genuine substrate of Msp1, which interacts with the substrate
trap mutant Msp1 (Supplementary Table S1 and Fig 5A). This Msp1
mutant can also stably bind to overexpressed Pex15, but for
unknown reasons, we did not observe Pex15 in the Msp1 co-purifi-
cation experiment. Presumably, the substrate trap mutant Msp1
stabilizes the physical interaction with substrates, while wild-type
Msp1 may bind to them transiently. It is also possible, however, that
the enhanced observed binding of mutant Msp1 is simply a function
of its elevated accumulation. Beyond Gos1 and Pex15, we expect
that additional substrates remain to be discovered. Interestingly, we
also identified Tom5 as another potential substrate by Msp1 co-puri-
fication; however, we failed to recapitulate this result using directed
co-immunoprecipitation experiments (Supplementary Fig S6A). It is
possible that the observation of co-purification is an artifact, and
Tom5 and Msp1 have no relationship. It is also possible, however,
that Tom5 is a bona fide substrate of Msp1, but we failed to obtain
evidence for this either due to the specific conditions of our experi-
ments or the use of a GFP-Tom5 fusion protein. As a result, we do
not firmly conclude that Msp1 cannot recognize native mitochon-
drial TA proteins as substrates. In addition, it is possible that Msp1
extracts a broader range of protein substrates, including non-TA
proteins, which is consistent with our observation of non-TA mito-
chondrial proteins bound specifically to the Msp1-E193Q mutant in
the two-step purification experiment (Supplementary Table S1). In
fact, mammalian ATAD1 (possibly the cytoplasmic pool) was
shown to extract or disassemble the AMPAR protein complex,
which has no TA protein constituents, from the cell surface (Zhang
et al, 2011). Therefore, while Msp1/ATAD1 clearly functions in the
degradation of mitochondrially mislocalized TA proteins, it appears
to function in a broader context as well.
Third, Msp1 is required for the normal rate of degradation of
mislocalized TA proteins. We repeatedly observed that the steady-
state level of Msp1 substrate proteins is higher in Msp1- or ATAD1-
depleted cells. Furthermore, we conducted a chase experiment on
Pex15 and Gos1 and demonstrated that their half-life is extended in
the absence of Msp1 (Fig 4E, Supplementary Figs S4B–E and S5C
and D). We speculate that Msp1 unfolds and extracts Pex15 and
Gos1 via ATP hydrolysis by the AAA+ domain. However, unlike m-
or i-AAA ATPase, which has an accessory proteolytic domain to
digest the unfolded peptide, Msp1 possesses only the AAA+ domain.
Therefore, the mechanisms whereby mislocalized TA proteins are
degraded in the cytosol remain to be explored. It is known that the
cytoplasmic proteasome is engaged to degrade membrane proteins
from various organelles, including the ER and mitochondria
(Neutzner et al, 2007; Karbowski & Youle, 2011; Taylor & Rutter,
2011). Therefore, it seems likely that proteasomes provide the major
degradative activity for TA proteins once they are extracted from the
mitochondria.
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Fourth, the Msp1 and ATAD1 proteins are essential for the main-
tenance of mitochondria. We observed that loss of both Msp1 and
the GET system causes loss of mtDNA and protein, and severe
morphological defects (Fig 2). Mammalian cells, however, seem to
be more susceptible to the depletion of ATAD1 as mutation of
ATAD1 is sufficient to cause significant mitochondrial impairment
(Fig 3A–D). Prior to this study, the major connection between the
GET system and mitochondria related to TA protein mislocalization
to mitochondria upon GET system disruption. Perhaps, the most
profound mitochondrial defect observed is the loss of mitochondrial
protein content in the get1D msp1D, get2D msp1D, and get3D msp1D
mutant strains, which cannot be explained by the loss of mtDNA.
Given that the TA proteins Tom5, Tom6, Tom7, and Tom22 are
critical components of the TOM complex, perhaps ectopic TA
protein accumulation causes defects in TOM complex formation.
The ectopic TA proteins could either displace one or more of the
tail-anchored components of the TOM complex, rendering it inac-
tive. Alternatively, hyper-accumulation of TA proteins could impair
the unknown mitochondrial TA protein import system, leading to
decreased import efficiency of Tom5, Tom6, Tom7 and/or Tom22
and therefore impaired mitochondrial protein import. We also
observed altered mitochondrial morphology in both msp1D yeast
and ATAD1 knockdown cells. Intriguingly, before the function of
the GET system was determined, Get1 (also known as Mdm39) was
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Figure 6. ATAD1 physically interacts with the TA protein, GOS28, and is required to limit the level of mislocalized GOS28 on mitochondria in mammals.
A Human dermal fibroblasts (HDFs) stably expressing GFP-GOS28 were treated with scr or siRNA (#1-4) against hATAD1, stained with Mitotracker Red, and visualized
by fluorescence microscopy.
B Whole-cell lysate of cells from (A) were immunoblotted using anti-ATAD1 and actin (loading control) antibodies.
C Crude mitochondria were extracted from HepG2 cells that stably co-express GFP-GOS28 with empty vector (!), HA-tagged wild-type ATAD1 (WT), or ATAD1E193Q
mutant. ATAD1 was immunoprecipitated using anti-HA antibody from digitonin-solubilized lysates and 5% of the crude lysates, and eluates were immunoblotted
with anti-GFP and HA antibodies.
D Mouse tissue lysates (30 lg protein) from three WT and ATAD1!/! mice were analyzed by immunoblot. S6 ribosomal protein and actin are used as loading controls.
E The optical densitometry quantification of (D). The values represent the mean " SEM (***P < 0.001, one-way ANOVA).
Source data are available online for this figure.
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discovered in a genetic screen for genes important for mitochondrial
distribution and morphology (Dimmer et al, 2002). Perhaps, this
observation relates to the effect of mislocalized TA proteins, caused
by mutation of GET1, to impair mitochondrial morphology. In fact,
many mitochondrial shaping factors such as Fis1 (yeast and
mammals), Mff (mammals), and Gem1 (yeast) are TA proteins.
Therefore, as speculated for the TOM complex above, mitochondrial
morphology and dynamics might be susceptible to aberrant accumu-
lation of non-mitochondrial TA proteins. For example, mislocaliza-
tion of the Gos1 v-SNARE protein might enable promiscuous fusion
events with organelles displaying cognate t-SNARE proteins.
Finally, our data suggest that the mitochondrial function of Msp1
protein family is conserved between yeast, flies, and mammals.
Both Drosophila CG5395 and human ATAD1 suppressed the respira-
tory growth phenotype of the get3D msp1D mutant strains (Fig 3E).
In addition, depletion of ATAD1 caused accumulation and mito-
chondrial localization of PEX26 and GOS28 as well as mitochondrial
defects (Figs 3, 4G and 6, and Supplementary Fig S3D). In Drosoph-
ila, mitochondria undergo dramatic morphological changes during
spermatogenesis. At the onion stage, mitochondria form a special-
ized structure called the nebenkern (Tokuyasu, 1975). Mutation of
the fly MSP1 ortholog CG5395 (nmd mutant, no mitochondrial deriv-
ative) leads to a much smaller nebenkern and a slight loss of mito-
chondrial membrane potential (Noguchi et al, 2011). While these
data do not implicate impaired protein quality control, it demon-
strates that this gene is important in mitochondrial morphology and
function. Furthermore, ATAD1 knockout mice exhibit severe neuro-
nal defects, including deficiencies in learning and memory and a
seizure-like syndrome (postnatal day 19–25) (Zhang et al, 2011).
Interestingly, we observed ectopic accumulation of GOS28 in
multiple tissues from ATAD1!/! mice, particularly the brain
(Fig 6D). Some of these neuronal deficits are likely due to the failure
of disassembly of the AMPAR receptor, but similar neuronal pheno-
types are observed with impaired mitochondrial quality control in
mice and humans (Rugarli & Langer, 2012). We speculate that the
mitochondrial defects caused by loss of ATAD1 might partially
contribute to the phenotype of the ATAD1!/! mice.
In conclusion, we suggest that the Msp1/ATAD1 protein family
performs an evolutionarily conserved role in quality control of the
mitochondrial outer membrane. This function, while perhaps
including additional activities, is likely to extract and promote the
degradation of TA proteins that have been mislocalized to mito-
chondria. The consequences for failure of this activity, particularly
under a stress to the GET system, are devastating for mitochondrial
morphology and function. Given the critical importance of mito-
chondrial quality control in human physiology and pathophysiol-
ogy, we anxiously await a broader and deeper understanding of this
protein family in health and disease.
Materials and Methods
Yeast strains and growth conditions
Saccharomyces cerevisiae W303-1a (MATa, his3 leu2 met15 trp1
ura3) was used in this study. The standard PCR-based homologous
recombination method was used to generate all mutant strains.
Briefly, drug selection cassette (KanMX4, hphMX4, or natMX4)
flanked with 45-bp fragments upstream and downstream of the
gene of interest was PCR amplified and transformed into the wild-
type diploid (Goldstein & McCusker, 1999) (Wach et al, 1994). The
haploid strain was generated by sporulation and tetrad analysis. The
strains with chromosomally integrated PGAL1-GFP-PEX15 were gener-
ated as described in (Longtine et al, 1998). The genotype of the
strain was verified by standard genotyping PCR. The genotypes of all
yeast strains used in this study are listed in Supplementary Table S2.
For yeast transformation, the standard lithium acetate procedure
was used (Gietz et al, 1992). Transformed yeast cells were grown in
synthetic complete dextrose (SD) medium lacking the appropriate
amino acid(s) for auxotrophic selection purposes at 30°C. Media
used in this study include standard YP and synthetic minimal
medium supplemented with 2% glucose, 2% raffinose, or 3% glyc-
erol. Solid plates contain 2.2% (w/v) agar.
Plasmid construction
To produce plasmids expressing non-tagged, C-terminal His6/HA3 or
GFP-tagged Msp1, the MSP1 ORF flanked with its upstream 500-bp
promoter region was PCR amplified from yeast genomic DNA and
ligated into the pRS416, pRS426, or pRS416 vector containing either
a C-terminal His6/HA3 or GFP tag. Msp1
E193Q construct was made
by site-directed mutagenesis of the Msp1-His6/HA3 construct. To
generate human ATAD1 and fly CG5393 constructs, ATAD1 and
CG5393 ORF were amplified from HepG2 and fly cDNA, respec-
tively, and ligated into pRS416-based vector containing the ADH1
promoter (Mumberg et al, 1995). N-terminal GFP-tagged Gos1
construct was made by ligating PGOS1, GFP, and GOS1 ORF frag-
ments together using the standard sewing PCR and ligating into the
pRS414 vector. The PGAL1::GFP-Gos1 construct was generated by
ligating GOS1 ORF into pRS414-based vector containing the GAL1
promoter and a N-terminal GFP tag. The Retro-XTMQ Vectors (Clon-
tech) were used to generate mammalian constructs. Human ATAD1
ORF fused with HA or GFP tag at the 30-end or PEX26 or GOS28 ORF
fused with GFP at the 50-end was ligated into pQCXIP or pQCXIZ
vector. Site-directed mutagenesis was used to convert ATAD1-HA
into ATAD1E193Q-HA. Peroxisomal fluorescent marker construct was
made by fusing RFP protein with the peroxisomal targeting
sequence (SKL) at the C-terminus.
Isolation of yeast mitochondria
Yeast cells were harvested at mid-log phase (OD600 = 2–3) unless
indicated otherwise. Preparation of crude and purified mitochondria
was as described previously (Boldogh & Pon, 2007). Yeast pellet
was washed once with ddH2O, resuspended, and incubated in TD
buffer (100 mM Tris-SO4, pH 9.4 and 100 mM DTT) for 15 min at
30°C. Spheroplasts were obtained by incubating cells in SP buffer
(1.2 M sorbitol and 20 mM potassium phosphate, pH 7.4) supple-
mented with lyticase (2 mg/g of cell pellet) (Sigma-Aldrich) for 1 h
at 30°C to digest the cell wall. Spheroplasts were gently washed
once in ice-cold SHE buffer (1.2 M sorbitol, 20 mM HEPES-KOH, pH
7.4, 2 mM MgCl2, 1 mM EGTA, and 1 mM PMSF) and homogenized
in ice-cold SHE buffer that contains 0.6 M sorbitol with a Dounce
homogenizer applied with 10-20 strokes. The crude mitochondrial
fraction was obtained by differential centrifugation. Protein concen-
tration was determined using Bradford protein assay (Bio-Rad).
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Continuous Nycodenz gradients were used to purify crude
mitochondria. To make a gradient, 2.1 ml of 5, 10, 15, 20, and 25%
Nycodenz in SHE buffer was layered in 14 × 89 mm Ultra-Clear
centrifuge tubes (Beckman) and the tubes were sat at room tempera-
ture for 3–4 h to allow the Nycodenz to diffuse. Crude mitochondria
were loaded on top of the chilled gradient and separated at
100,000 × g for 1 h at 4°C (SW41 rotor; Beckman). Intact purified
mitochondria were recovered from a brown band at around 16%
Nycodenz concentration.
Assessment of sub-mitochondrial localization
The experiment was conducted as described previously (Chen et al,
2012). Briefly, proteinase-free mitochondria were incubated in the
isotonic SH buffer (0.6 M Sorbitol, 20 mM HEPES-KOH) or hypo-
tonic H buffer (20 mM HEPES-KOH) with and without 1% Triton
X-100. Proteinase K (10 lg/ll) was then added and incubated on ice
for 20–30 min. The digestion was stopped by adding phenylmethyl-
sulfonyl fluoride (PMSF) to 2 mM. The reaction mixtures were
denatured in 6× Laemmli buffer and resolved by 12% SDS-PAGE,
followed by immunoblot.
The high-salt and alkaline extraction were adapted from a previ-
ously described protocol (Boldogh & Pon, 2007). Intact mitochon-
dria were treated with salt (100 mM KCl in SHE buffer without
sorbitol) or carbonate (100 mM Na2CO3 in SHE buffer) for 30 min
on ice and subjected to ultracentrifugation (100,000 × g for 20 min)
to separate soluble and insoluble proteins. Soluble fractions were
precipitated by 15% trichloroacetic acid (TCA) and dissolved in 1×
Laemmli buffer. An equal amount of lysate from both the soluble
and insoluble fraction was analyzed by immunoblot.
Two-step Msp1-His6/HA3 purification
Crude mitochondria isolated from strains grown in synthetic raffi-
nose medium to mid-log phase (OD600 = 2.5) were solubilized in
lysis buffer (20 mM HEPES, pH 7.4, 10 mM KCl, 1.5 mM MgCl2,
1 mM EDTA, 150 mM NaCl, 10 mM imidazole, 2.1 mg/ml NaF,
10.8 mg/ml 2-glycerolphosphate, 0.5% digitonin and protease
inhibitors) for 1 h at 4°C. For the first step of the purification,
cleared mitochondria lysates were incubated with equilibrated
Ni-NTA beads for 1 h at 4°C. Ni-NTA beads were washed 5 times
with wash buffer (compositions are same as lysis buffer except for
20 mM imidazole and 0.05% digitonin). Proteins were eluted three
times by 250 mM imidazole under non-denaturing conditions. For
the second step of the purification, final eluates of the first purifica-
tion were combined and mixed with anti-HA antibody-conjugated
agarose (A2095; Sigma) for 1 h at 4°C. The agarose was then
washed five times, and proteins were eluted five consecutive times
by 1 mg/ml HA peptides. Final eluates were precipitated in 15%
TCA overnight at 4°C and analyzed by mass spectrometry.
Fluorescence microscopy
Yeast samples were prepared by growing yeast cells to early log
phase (OD600 = 0.8–1) in synthetic dropout medium with appropri-
ate carbon sources at 30°C. To prepare mammalian cell samples, we
cultured cells on Poly-L-Lysine-coated Lab-Tek II chamber slides for
a day to allow them to fully attach. They were either visualized
directly or stained with 25 nM Mitotracker Red CMXRos (Life Tech-
nologies) in FBS-free medium for 5 min at 37°C before imaged. To
examine morphological changes in mitochondria from ATAD1!/!
MEFs, they were transiently transfected with Mito-RFP to label the
mitochondria. Transfected cells were fixed for 15 min with 4%
PFA + 4% sucrose in PBS without permeabilization. Cells were
washed three times with PBS buffer, stained with DAPI, and washed
three more times with PBS buffer. Images of the cells were acquired
by using a Zeiss LSM 710 laser-scanning confocal microscope using
a 40× oil-immersion objective.
Cells were imaged on the Axio Observer. Z1 imaging system
(Carl Zeiss) equipped with 40× and 100× objectives (oil-immersion).
Digital fluorescence and differential interference contrast (DIC)
images were acquired using a monochrome digital camera (Axio-
Cam MRm, Carl Zeiss). Z-stacks of 0.35-lm slides were obtained
and deconvolved using the AxioVision software (Version 4.8, Carl
Zeiss). 2D projection of the z-stacks was performed using the ImageJ
software. The final images were adjusted and assembled using
Adobe Photoshop CS5.1. Brightness and contrast were adjusted only
using linear operation on the entire image.
The yeast fluorescent images shown in this study are representa-
tive pictures from at least two independent experiments (n ≥ 2).
The images of the mammalian cells are representative of three inde-
pendent experiments (n = 3).
Mass spectrometry
TCA pellets were resuspended in 8 M urea, 50 mM HEPES, and pH
8.8. Proteins were reduced by the addition of dithiothreitol to 5 mM
and incubation at room temperature for 30 min. Cysteines were
alkylated by adding iodoacetamide to 15 mM and incubating in the
dark at room temperature for 60 min. Iodoacetamide was quenched
with an additional 10 mM DTT. Samples were digested with lysyl
endopeptidase (lysC) at 20 ng/ll overnight at room temperature
after diluting the urea to 2 M by adding 3 volumes of 50 mM HEPES,
pH 8.8. LysC-digested peptides were subsequently digested with
trypsin at 15 ng/ll for 60 min at 37°C. Doubly digested peptides
were acidified by adding trifluoroacetic acid to 0.2% and desalted on
hand-packed C18 STAGE tips (Rappsilber et al, 2007). Peptides were
eluted with 70% acetonitrile and 1% formic acid and dried under
vacuum. Desalted peptides were resuspended in 5% formic acid, and
each sample was analyzed in technical duplicate by reverse-phase
liquid chromatography electrospray mass spectrometry on a LTQ
Orbitrap Velos Pro (Thermo Fisher Scientific). Peptides were
analyzed on a LTQ Orbitrap Velos Pro mass spectrometer (Thermo
Fisher Scientific). Nanospray tips were hand-pulled with 100-lm
inside diameter fused-silica tubing and packed with 20 cm of Maccel
C18AQ resin (3 mm, 200 A˚; Nest Group). Peptides were separated
with a gradient of 6–30% CH3CN in 0.125% formic acid over 60 min
at a flow rate of 300 nl/min. Peptides were detected using a data-
dependent Top20 MS2 method. For each cycle, one full MS scan of
mass/charge ratio (m/z) = 400–1,200 was acquired in the Orbitrap
at a resolution of 60,000 at m/z = 400 with automatic gain control
(AGC) target of 1 × 106. Each full scan was followed by the selection
of the most intense ions, up to 20, for collision-induced dissociation
(CID) and analysis in the linear ion trap. Selected ions were excluded
from subsequent selection for 60 s. Ions with a charge of 1 or
unassigned were also excluded from MS2 analysis. Maximum ion
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accumulation times were 100 ms for both full MS and MS2 scans.
Lockmass, with atmospheric polydimethylsiloxane (m/z = 371.1012)
as an internal standard, was used for internal mass calibration.
Peptide identification and filtering
MS2 spectra were searched using SEQUEST v.28 (rev. 13) against a
composite database containing the translated sequences of all
predicted open reading frames of S. cerevisiae (http://down-
loads.yeastgenome.org, downloaded 30 October 2009) and its
reversed complement with the following parameters: a precursor
mass tolerance of ! 20 parts per million (ppm); 1.0-dalton product
ion mass tolerance; combined lysC–trypsin digestion; up to two
missed cleavages; a static modification of carbamidomethylation on
cysteine (+57.0214); and a dynamic modifications of methionine
oxidation (+15.9949). Peptide spectral matches were filtered to 1%
FDR using the target-decoy strategy combined with linear discrimi-
nant analysis (LDA) using several different parameters including the
SEQUEST Xcorr and DCn0 scores, and precursor mass error (Elias &
Gygi, 2007; Huttlin et al, 2010). The data were further filtered to
control protein-level FDRs. Peptides from all fractions in each exper-
iment were combined and assembled into proteins. Protein scores
were derived from the product of all LDA peptide probabilities,
sorted by rank, and filtered to 1% FDR. The FDR of the remaining
peptides fell markedly after protein filtering.
Steady-state protein analysis
Yeast whole-cell lysates were prepared from 1 OD600 of yeast cells
harvested from raffinose medium at mid-log phase. Yeast pellets
were washed with ddH2O once, resuspended in 200 ll of 20 mM
NaOH, incubated at room temperature for 5 min, and pelleted.
Laemmli buffer was added to resuspend pellets, and they were
denatured at 95°C for 5–10 min (Kushnirov, 2000). Anti-Cox2, Cox3
(MitoSciences), Por1, and Pgk1 (3-phosphoglycerate kinase)
(Abcam) were used on immunoblots.
Animal tissue lysates were obtained from brain homogenates of
4- to 5-week-old wild-type and ATAD1"/" mice (C57BL/6) (Zhang
et al, 2011). Freshly isolated whole brains were powderized on dry ice
and homogenized in lysis buffer (50 mM HEPES, pH 7.5, 150 mM
NaCl, 1 mM DTT, 5% glycerol, 1% Triton X-100) containing protease
inhibitors (Sigma-Aldrich). The brain extracts were kept on ice for 1 h
and then centrifuged at 15,000 × g for 30 min. Protein concentration
was determined using the BCA protein assay (Thermo Scientific).
Twenty lg of lysates was resolved on 4–20% gradient NuPAGE (Invi-
trogen) and transferred to PVDF membranes. Immunoblot analyses
were performed using ATAD1 antibodies (NeuroMab or abcam) and
mitochondrial antibodies, TOMM20, COX1, COX4, hexokinase 1,
hexokinase 2, VDAC1, pyruvate dehydrogenase, and S6 ribosomal
protein (Cell Signaling Tech.). b-actin, b-tubulin, and MAP2 (SIGMA)
antibodies were used for controls. All mouse experiments were
performed under approved protocols of the Institutional Animal Care
and Use Committee at Johns Hopkins University School of Medicine.
Measurement of oxygen consumption rate
Mitochondrial oxygen consumption rate (OCR) was assessed using
WT and ATAD1 KO MEFs in an XF24 Extracellular Flux Analyzer
(Seahorse Bioscience), as described previously (Cooper et al, 2012).
Culture media of MEF cells plated at a density of ~0.5 × 106 per well
in an XF24 cell culture microplates were replaced with XF24
Dulbecco’s modified Eagle medium (DMEM) containing 10 mM
glucose, 2 mM L-glutamine (Life Technologies), and 2 mM sodium
pyruvate (Life Technologies). OCR was measured at 37°C with
1-min mix, 1-min wait, and 5-min measurement protocol. OCR
was analyzed after 30 min incubation in a CO2-free incubator.
Oligomycin, carbonilcyanide m-chlorophenylhydrazone (CCCP),
and rotenone were sequentially injected into each well to assess
basal respiration, coupling of respiratory chain, and mitochondrial
respiratory capacity. OCRs were normalized relative to protein
concentration in each well, and the data are presented as % change
of control.
Co-immunoprecipitation
One milligram of crude mitochondria extracted from each strain was
solubilized in 0.5% digitonin for 1 h at 4°C. Cleared mitochondria
lysates were mixed with anti-HA antibody-conjugated agarose for
1 h at 4°C. Agarose was washed two times with buffer containing
250 mM NaCl and 0.05% digitonin and three times with buffer
containing 600 mM NaCl and 0.05% digitonin. Laemmli buffer with-
out b-ME was added to the agarose to elute proteins. Final eluate
and 4–5% of the mitochondria lysate were resolved by 12% SDS-
PAGE followed by immunoblot. Results shown in this study are
representatives of two independent experiments (n = 2).
Mammalian cell culture
HepG2 (human hepatocellular carcinoma) cells were maintained in
DMEM/F12 (Thermo Scientific) with 10% FBS. HEK293T, HDF
(human dermal fibroblasts), and HeLa cells were maintained in
DMEM (Thermo Scientific) with 10% FBS. Cells were cultured at
37°C with 5% CO2. To establish stable cell lines, retrovirus was
produced in HEK293T cells that were co-transfected with the
vector containing the gene of interest, Gag-pol, and VSVG (amount
ratio is 3:2:1) using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions. Retrovirus was harvested from the
medium at 48 h post-transfection and applied to the target cells.
After 24 h post-infection, target cells were selected in 4 lg/ml
puromycin and/or 150 lg/ml zeocin for 5–7 days. Stable cell lines
were maintained in the appropriate medium with 0.5 lg/ml puro-
mycin and/or 20 lg/ml zeocin. All knockdowns were performed
by treating cells with 10 nM siRNA, using the Lipofectamine
RNAiMax reagent, according to the manufacturer’s instructions
(Invitrogen). The All-Stars non-targeting siRNA (Qiagen) was used
as the control (scr). siRNAs targeting human ATAD1
(NM_032810.2) were designed with the Dharmacon siDesign
Center tool (http://www.thermoscientificbio.com/design-center/).
Sequences of the sense strands of targeting siRNAs, which include
a 30 tt DNA overhang, are as follows: (#1) GAAGCAAAUUGGAGU-
GAAAtt, (#2) GAAUGAAGUUGUUGGUUUAtt, (3) CAUGUUACU-
UGGAGUGAUAtt and (4) GAUAAGUGGUAUGGAGAAUdtt. Cells
were subjected to knockdown on day 0, again on day 3, and
analyzed on day 6. Efficacy of ATAD1 knockdown was verified by
immunoblot with mouse monoclonal anti-ATAD1 antibody
(1:1,000) (Abcam).
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Mouse embryonic fibroblasts (MEFs) were prepared from embry-
onic day 13 mouse pups as described previously with some modifi-
cation (Jozefczuk et al, 2012). MEFs were isolated from tissues by
0.05% trypsin/EDTA (Gibco, Invitrogen) dissociation. Cells were
strained using 40-lm cell strainer (BD Falcon) and resuspended in
Dulbecco’s modified Eagle’s medium (Gibco, Invitrogen), supple-
mented with 10% fetal bovine serum, 100 lg/ml penicillin, and
100 g/ml streptomycin. Cells were plated on poly-D-lysine-coated
cell culture dishes. All mouse experiments were performed under
approved protocols of the Institutional Animal Care and Use
Committee at Johns Hopkins University School of Medicine.
Supplementary information for this article is available online:
http://emboj.embopress.org
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Note added in proof
In agreement with our conclusions, Okreglak and Walter (2014) independently
demonstrated that yeast Msp1 promote the degradation of the mistargeted
Pex15 tail-anchored protein on the mitochondrial outer membrane.
Okreglak V, Walter P (2014) The conserved AAA-ATPase Msp1 confers
organelle specificity to tail-anchored proteins. Proc Natl Acad Sci U S A, in press
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Supplementary Figure 1. Yeast Msp1 and human ATAD1 localize to both mitochondria and 
peroxisomes. (Related to Figure 1) 








































Haploids obtained from tetrad dissection of diploids transformed with plasmids 
Haploids directly transformed with plasmids 










Supplementary Figure 2. The msp1уPXWDQWH[KLELWVJURZWKGHIHFWVDQGVHYHUHPLWRFKRQGULD
GDPDJHZKHQFRPELQHGZLWK*(7PXWDQWV5HODWHGWR)LJXUH
(A) The heterozygous get3уGET3 msp1уMSP1 diploid strain was transformed with EV, wild-type, 
N-terminal HA tagged (HA-Msp1), or C-terminal GFP (Msp1-GFP) or His6-HA3 (Msp1-His6-HA3) tagged 
Msp1 construct, was sporulated and tetrads were dissected. The obtained haploid strains harboring 
different vectors as well as the wild-type (WT) and the get3уVWUDLQVWKDWZHUHWUDQVIRUPHGZLWK(9
were spotted on SD-Ura or SGly-Ura plates and cultured at 30 or 37°C. (B) The get3уmsp1уKDSORLG
strains harboring the indicated constructs were prepared as in (A). Five-fold dilutions of these strains 
and the WT, msp1у RU get3у VWUDLQ WUDQVIRUPHG ZLWK (9 RU 0VSE193Q construct were spotted on 
SD-Ura or SGly-Ura plates and incubated at 30 or 37°C. (C) The indicated strains were transformed 
with EV, wild-type or the tagged Msp1 construct, and five-fold dilutions were spotted on SD-Ura or 
SGly-Ura plates and incubated at 30 or 37°C. (D) Whole-cell lysates extracted from the WT and the 
rho0 strain were immunoblotted for mitochondrial proteins and the Pgk1 cytoplasmic protein. (E) The 
rho0  strain expressing a Mito-RFP was visualized by fluorescence microscopy.  (F) Images of cells from 
Figure 2D, but more similar exposure time images are shown here. Even still, the images of the get1у
msp1уget2уmsp1уDQGget3уmsp1уVWUDLQVZHUHH[SRVHG;ORQJHUPVWKDQWKH:7DQG
single mutant strains (200 ms). When we image the get1уmsp1уget2уmsp1уDQGget3уmsp1у
strains with 200 ms exposure times, we see no or very dim RFP signal. (G) Another set of images 
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Supplementary Figure 3. Depletion of human ATAD1 causes mitochondrial fragmentation  
in HeLa cells. (Related to Figure 3) 
(A) HeLa cells were treated with the control siRNA (scr) or siRNAs (#1-#3) targeting human 
ATAD1 for 6 days and stained with Mitotracker Red for fluorescence microscopic imaging. (B) The 









Supplementary Figure 4. Msp1 and ATAD1 facilitate the turnover of Pex15 and Pex26, respec-
tively. (Related to Figure 4)
(A)The indicated strains co-expressing GFP-Pex15 from the GAL1 promoter and RFP-SKL were 
cultured in galactose medium for 6 hr and imaged by fluorescence microscopy. (B)The wild-type and 
msp1уVWUDLQ expressing GFP-Pex15 from the GAL1 promoter were grown in SGal medium for 5-6 hr 
to induce GFP-Pex15 accumulation and then pulsed in glucose medium. Whole-cell lysates were 
prepared from cells harvested every 30 min and analyzed by immunoblot. Por1 is the loading control. 
(C) The optical densitometry quantification of (B). The values represent mean ± SEM (n=3, * p<0.05, 
**<0.01, t-test, two-tail). (D) Representative images of the galactose promoter-based shut-off experi-
ment shown in Figure 4E. Arrows mark the area of mitochondria. (E)The optical densitometry quantifi-
cation of Figure 4E. The values represent mean ± SEM (n=3, * p<0.05, **<0.01, t-test, two-tail). (F) 
HeLa cells and HDFs stably expressing GFP-PEX26 protein were treated with the control siRNA (scr) 
or the siRNAs (#1-#3) against human ATAD1 for 6 days. Whole-cell lysates were harvested and immu-
noblotted with anti-ATAD1, GFP and QCR2 antibodies. QCR2 is a mitochondrial protein used as a 
loading control.  
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Supplementary Figure 5. Msp1 physically interacts with the TA protein Gos1 and is required to 
limit the level of mislocalized Gos1 on mitochondria. (Related to Figure 5)
(A) Representative images of the get3уPXWDQWVWUDLQH[SUHVVLQJ*)3*RVZLWK0VS(4RUZLWKRXW
0VS(4 (9&HOOVZHUHJURZQLQ6'PHGLXPWRORJSKDVHDQGLPDJHGE\IOXRUHVFHQFHPLFURVFRS\
(B)The gos1уGOS1 msp1уMSP1 sgt2у6*7GLSORLGVWUDLQWUDQVIRUPHGZLWKDZLOGW\SH*RVFRQ
VWUXFWS56EDVHGZDVVSRUXODWHGDQGWHWUDGDQDO\]HG7KHLQGLFDWHGKDSORLGVWUDLQVKDUERULQJ
WKHSODVPLGZHUHVWUHDNHGRQ6'SODWHVFRQWDLQLQJ)2$DQGLQFXEDWHGDW&IRUGD\V&7KH
LQGLFDWHGVWUDLQVZLWKRUZLWKRXWRYHUH[SUHVVLRQRI WKH6EKSURWHLQ IURP WKHTEF1 SURPRWHUZHUH
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Supplementary Figure 6. Mitochondrial TA proteins are poor substrates of yeast Msp1.
(A) The wild-type strain harboring the N-terminally GFP tagged mitochondrial TA proteins (Tom5, Tom6, 
Tom7, Tom22, Fis1, Gem1 and Fmp32) expressed from the GAL1 promoter and empty vector (-), 
Msp1-His6-HA3 or Msp1E193Q-His6-HA3 fusion were cultured in galactose medium for 6 hours and sub-
jected to co-immunoprecipitation. Both 1% whole-cell lysates and anti-HA antibody-precipitated final 
eluates were analyzed and immunoblotted with anti-HA, GFP and Por1 antibodies. (B) Both the wild-
type (WT) and msp1уPXWDQWVWUDLQVH[SUHVVLQJWKHLQGLFDWHG*)3WDJJHGPLWRFKRQGULDO7$SURWHLQV
from the GAL1 promoter were cultured in galactose medium for 6 hours to induce protein expression 
and switched back to glucose medium. Whole-cell lysates were harvested every hour post-induction 
and analyzed by immunoblot. Pgk1 is a cytoplasmic protein used a loading control.  (C) The indicated 
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Supplementary Figure 7. Expression of the dominant-negative mutant ATAD1-E193Q causes 
mislocalization of GOS28 to the mitochondria. (Related to Figure 6)
HepG2 cells stably expressing the GFP-GOS28 fusion protein and empty vector (EV), wild-type ATAD1 
or mutant ATAD1 (ATAD1E193Q) protein were stained with Mitotracker Red and visualized by fluores-
cence microscopy. (B) WT and ATAD1-/- mouse heart were homogenized and analyzed by immunoblot. 





















shown in this 
table 
NSAF>100 
WT EV wild-type strain harboring empty vector 
WT Msp1 wild-type strain harboring Msp1-6His-3HA construct 
WT Msp1-
E193Q wild-type strain harboring Msp1(E193Q)-6His-3HA construct 
get3Δ Msp1-
E193Q get3 null mutant harboriing Msp1(E193Q)-6His-3HA construct 
Reference sgd ORF name 
Gene Symbol sgd gene symbol 
description sgd gene description 
prot_len # amino acids in predicted ORF 
NSAF 
NSAF = normalized spectral abundance factor, a crude 
quantitative measure that is simply the fraction of total psms 






Reference Gene(symbol SeqLen control WT(Msp1 ctl(NSAF WT(Msp1_NSAF
YGR028W MSP1 362 0 191 0 1416
YNL055C POR1 283 1 50 17 474
YCL057C1A YCL057C-A 97 0 16 0 443
YOR354C MSC6 692 0 69 0 268
YDR481C PHO8 566 5 52 43 247
YDL174C DLD1 587 0 47 0 215
YMR209C YMR209C 457 0 36 0 211
YER086W ILV1 576 1 42 8 196
YGR132C PHB1 287 1 20 17 187
YOR317W FAA1 700 3 47 21 180
YOR125C CAT5 233 0 14 0 161
YKL212W SAC1 623 0 37 0 159
YPL218W SAR1 190 1 11 26 155
YCR003W MRPL32 183 1 10 27 147
YGL037C PNC1 216 1 11 22 137
YHR190W ERG9 444 0 22 0 133
YGR157W CHO2 869 0 43 0 133
YMR089C YTA12 825 4 40 24 130
YMR129W POM152 1337 0 64 0 128
YER017C AFG3 761 2 34 13 120
YBR106W PHO88 188 0 8 0 114
YDR513W GRX2 143 0 6 0 113
YNL111C CYB5 120 0 5 0 112





Reference Gene(symbol SeqLen control get3Δ(Msp1ctl(NSAF get3Δ(Msp1_NSAF
YGR028W MSP1 362 0 676 0 4248
YDR231C COX20 205 0 44 0 488
YNL055C POR1 283 1 58 17 466
YDL067C COX9 59 0 11 0 424
YCR003W MRPL32 183 1 28 27 348
YPR133W4A TOM5 50 0 7 0 318
YPL249C4A RPL36B 100 1 14 49 318
YJL189W RPL39 51 0 7 0 312
YPR010C4A YPR010C-A 72 0 8 0 253
YMR194W RPL36A 100 1 11 49 250
YML030W AIM31 159 0 15 0 215
YLR167W RPS31 152 1 14 32 210
YKR094C RPL40B 128 1 11 38 195
YIL148W RPL40A 128 1 11 38 195
YMR193W MRPL24 258 0 18 0 159
YJR094W4A RPL43B 92 0 6 0 148
YPR043W RPL43A 92 0 6 0 148
YGL037C PNC1 216 1 14 22 147
YBL068W4A YBL068W-A 78 0 5 0 146
YPL218W SAR1 190 1 11 26 132
YIL083C CAB2 365 0 20 0 125
YDL174C DLD1 587 0 31 0 120
YBL026W LSM2 95 0 5 0 120
YCL057C4A YCL057C-A 97 0 5 0 117
YOR317W FAA1 700 3 35 21 114
YMR203W TOM40 387 0 19 0 112
YDR513W GRX2 143 0 7 0 111
YIL136W OM45 393 0 19 0 110
YCR046C IMG1 169 0 8 0 108
YBL030C PET9 318 0 15 0 107
YGL191W COX13 129 0 6 0 106










Reference Gene(symbol SeqLen control get3Δ_Msp1:E193Qctl_NSAF get3Δ_Msp1:E193Q_NSAF
YGR028W MSP1 362 0 512 0 3065
YNL055C POR1 283 1 67 17 513
YHL031C GOS1 223 0 36 0 350
YPR133W2A TOM5 50 0 8 0 347
YCL057C2A YCL057C-A 97 0 15 0 335
YDL067C COX9 59 0 9 0 331
YDR231C COX20 205 0 29 0 307
YMR203W TOM40 387 0 44 0 246
YDL174C DLD1 587 0 61 0 225
YPR010C2A YPR010C-A 72 0 7 0 211
YML030W AIM31 159 0 15 0 204
YJL062W2A YJL062W-A 85 0 8 0 204
YBL030C PET9 318 0 29 0 198
YJR085C YJR085C 105 0 9 0 186
YDR513W GRX2 143 0 12 0 182
YGR132C PHB1 287 1 23 17 174
YLR142W PUT1 476 0 38 0 173
YIL083C CAB2 365 0 29 0 172
YMR209C YMR209C 457 0 36 0 171
YER120W SCS2 244 0 19 0 169
YGR174C CBP4 170 0 13 0 166
YGL231C EMC4 190 0 14 0 160
YMR029C FAR8 523 0 37 0 153
YJL066C MPM1 252 0 17 0 146
YMR052W FAR3 204 0 12 0 127
YNL111C CYB5 120 0 7 0 126
YOR065W CYT1 309 0 18 0 126
YER141W COX15 486 0 27 0 120
YDR079W PET100 111 0 6 0 117
YNL131W TOM22 152 0 8 0 114
YCR031C RPS14A 137 0 7 0 111
YJL191W RPS14B 138 0 7 0 110
YMR129W POM152 1337 0 66 0 107
YMR264W CUE1 203 0 10 0 107
YMR110C HFD1 532 0 26 0 106
YML120C NDI1 513 0 25 0 106
YER086W ILV1 576 1 28 8 105
YDR292C SRP101 621 0 30 0 105
YPL224C MMT2 449 0 21 0 101




Supplementary Table S2. List of yeast strains used in this study
Number Strains Genotype Source
JRY245 WT (W303) MATa his3 leu2 lys2 met15 trp1 ura3 David Stillman
MATa his3 leu2 lys2 met15 trp1 ura3
msp1::kanMX4
MATa his3 leu2 lys2 met15 trp1 ura3
get1::hphMX4
MATa his3 leu2 lys2 met15 trp1 ura3
get2::hphMX4
MATa his3 leu2 lys2 met15 trp1 ura3
get3::hphMX4
MATa his3 leu2 lys2 met15 trp1 ura3
get4::hphMX4
MATa his3 leu2 lys2 met15 trp1 ura3
get5::hphMX4
MATa his3 leu2 lys2 met15 trp1 ura3
sgt2::hphMX4
MATa his3 leu2 lys2 met15 trp1 ura3
get1::hphMX4 msp1::kanMX4
MATa his3 leu2 lys2 met15 trp1 ura3
get2::hphMX4 msp1::kanMX4
MATa his3 leu2 lys2 met15 trp1 ura3
get3::hphMX4 msp1::kanMX4
MATa his3 leu2 lys2 met15 trp1 ura3
get4::hphMX4 msp1::kanMX4
MATa his3 leu2 lys2 met15 trp1 ura3
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MSP1/ATAD1 PARTICIPATES IN MITOCHONDRIA-TO-PEROXISOME 


















Peroxisomes are single membrane organelles that are known for their conserved 
functions in the metabolism of fatty acids and scavenging of reactive oxygen species.  
They are present in virtually all eukaryotes. In spite of these common functions, 
peroxisomes also possess diverse and specialized functions according to the cell type and 
organism (Smith and Aitchison, 2013).  The mammalian peroxisome is involved in the 
biosynthesis of many biomolecules, including plasmalogen, the precursor used for 
making myelin for neurons, bile acids, purine and fatty acids.  This organelle also serves 
as an antiviral signaling platform that is activated upon infection by a peroxisome-
localized antiviral protein (Dixit et al., 2010; Lodhi and Semenkovich, 2014).  The plant 
peroxisome is specialized for photorespiration and the glyoxylate cycle, particularly 
during seed germination (Hu et al., 2012).  The fungal peroxisome synthesizes antibiotics 
and pathogenic toxins (van der Klei and Veenhuis, 2013).  The majority of peroxisomal 
reactions occur inside the organelle, into which more than 50 enzymes are imported.  On 
the membrane, peroxisomal membrane proteins (PMPs) comprise primarily metabolite 
transporters and peroxins (Theodoulou et al., 2013).  Peroxins are peroxisome biogenesis 
factors that participate in different aspects of peroxisomal biogenesis ranging from 
protein import, inheritance, and division.  Peroxisome biogenesis disorders (PBDs) are 
severe inherited metabolic and neuropathic diseases that often lead to early childhood 
death.  Mutations affecting almost all peroxins are linked to PBD with various degrees of 
severity (Delille et al., 2006).  PBDs include Zellweger syndrome (ZS), neonatal 
adrenoleukodystrophy and infatile Refsum disease.  ZS is among the most severe 
presentations of the PDBs, with clinical features of dysmorphia, neonatal seizures, 
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hematomegaly, renal cysts, skeletal abnormalities and impaired hearing (Crane, 2014).    
 Like mitochondria, peroxisomes have been postulated to be autonomous organelles 
because peroxisomal proteins are synthesized on free polyribosome and post-
translationally incorporated into the pre-existing peroxisomes and they can multiply by 
division (Lazarow and Fujiki, 1985).  However, this idea has been challenged by the 
observations that peroxins localize to ER in mutants lacking peroxisomes and 
peroxisomes can be formed de novo from ER upon complementation (South and Gould, 
1999).  A subset of peroxins (e.g., Pex3 in yeast and PEX16 in mammals) were shown to 
traffic from ER to peroxisomes in both yeast and mammalian cells.  The peroxins are 
targeted to ER after being translated and sorted into ER subdomains (Hoepfner et al., 
2005).  Subsequently, the pre-peroxisomal vesicles carrying different peroxin cargoes 
bud off from the ER and eventually fuse to form mature and import-competent 
peroxisomes in the cytoplasm (van der Zand et al., 2012).  
Apparently, in spite of coupling with ER, peroxisomes and mitochondria are 
functionally and physically engaged based on several observations (Schrader and Yoon, 
2007).  First, mammalian β-oxidation is shared between the two organelles.  Peroxisomes 
break down long chain fatty acids, leukotrienes and prostaglandins, and the shortened 
fatty acids can be transported into mitochondria for further oxidation into acetyl-coA, 
which is then fed into the TCA cycle (Poirier et al., 2006).  How fatty acids are 
transported from peroxisomes to mitochondria is still under debate.  Second, several 
studies suggest that mitochondria and peroxisomes might be physically adjacent to each 
other (Cohen et al., 2014).  Third, they share the same set of fission machinery.  Both 
peroxisomes and mitochondria can multiply by fission of preexisting organelles.  The 
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peroxin, Pex11, first works on membrane elongation and deformation and then the 
components of the classical mitochondrial fission machinery are recruited to the 
peroxisomes (Opalinski et al., 2011).  This includes the adaptor proteins, FIS1 and MFF 
in mammals; Fis1, Caf4 and Mdv1 in yeast; the large GTPase, DLP1/DRP1 in mammals; 
and Dnm1 in yeast, which performs the terminal membrane scission reaction (Schrader et 
al., 2012).  Last but not least, recent research indicates that there are vesicles trafficking 
from mitochondria to peroxisomes (Braschi et al., 2010; Mohanty and McBride, 2013; 
Neuspiel et al., 2008).  Mitochondria-derived vesicles (MDVs), by which a cargo protein, 
mitochondrial anchored protein ligase MAPL, is trafficked from mitochondria to 
peroxisomes were first discovered several years ago.  MAPL was shown to localize to 
both mitochondria and a subpopulation of peroxisomes.  Live-cell imaging showed that 
MAPL-decorated vesicles bud off from mitochondria and eventually fuse with a subset of 
peroxisomes (Neuspiel et al., 2008).  The formation of MAPL decorated-MDVs appears 
to depend on the retromer complex, a critical component for vesicle transport (Braschi et 
al., 2010).  The function of MAPL or MDVs has not yet been determined but a few ideas 
have been proposed, including peroxisomal biogenesis and metabolite shuttling (Mohanty 
and McBride, 2013).  
Yeast Msp1 and mammalian ATAD1 (also known as Thorase) belong to the AAA+ 
(ATPase associated with various cellular activities) ATPase protein family.  We 
previously described this protein in facilitating the extraction and degradation of mis-
localized tail-anchored proteins from mitochondria (Chen et al., 2014).  Since 
Msp1/ATAD1 localizes to mitochondria and peroxisomes and perhaps the plasma 
membrane, we believe that it must perform multiple tasks in the cell (Chen et al., 2014; 
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Zhang et al., 2011).  Most AAA+ ATPases oligomerize to form a channel that 
translocates and unfolds protein complexes using the energy derived from ATP 
hydrolysis (Hanson and Whiteheart, 2005).  It is known that a subset of AAA+ ATPases 
play a specialized role in membrane dynamics and trafficking (e.g., VPS4 in 
multivesicular body budding; NSF in disassembly of SNARE proteins; Torsin in budding 
of large ribonucleiprotein granules at the nuclear envelope) (Babst, 2005; Jokhi et al., 
2013; Littleton et al., 2001).  Intriguingly, mammalian ATAD1 was shown to participate 
in the disassembly of α-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid receptor 
(AMPAR) complex on the synaptic membrane, which determines the rate of endocytosis 
of AMPAR receptor (Zhang et al., 2011).  This result suggests that members of the 
Msp1/ATAD1 protein family likely also play a role in membrane internalization and 
vesicle trafficking.  
In this study, we provide evidence that Msp1/ATAD1 participates in mitochondria-to-
peroxisome trafficking via small vesicles.  These data include: first, the AAA+ ATPase 
domain on Msp1 is sufficient for Msp1 localization to peroxisomes.  Second, pulse-chase 
experiments indicate that Msp1 first localizes to mitochondria and then traffics to 
peroxisomes.  Third, in a mutant yeast strain lacking peroxisomes, Msp1 colocalizes to 
vesicle-like structures.  Fourth, we show that the mitochondrial fusion protein, Fzo1 
(fuzzy onion 1) is crucial for Msp1 localization to peroxisomes.  Last, we show that 
Msp1 plays a crucial role in maintaining peroxisome morphology and peroxin 
localization as depletion of Msp1 causes peroxisome fragmentation and peroxin 
localization to mitochondria.  Overexpression of ATAD1, however, sequesters peroxins 
to vesicle-like structures from the mitochondria in mammalian cells.  Therefore, we 
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hypothesize that Msp1/ATAD1 plays a role in sorting peroxins from mitochondria to 
peroxisomes via a novel vesicular trafficking pathway. 
 
Results 
The AAA+ ATPase domain is necessary and sufficient for  
Msp1 localization to peroxisomes 
We previously showed that Msp1/ATAD1 localizes to both mitochondria and 
peroxisomes (Chen et al., 2014).  We wanted to know how this dual localization is 
achieved.  As both proteins share a highly conserved AAA+ domain at the C-terminus 
and a semiconserved TMD at the N-terminus, we hypothesized that one of these elements 
should contribute to this unique localization pattern.  First, to test if ATPase activity of 
the AAA+ domain is required for the dual localization, we co-expressed GFP-tagged 
wild-type- (Msp1-GFP) or ATPase-inactive Msp1 (Msp1E193Q-GFP) and mitochondria- or 
peroxisome-targeted red fluorescent protein (mito-RFP or RFP-SKL) in the msp1Δ strain.  
As shown in Figure 4-1A, Msp1-GFP signal overlapped with mito-RFP signal with extra-
mitochondrial puncta, which were demonstrated to be peroxisomes based on co-
localization with RFP-SKL.  However, Msp1E193Q-GFP, despite colocalizing normally 
with mito-RFP, did not exhibit any extra-mitochondrial signal.  We then confirmed that 
Msp1E193Q had lost the ability to localize to peroxisomes, because Msp1E193Q-GFP 
showed almost no colocalization with RFP-SKL (Figure 4-1A, middle panel).  The loss 
of peroxisome localization of the Msp1E193Q mutant was also observed when these same 
strains were cultured in oleic acid medium to induce peroxisome biogenesis (Figure 4-
















Figure 4-1. The Msp1 AAA+ domain is necessary and sufficient for the 
peroxisomal localization 
(A) Representative images of the msp1Δ mutant co-expressing Msp1-GFP or 
Msp1E193Q-GFP and mito-RFP or RFP-SKL.  Overnight yeast cultures were diluted 
and grown to early log-phase at 30°C in synthetic glucose medium for 6 hr or oleate 
medium for 10 hr, and visualized by fluorescence microscopy.  (B) Representative 
images of the msp1Δ mutant co-expressing Msp1-GFP, Msp1K139A-GFP, Msp1R248E-
GFP or Msp1W166G/Y167D-GFP and mito-RFP or RFP-SKL.  (C) Representative images 
of the msp1Δ mutant co-expressing TOM70TMD-Msp1-GFP, TOM70TMD-Msp1E193Q-
GFP, OM45TMD-Msp1-GFP or OM45TMD-Msp1E193Q-GFP and mito-RFP or RFP-SKL. 
(D) Plasmid borne-wild-type Msp1, TOM70TMD-Msp1-GFP, TOM70TMD-Msp1E193Q-
GFP, OM45TMD-Msp1-GFP or OM45TMD-Msp1E193Q-GFP was shuffled into get3Δ 
msp1Δ strain.  Five-fold dilutions of the indicated yeast strains were spotted on 
synthetic glucose (SD) or synthetic glycerol plates (SGly), and incubated at 30 or 
37°C, respectively  (E) Representative images of the msp1Δ mutant co-expressing 
Msp1TMD-Tom70-GFP or TOM70-GFP and mito-RFP or RFP-SKL.  Overnight 
cultured yeast strains in (B), (C) and (E) were diluted and grown to early log-phase at 























drastically diminished peroxisomal localization of Msp1, but did not affect mitochondrial 
localization (Figure 4-1B).  These data demonstrate that activity of the AAA+ domain is 
crucial for Msp1 localizing to peroxisomes but not to mitochondria.  
To further test if the C-terminal region that contains primarily the AAA+ domain 
is sufficient for Msp1 to localize to peroxisomes, we fused the Msp1 C-terminal fragment 
(lacking the N-terminal TMD) with Tom70 TMD (Tom70TMD-Msp1-GFP) or OM45 
TMD (OM45TMD-Msp1-GFP) and assessed the localization.  Tom70 and OM45 are two 
mitochondrial membrane proteins that are anchored to the OMM by their N-terminal 
TMD.  Neither of them has ever been shown to localize to peroxisomes (see Figure 4-1E, 
right panel and data not shown).  As shown in Figure 4-1C, the subcellular localization of 
Tom70TMD-Msp1 and OM45TMD-Msp1 resembles that of the wild-type Msp1.  The 
msp1Δ strain co-expressing Tom70TMD-Msp1-GFP or OM45TMD-Msp1-GFP and mito-
RFP exhibits a complete overlap of the GFP and RFP signal, and extra-mitochondrial 
puncta that were confirmed to be peroxisomes based on colocalization with the RFP-SKL 
marker (Figure 4-1C, left panel).  Similar to intact Msp1, a mutation that impairs the 
ATPase activity of the AAA+ domain of the chimeric proteins (Tom70TMD-Msp1 E193Q-
GFP or OM45TMD-Msp1E193Q-GFP) abolished the peroxisomal localization (Figure 4-1C, 
right panel).  Both chimeric proteins were functional as they can completely or partially 
rescue the growth defect of the get3Δmsp1Δ on a nonfermentable carbon source, whereas 
the AAA+ inactive proteins failed to do so (Figure 4-1D)	  (Chen et al., 2014).  These data 
demonstrate that the AAA+ domain of Msp1 is not only necessary but also sufficient for 
Msp1 to localize to peroxisome.  
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Next, to determine the role of the N-terminal TMD for the dual localization 
pattern of Msp1, we replaced the N-terminal TMD of Tom70 protein with Msp1 TMD 
(Msp1TMD-Tom70) and observed its localization.  Similar to the wild-type Tom70, GFP-
tagged Msp1TMD-Tom70 shows complete colocalization with mito-RFP and appears to 
not colocalize with RFP-SKL (Figure 4-1E).  Hence, the peroxisomal localization of 
Msp1 is unlikely the result of direct protein import and insertion posttranslationally.  In 
conclusion, these data suggest that the peroxisomal localization of Msp1 depends 
primarily on the ATPase activity of the AAA+ domain instead of the TMD domain.  We 
speculate that perhaps Msp1 is imported into mitochondria, from where it is transported 
to peroxisomes in an ATPase activity-dependent manner.   
 
Msp1 traffics from mitochondria to peroxisomes via vesicles  
 Similar to MAPL, Msp1 localizes to both mitochondria and peroxisomes, the latter 
of which appears to depend on the AAA+ domain.  Previously, we hypothesized that 
Msp1 is imported to mitochondria and then transported to peroxisomes.  Furthermore, 
members of the AAA+ proteins (e.g., VPS4, Torsin and NSF) are known to play a crucial 
role in membrane dynamics and vesicle trafficking	   (Babst, 2005; Jokhi et al., 2013; 
Littleton et al., 2001; Rabouille et al., 1995; Woodman, 2003).  Therefore, it is tempting 
to speculate that Msp1 traffics from mitochondria to peroxisomes through a vesicular 
trafficking pathway.  To tackle this question, we generated a GFP-tagged Msp1 expressed 
from the inducible GAL1 promoter and performed galactose pulse-chase experiments.  
The msp1Δ mutant co-expressing Msp1-GFP and mito-RFP or RFP-SKL was cultured in 
galactose medium to induce overexpression of Msp1 and then switched to glucose 
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medium to stop transcription.  We observed that Msp1 localized primarily to 
mitochondria starting at 1 hr of induction, and then to both mitochondria and 
peroxisomes at 1.5 hr of induction (data not shown).  Thirty minutes after the induction 
was pulsed, we started observing that the GFP signal localized to small puncta, which 
was maximal at about 90 min, as shown in Figure 4-2A, top panel.  Neither mitochondrial 
nor peroxisomal RFP overlapped with the small puncta (indicated by arrows).  The 
diameter of the puncta is smaller than that of peroxisomes.  When we induced 
overexpression of the AAA+ ATPase inactive Msp1 (Msp1E193Q), we did not observe that 
Msp1-GFP localized to these small puncta (Figure 4-2A, bottom panel).  Instead, in spite 
of fully colocalizing with the mitochondrial RFP, we observed that the GFP signal was 
accumulated massively on subdomains of the mitochondria (indicated by arrows).  This 
unusual mitochondrial localization was also observed when we expressed the AAA+ 
ATPase inactive Msp1 constructs from the MSP1 promoter (Figure 4-1A-C).  It appears 
that upon overexpression, Msp1 localizes to small puncta and the AAA+ domain is 
required for this localization.  We speculated that these puncta are likely vesicles that bud 
from mitochondria.  When the ATPase activity is impaired, however, the vesicles fail to 
bud off, which results in over-accumulation of Msp1 on the mitochondria.   
We reasoned if these puncta represent vesicles derived from mitochondria, they 
might only exist transiently as they rapidly traffic to and fuse with peroxisomes.  In fact, 
we have never observed that Msp1 localizes to small puncta when it is expressed from 
the native MSP1 promoter.  Therefore, in order to trap these vesicle-like puncta, we 
expressed Msp1-GFP from the native promoter in the pex19Δ mutant that lacks 





Figure 4-2 Msp1 localizes to vesicle-like puncta 
(A) Representative images of the msp1Δ mutant co-expressing Msp1-GFP or 
Msp1E193Q-GFP expressed from the GAL1 promoter and mito-RFP or RFP-SKL.  
Overnight yeast cultures grown in synthetic glucose medium were harvested, 
incubated in the galactose medium for 1.5 hr and switched to glucose medium to pulse 
the expression of Msp1 protein.  Cells were harvested at 90 min after being grown in 
glucose medium and examined by fluorescence microscopy.  Arrows in the upper 
panel indicate extra-mitochondrial and peroxisomal puncta and arrows in the lower 
panel indicate unusual mitochondrial accumulation of Msp1.  (B) Representative 
images of the wild-type and pex19Δ mutant co-expressing Msp1-GFP and mito-RFP.  
Overnight cultures of the wild-type and pex19Δ mutant harboring Msp1-GFP and 
mito-RFP were diluted in synthetic glucose medium and cultured for 6 hr to early log-





      
	   
107 
synthesized PMPs in the cytoplasm and delivers them to peroxisomes for insertion into 
the peroxisomal membrane.  Thus, deletion of PEX19 completely abolishes peroxisome 
biogenesis (Heiland and Erdmann, 2005; Hettema et al., 2000).  When we expressed 
Msp1-GFP in the pex19Δ mutant as shown in Figure 4-2B, we observed that the Msp1-
GFP signal localized to extra-mitochondrial small puncta (indicated by arrows).  Similar 
to the puncta shown in Figure 4-2A, they are also significantly smaller than peroxisomes 
that are observed as extra-mitochondrial puncta in the wild-type strain.  Hence, we 
hypothesized that the Msp1-decorated puncta might be vesicles that have budded from 
mitochondria in an AAA+ domain-dependent manner and are destined to eventually fuse 
with peroxisomes in wild-type cells. 
To directly test whether Msp1 traffics from mitochondria to peroxisomes, we 
utilized the galactose pulse-chase system previously described.  We induced the 
expression of Msp1-GFP for the minimal time (1.25 hr), and found that the majority of 
the protein only localized to mitochondria rather than to both peroxisomes and 
mitochondria.  The time-course distribution of the Msp1-GFP signal was examined after 
yeast were switched to glucose medium to turn off Msp1-GFP expression (Figure 4-3).  
We observed that yeast co-expressing Msp1-GFP and RFP-SKL showed a minimal co-
localization of the GFP and RFP signal at 0 min postinduction.  At 60 and 150 min, there 
was an increased colocalization of GFP and RFP-SKL (Figure 4-3, left panel).  
Concomitantly, we saw a slight decrease of the mitochondrial Msp1 signal through the 
time-course in the strain co-expressing Msp1-GFP and mito-RFP (Figure 4-3, right 
panel).  Taken together, these data are suggestive that Msp1 might traffic from 





Figure 4-3. Msp1 traffics from mitochondria to peroxisomes 
Representative images of the galactose shut-off experiment.  Overnight cultures of the 
msp1Δ mutant co-expressing Msp1-GFP from the GAL1 promoter and mito-RFP or 
RFP-SKL were harvested, incubated in the galactose induction medium for 1.25 hr 
and switched to glucose medium to pulse the expression of Msp1 protein.  Cells were 
harvested at 0, 60 and 150 min after being incubated in glucose medium and examined 
by fluorescence microscopy.	  









Fzo1 is required for Msp1 peroxisomal localization 
 To determine if the formation of vesicle-like Msp1 puncta requires the shared 
mitochondrial/peroxisomal fission machinery, we assessed the localization of Msp1 in 
various fission mutants including fis1Δ, mdv1Δ and dnm1Δ (Figure 4-4A).  By co-
expressing Msp1-GFP and RFP-SKL (top panel) or mito-RFP (bottom panel) in the wild-
type and mutant strains, we showed that Msp1-GFP colocalized with both mitochondrial 
and peroxisomal RFP signal in each of these mutant strains.  Thus, the conventional 
fission machinery appears to be dispensable for Msp1 localization to peroxisomes.  
Unlike the fission machinery, the mitochondrial fusion machinery has never been 
reported to function on peroxisomes.  To our surprise, however, when we assessed Msp1 
localization in the fzo1Δ mitochondrial fusion mutant, we observed that Msp1 no longer 
colocalized to peroxisomes but its mitochondrial localization was unaffected (Figure 4-
4B).  As depletion of FZO1 progressively leads to loss of mitochondria DNA, which 
impacts many aspects of mitochondrial function, this loss of peroxisomal localization 
could be an artifact of mitochondrial impairment (Hermann et al., 1998; Rapaport et al., 
1998).  To further test the Fzo1 requirement for Msp1 peroxisomal localization, we 
utilized the fzo1-1 temperature-sensitive mutant to acutely deplete FZO1 and assessed 
Msp1 localization	  (Hermann et al., 1998; Rapaport et al., 1998).  When we cultured the 
fzo1-1 mutant harboring Msp1-GFP and mitochondrial or peroxisomal RFP under the 
restrictive temperature at 37°C for 15 min as suggested in the literature, we still observed 
that Msp1 localized to both organelles (data not shown).  We suspected that 15 min was 
likely too short to observe decay of peroxisomal Msp1.  Thus, we decided to increase the 
incubation time of the fzo1-1 mutant to 6 and 12 hr but at a moderately restrictive 
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Figure 4-4.  Peroxisomal localization of Msp1 is dependent on Fzo1 
(A) Representative images of the wild-type, fis1Δ, mdv1Δ, dnm1Δ and mdm30Δ and 
rho0 strain co-expressing Msp1-GFP and mito-RFP or RFP-SKL.  (B) Representative 
images of the wild-type and fzo1Δ strain co-expressing Msp1-GFP and mito-RFP or 
RFP-SKL.  Overnight culture of the yeast strains indicated in (A) and (B) was diluted 
in synthetic glucose medium and examined by fluorescence microscopy.  (C) 
Representative images of the fzo1-1 strain co-expressing Msp1-GFP and mito-RFP or 
RFP-SKL. Overnight yeast culture grown at 25 °C was diluted in synthetic glucose 
medium, incubated at 25 for 6 hr and 30 °C for 6 and 12 hr, respectively and examined 

















temperature, 30°C.  As shown in Figure 4-4C, in comparison to cells grown at 25°C 
(permissive temperature), we observed that at 6 hr after temperature shift, there was some 
colocalization of Msp1-GFP with RFP-SKL.  After 12 hr, however, Msp1 no longer 
localized to peroxisomes, but localized normally to the mitochondria, which were 
fragmented under these conditions.  To verify that mitochondrial dysfunction is not 
sufficient to prevent Msp1 localization to peroxisomes, we also tested the localization of 
Msp1 in a strain that was treated with ethidium bromide to deplete mitochondrial DNA 
(rho0).  We observed that Msp1 localized to both mitochondria and peroxisomes similar 
to wild-type cells (Figure 4-4A).  Thus, we confirmed that loss of peroxisomal 
localization of Msp1 is an Fzo1-specific phenomenon.  On the other hand, 
hyperaccumulation of Fzo1 caused by mutating Mdm30, a ubiquitin E3 ligase that 
promotes Fzo1 degradation, does not affect Msp1 localization (Figure 4-4A).  Taken 
together, these results demonstrate that the peroxisomal localization of Msp1 is 
dependent on Fzo1 but independent of the fission machinery.  We are currently 
investigating the mechanism of Fzo1-mediated localization of Msp1 on peroxisomes.  
 
Msp1/ATAD1 is crucial to maintain peroxisome morphology 
 Because Msp1 localizes to peroxisomes, we asked whether it is important for 
peroxisomal function.  As one of the major functions of yeast peroxisomes is to catalyze 
β-oxidation of lipids, we first tested whether deletion of MSP1 affected the ability of cells 
to utilize oleic acid as the sole carbon source to survive and grow.  We cultured both the 
wild-type and the msp1Δ mutant in liquid oleate medium and recorded their growth 




















Figure 4-5. Msp1/ATAD1 plays a role in maintaining peroxisomal morphology 
(A) Growth curve of the wild-type and msp1Δ mutant in oleate medium.  The yeast 
strains were grown overnight in YPD medium and diluted into fresh oleate medium.  
Cell density was measured by OD600 every 2-3 hr.  (B) Representative images of the 
peroxisome in the wild-type and msp1Δ mutant.  Overnight cultures of the wild-type 
and msp1Δ mutant harboring RFP-SKL were diluted in synthetic glucose medium and 
cultured for 6 hr until early log-phase.  Cells were examined by fluorescence 
microscopy.  (C) Representative images of the peroxisome in the wild-type and atad-/- 
mouse embryonic fibroblasts (MEFs). MEFs were immunostained with anti-PMP70 









As peroxisomes perform other functions in addition to β-oxidation, we believed that this 
growth assay is probably not sufficient to reveal the functionality of every aspect of this 
organelle.  Next, we directly visualized the morphology of peroxisomes with 
fluorescence microscopy by labeling peroxisomes with RFP-SKL.  In the wild-type 
strain, there were an average of 3-8 large peroxisomes per cell, whereas the msp1Δ strain 
exhibited a larger number of smaller peroxisomes (Figure 4-5B).  We also confirmed the 
same phenotype in mammalian cells by immunostaining peroxisomes in the wild-type 
and atad1-/- mouse embryonic fibroblasts (MEFs), as shown in Figure 4-5C.  The wild-
type cells contained a mixture of tubular and punctate peroxisomes but atad1-/- MEFs 
only exhibited punctate peroxisomes.  It seems that deletion of MSP1 in yeast and 
ATAD1 in mammalian cells both cause similar fragmentation of peroxisomes, implying 
that they perform a conserved function that is required for normal peroxisome 
morphology, but we do not yet know the nature of this function. 
 
Msp1/ATAD1 participates in sorting peroxins from  
mitochondria into vesicles 
 Peroxisomes can be formed de novo from the ER according to the observation that 
in mutant cells lacking peroxisomes, some peroxins were shown to localize to ER 
(Nagotu et al., 2010; Smith and Aitchison, 2013). These peroxins, after being 
synthesized, are incorporated into ER and sorted into vesicles, which then bud out from 
ER (Hoepfner et al., 2005; van der Zand et al., 2012).  Intriguingly, a subset of peroxins 
were observed to “mislocalize” to mitochondria in cells from Zellweger syndrome 
patients or peroxin mutant mammalian cells	  (Sacksteder et al., 2000; South et al., 2000;  
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Toro et al., 2009).  These results have to been thought to be artifacts, because it has been 
assumed that there is no way out for those “mislocalized” peroxins.  Given our results 
described above, we are interested in exploring the possibility that mitochondria-derived 
vesicles contribute to peroxisome biogenesis.  Therefore, these peroxins, instead of being 
mislocalized, might be targeted mitochondria as part of their normal trafficking pathway.  
As localization of peroxins to mitochondria has never been observed in yeast before, we 
tried to recapitulate this phenomenon in a peroxisomal biogenesis defective mutant strain.  
We generated RFP-tagged peroxins including Pex1, Pex3, Pex10, Pex11, Pex12, Pex13, 
Pex14, Pex15, Pex16, Pex18 and Pex22 and examined their localization in a pex19Δ 
mutant that also co-expressed a mitochondrial GFP marker (mito-GFP).  We observed 
that, similar to the peroxisome biogenesis-defective mammalian cells, a subset of these 
peroxins (Pex1l, Pex13 and Pex22) colocalized to mitochondria in the pex19Δ strain 
when expressed from their endogenous promoters (Figure 4-6A, top panel).  Furthermore, 
when we deleted MSP1 in the pex19Δ strain, Pex1, Pex10 and Pex12 also localized to 
mitochondria in addition to the three peroxins mentioned above (Figure 4-6A, bottom 
panel).  It also appears that deletion of MSP1 further increased the amount of each of 
these peroxins localizing to mitochondria, as compared to the pex19Δ single mutant 
strain.  One potential explanation for the mitochondrial localization of peroxins caused by 
Msp1 mutation is that, like tail-anchored proteins, they are direct substrates of Msp1. 
Msp1 can directly interact with them and facilitate their extraction and degradation.  
Thus, our hypothesis is that MSP1 could cause the accumulation of peroxins on the 
mitochondria.  To test that, we performed co-immunoprecipitation experiments.  As 









Figure 4-6. Msp1/ATAD1 is required for peroxin localization 
(A) Representative images of the pex19Δ and msp1Δ pex19Δ co-expressing Pex11-
RFP, Pex10-RFP, Pex13-RFP, Pex22-RFP, Pex1-RFP or Pex12-RFP with mito-GFP.  
Overnight cultures of the indicated strain were diluted in synthetic glucose medium 
and cultured for 6 hr until early log-phase and examined by fluorescence microscopy.  
(B) Co-immunoprecipitation of Msp1 with peroxins.  Crude mitochondria extracted 
from the msp1Δ pex19Δ strain expressing Pex1-RFP, Pex12-RFP, Pex13-RFP or 
Pex22-RFP and empty vector (EV), Msp1-HA (Msp1) or Msp1E193Q-HA (E193Q) 
were solubilized in 0.5% digitonin and subjected to anti-HA antibody agarose pull-
down.  (C) Representative images of peroxin localization in the ZS patient fibroblasts 
(pex16 mutant) upon ATAD1 overexpression.  Both the wild-type and the ZS patient 
fibroblasts stably expressing PEX10 or PEX13 were infected with empty vector (EV) 













to co-immunoprecipitate any of these peroxins under conditions that were identical to 
those where we saw strong interaction with tail-anchored proteins, demonstrating that the 
mitochondria-localized peroxins are probably not direct substrates of Msp1.      
As yeast Msp1 traffics from mitochondria to peroxisomes, we next speculated that 
Msp1/ATAD1, instead of functioning in protein quality control on peroxisomes, 
participates in sorting peroxins from mitochondria to peroxisomes via vesicles.  We 
stably expressed GFP-tagged PEX10 and PEX13 in both wild-type and Zellweger 
syndrome patient (PEX16 mutation) fibroblasts.  Figure 4-6C shows that both proteins 
partially colocalized to mitochondria in the patient fibroblasts in addition to exhibiting 
strong cytoplasmic accumulation. In the wild-type cells, however, they both localized to 
puncta that are presumably peroxisomes (but this awaits verification) and showed little or 
no mitochondrial colocalization.  The most important question is whether ATAD1 
expression has any effect on this mitochondrial localization and whether perhaps ATAD1 
overexpression is capable of sorting these peroxins into vesicles.  We overexpressed 
ATAD1 in both the wild-type and PEX16 mutant fibroblasts and found that ectopic 
expression of ATAD1 promoted the removal of both PEX10 and PEX13 from 
mitochondria (Figure 4-6C).  Interestingly, the GFP signal now also began to localize to 
extra-mitochondrial puncta.  We speculate that these puncta are perhaps the vesicles that 
are formed from the mitochondria via the assistance of ATAD1, their nature and content 
requires further characterization.  To summarize, we show evidence suggesting that 
Msp1/ATAD1 plays a critical role in mediating the sorting of peroxins from 
mitochondria into vesicles.  Whether these puncta eventually fuse with peroxisomes 




Based on the data presented herein, we conclude that Msp1/ATAD1 participates in 
a novel vesicular trafficking pathway, which is likely crucial for sorting peroxins from 
mitochondria to peroxisomes.  We show that yeast Msp1 traffics from mitochondria to 
peroxisomes, probably in small vesicles, in an AAA+ domain-dependent manner.  To our 
surprise, the Fzo1 mitochondria fusion protein is required for the peroxisomal 
localization of Msp1 via a mechanism that remains unknown.  The consequences of loss 
of Msp1/ATAD1 include peroxisome fragmentation and peroxin localization to 
mitochondria.  Finally, we show that overexpression of mammalian ATAD1 in Zellweger 
syndrome patient cells facilitates the removal of peroxins from mitochondria, which then 
accumulate in vesicle-like structures, suggesting that Msp1/ATAD1 functions in sorting 
peroxins from mitochondria into vesicles.  Several additional interesting observations 
related to this study are discussed below. 
First, it has been a matter of debate whether vesicles bud out of mitochondria.  In 
the past few years, two types of MDVs en route to distinct destinations have been 
described	  (Braschi et al., 2010; Neuspiel et al., 2008; Soubannier et al., 2012; Sugiura et 
al., 2014).  One of these vesicle systems, which carries only one known protein, MAPL,	  
is trafficked to and fused with peroxisomes (Braschi et al., 2010; Neuspiel et al., 2008).  
In this study, we appear to have identified peroxisome-targeted MDVs that contains 
Msp1. Like MAPL, Msp1/ATAD1 localizes to both mitochondria and peroxisomes (see 
Figure 4-1A and	   (Chen et al., 2014), raising the question whether the Msp1-decorated 
and MAPL-decorated MDVs are the same objects.  Unfortunately, we do not yet know 
enough about either system to answer this question.  We do know, however, that the 
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mitochondrial fission machinery is dispensable for trafficking Msp1 to peroxisomes in 
yeast and is also dispensable for the formation of MAPL-decorated vesicles in 
mammalian cells (Figure 4-4A and Neuspiel et al., 2008).  Nonetheless, to address this 
question directly, double labeling of MAPL and ATAD1 in mammalian cells is required.  
Another interesting question is what proteins or protein complexes participate in the 
Msp1/ATAD1 vesicular trafficking pathway. The retromer complex was shown to be 
important for MAPL trafficking; we will first test whether it is also crucial for ATAD1 
trafficking	   (Braschi et al., 2010).  Second, we previously performed a two-step tandem 
affinity purification to identify the binding partners of Msp1 and found some components 
of the COPII vesicle trafficking pathway (data not shown).  Although there is not yet any 
evidence indicating that the COPII pathway is involved in mitochondrial vesicle 
formation, we suspect that some players in this pathway might play a role on 
mitochondria.  Future work is needed to verify the interaction between the COPII 
components and Msp1 and, more importantly, to test whether they are required for Msp1 
vesicle formation. 
The functional role of Msp1 in vesiculation is also of interest.  AAA+ proteins are 
crucial for membrane dynamics and vesicle trafficking and we have shown that the 
AAA+ domain of Msp1 is required for Msp1 localization to vesicle-like punta and to 
peroxisomes (Figure 4-1C and 4-2A).  Intriguingly, when we expressed the ATPase-
inactive Msp1, we observed an unusual accumulation of Msp1 on subdomains of 
mitochondria (Figure 4-1A-C and Figure 4-2A).  We speculate that this phenomenon is 
likely caused by the Msp1-decorated vesicles that stall in the scission step on the 
mitochondrial membrane.  Similar to the Msp1 protein, Torsin is another AAA+ ATPase 
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that has a N-terminal TMD and a C-terminal AAA+ domain.  It appears to be involved in 
formation of vesicels that bud from the inner nuclear membrane into the internuclear 
space, perhaps helping to mediate the terminal fission step. These vesicles carry large 
ribonucleoproteins (MegaRNPs) and help viral cores from the nucleus into the cytoplasm.  
Mutation of the AAA+ domain causes Torsin to accumulate on the necks of the 
enveloped MegaRNPs, implying that Torsin may be required for the scission step of the 
nuclear membrane (Jokhi et al., 2013).  Therefore, we speculatively hypothesize that like 
Torsin, Msp1 participates in the budding of vesicles from mitochondria. Immuno-electron 
microscopy will be required to show the suborganellar localization of Msp1, including in 
mutants with these mitochondrial accumulations. 
It is also a surprising and intriguing observation that the mitochondrial fusion 
protein, Fzo1, is required for Msp1 localization to peroxisomes.  It is widely accepted 
that the same fission machinery is shared between mitochondria and peroxisomes in both 
yeast and mammals	  (Delille et al., 2009).  The mitochondrial fusion machinery, however, 
has never been shown to play a role in any aspect of peroxisomal function.  As Fzo1 
mediates mitochondrial fusion by homo-oligomerization	   (Meeusen et al., 2004), we 
initially hypothesized that Fzo1 is present on both mitochondria and peroxisomes and that 
it mediates the fusion of the mitochondrial-derived Msp1-vesicles with peroxisomes.  
However, we have only been able to visualize the yeast Fzo1 protein localizing to 
mitochondria using the Fzo1 protein with different tags on either end (data not shown).  
Since the tagged proteins were not fully functional, these results were difficult to interpret 
and we cannot exclude the possibility that a small subset of Fzo1 localizes to 
peroxisomes.  Nevertheless, given that a previous study showed that none of the fusion 
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proteins (MFN1, MFN2 and UGO1) localize to peroxisomes in mammalian cells	  
(Bonekamp et al., 2012), it seems unlikely that the mitochondrial fusion machinery 
mediates fusion of the Msp1-decorated vesicles with perixosmes.  An alternative 
possibility is that fusion of mitochondria might sequester proteins or lipids that are 
required for Msp1-decorated vesicle formation.  Future studies will be required to 
uncover the role of the mitochondrial fusion proteins in this process. 
Finally, we speculate that Msp1 could play a role in the de novo biogenesis of 
peroxisomes from mitochondria.  Peroxisomes are currently believed to form either by 
self-dividing or by de novo synthesis from the ER subdomain	   (Smith and Aitchison, 
2013).  It is still debatable which of these mechanisms prevails under normal conditions.  
Both pathways have been verified in yeast, but fission is mostly likely the predominant 
mechanism of peroxisome proliferation under wild-type conditions (Motley and Hettema, 
2007; Nagotu et al., 2008).  It appears that cells only utilize de novo biogenesis under 
specific circumstances, because ER was found to be the receptive host for a subset of 
peroxins in peroxisome-deficient mutants.  As we observed that some peroxins also 
localize to mitochondria in peroxisome-deficient mutants, we should consider the 
possibility that mitochondria also contribute to the biogenesis of peroxisomes.  Another 
line of evidence supporting the possibility that mitochondria contribute to peroxisomal 
biogenesis is that artificially targeting Pex3 to mitochondria in the pex3Δ mutant fully 
regenerates peroxisomes	   (Rucktaschel et al., 2010).  In our case, we have show that 
deletion of MSP1 and PEX19 leads to peroxin localization to mitochondria in yeast 
(Figure 4-6A).  More importantly, we showed that in mammalian cells, overexpression of 
ATAD1 is capable of removing peroxins from mitochondria in Zellweger syndrome 
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patient cells, and induces accumulation of the protein in vesicle-like cytoplasmic 
structures (Figure 4-6C).  It is possible that under some conditions, a subset of peroxins 
may first target mitochondria and then be sorted into Msp1-decorated vesicles. These 
“pre-peroxisome” vesicles could then fuse with other pre-peroxisome vesicles, thereby 
delivering different peroxins to form mature peroxisomes. One potential experiment that 
would directly tackles this hypothesis would be to perform cell fusion assays.  We plan to 
fuse the ATAD1-overexpressing ZS patient cells harboring GFP-tagged peroxins and 
wild-type cells and test if GFP-tagged peroxins will end up localized to peroxisomes.  On 
the other hand, we also do not have enough evidence to completely exclude the 
possibility that the peroxin-containing vesicles are destined for degradation.  Theses 
vesicles, instead of fusing with other pre-peroxisomal vesicles for peroxisomes 
biogenesis, might engage with lysosomes for protein turnover.  Certainly, more work is 
needed to rigorously test these hypotheses.       
In conclusion, we suggest that in addition to the role in protein quality control that 
we described previously, Msp1/ATAD1 performs a second role in mitochondria to 
peroxisome trafficking, which might directly impact peroxisome biogenesis.  Give the 
importance of Msp1/ATAD1 in both mitochondria and peroxisomal functions, and the 
extent to which the integrity of both of these organelles directly impacts human health, 
we eagerly await a deeper understanding of the molecular mechanisms underlying the 






Materials and methods 
Yeast strains and growth conditions 
Saccharomyces cerevisiae W303-1a (MATa, his3 leu2 met15 trp1 ura3) was used in 
this study.  The standard PCR-based homologous recombination method was used to 
generate all mutant strains.  Briefly, drug selection cassette (KanMX4 or hphMX4) 
flanked with 45-bp fragments upstream and downstream of the gene of interest was PCR 
amplified and transformed into the wild-type diploid (Goldstein and McCusker, 1999) 
(Wach et al., 1994).  The haploid strain was generated by sporulation and tetrad analysis.  
The genotype of the strain was verified by standard genotyping PCR.  The genotypes of 
all yeast strains used in this study are listed in Table 4-1.   
For yeast transformation, the standard lithium acetate procedure was used (Gietz et 
al., 1992).  Transformed yeast cells were grown in synthetic complete dextrose (SD) 
medium lacking the appropriate amino acid(s) for auxotrophic selection purposes at 
30°C.  Media used in this study includes standard YP and synthetic minimal medium 
supplemented with 2% glucose or 3% glycerol.  Oleate medium is composed of 0.67% 
yeast nitogen base without amino acid, 0.1% yeast extract, 0.1% oleate and 0.25% tween-
40 and filter sterilized   Solid plates contain 2.2% (w/v) agar. 
 
Plasmid construction 
The plasmids expressing nontagged, C-terminal HA or GFP-tagged Msp1 and 
Msp1E193Q were reported previously (Chen et al., 2014).  Msp1K139A-GFP, Msp1R248E-
GFP and Msp1W166G/Y167D-GFP were generated by site-directed mutagenesis.  Tom70TMD- 
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Table 4-1. Yeast strains used in this study 
 
Number Strains Genotype Source 
JRY245 WT (W303) MATa his3 leu2 lys2 met15 trp1 ura3 David Stillman 
JRY1816 msp1Δ 
MATa his3 leu2 lys2 met15 trp1 ura3 Chen et al., 2014 msp1::kanMX4 
JRY1814 get3Δ msp1Δ 
MATa his3 leu2 lys2 met15 trp1 ura3 
Chen et al., 2014 get3::hphMX4 msp1::kanMX4 
JRY490 rho0 




MATα his3 leu2 lys2 met15 trp1 ura3 This study pex19::natMX 
JRY2726 msp1Δ pex19Δ 




MATa ade2 his3 leu2  trp1 ura3 can1 
Janet Shaw fis1::His3MX 
JRY2617 mdv1Δ 
MATa ade2 his3 leu2  trp1 ura3 can1 
Janet Shaw mdv1::His3MX 
JRY2616 dmn1Δ 
MATa ade2 his3 leu2  trp1 ura3 can1 
Janet Shaw dmn1::His3MX 
JRY252 fzo1Δ 
MATa ade2 his3 leu2  trp1 ura3 can1 
Janet Shaw fzo1::TRP1 
JRY1040 mdm30Δ 
MATa his3 leu2 lys2 met15 trp1 ura3 
Janet Shaw mdm30::kanMX 
JRY2620 WT 
MATa his3 leu2 LYS2 met15 trp1 ura3 
Janet Shaw   
JRY2619 fzo1-1 
MATa ade2 his3 leu2  trp1 ura3  
Janet Shaw fzo1-1 
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Msp1-GFP was generated by fusing MSP1 promoter (509 bp upstream of MSP1 ORF), 1-
30 amino acid of Tom70 and 31-364 amino acid of Msp1 by sawing PCR and ligating 
into a pRS416-based vector with a c-terminal GFP.  Om45TMD-Msp1-GFP was made 
similarly except that 1-26 amino acid of Om45 was fused with Msp1.  GAL1 promoter 
driven Msp1-GFP constructs were generated by ligating Msp1-GFP into pRS414-GAL1 
vector (Mumberg et al., 1995).  E193Q mutation was introduced by site-directed 
mutagenesis.  RFP-tagged peroxin constructs were created by amplifying the ORF of 
each peroxin with about 500 bp upstream of the starting codon and ligated into a 
pRS414-based vector containing a c-terminal RFP tag. GFP-tagged PEX10 and PEX13 
was generated by amplifying PEX10 and PEX13 ORF from human cDNA and ligated 
into a pLenti-CMV-GFP-Puro vector (Campeau et al., 2009). Peroxisomal fluorescent 
marker construct was made by fusing RFP protein with the peroxisomal targeting 
sequence (SKL) at the C-terminus.    
 
Isolation of yeast mitochondria 
Yeast cells were harvested at midlog phase (OD600=2-3) in 2% synthetic reffinose 
medium.  Preparation of crude and purified mitochondria was as described previously 
(Boldogh and Pon, 2007).  Yeast pellet was washed once with ddH2O, resuspended and 
incubated in TD buffer (100 mM Tris-SO4, pH 9.4 and 100 mM DTT) for 15 min at 
30°C.  Spheroplasts were obtained by incubating cells in SP buffer  (1.2 M sorbitol and 
20 mM potassium phosphate, pH 7.4) supplemented with lyticase (2 mg/g of cell pellet) 
(Sigma-Aldrich) for 1 hr at 30°C to digest the cell wall.  Spheroplasts were gently 
washed once in ice-cold SHE buffer (1.2 M sorbitol, 20 mM HEPES-KOH, pH 7.4, 2 
mM MgCl2, 1 mM EGTA, and 1 mM PMSF) and homogenized in ice-cold SHE buffer 
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that contains 0.6 M sorbitol and a Dounce homogenizer was applied with 10-20 strokes.  
The crude mitochondrial fraction was obtained by differential centrifugation.  Protein 
concentration was determined using Bradford protein assay. 
 
Fluorescence microscopy 
Yeast samples were prepared by growing yeast cells to early-log phase (OD600= 
0.8-1) in synthetic dropout medium with appropriate carbon sources at 30°C or otherwise 
indicated.  To prepare mammalian cell samples, we cultured cells on Poly-L-Lysine-
coated Lab-Tek® II chamber slides for a day to allow them to fully attach.  They were 
stained with 25 nM Mitotracker® Red CMXRos (Life Technologies) in FBS-free 
medium for 5 min at 37°C before being imaged.  To examine morphological changes of 
peroxisomes on ATAD1-/- MEFs, cells were grown on coverslips, washed with PBS and 
fixed with 4% PFA in PBS for 20 min at room temperature. Cells were then blocked in 
10% normal goat serum and 5% ultrapure BSA for 1 hr, stained with anti-PMP70 
antibody (1/500, Abcam) and Alexa flour® 546 secondary antibody (Life Technologies).  
Cells were washed three times with PBS buffer and stained with DAPI.  Cells were 
imaged on the Axio Observer.Z1 imaging system (Carl Zeiss) equipped with 40X and 
100X objectives (oil-immersion).  Digital fluorescence and differential interference 
contrast (DIC) images were acquired using a monochrome digital camera (AxioCam 
MRm, Carl Zeiss).  The final images were adjusted and assembled using Adobe 
Photoshop CS5.1.  Brightness and contrast were adjusted only using linear operation on 






 One mg of crude mitochondria extracted from each strain was solubilized in 0.5% 
digitonin for 1 hr at 4°C.  Cleared mitochondria lysates were mixed with anti-HA 
antibody conjugated agarose for 1 hr at 4°C.  Agarose was washed two times with buffer 
containing 250 mM NaCl and 0.05% digitonin, and three times with buffer containing 
600 mM NaCl and 0.05% digitonin.  Laemmli buffer without β-ME was added to the 
agarose to elute proteins.  Final eluate and 4-5% of the mitochondria lysate were resolved 
by 12% SDS-PAGE followed by immunoblot.   
 
Mammalian cell culture 
MEFs and HEK293T were maintained in DMEM with 10% FBS.  Human 
fibroblasts were maintained in DMEM with 20% FBS.  Cells were cultured at 37°C with 
5% CO2.  To establish stable cell lines, lentivirus was produced in HEK293T cells that 
were co-transfected with the vector containing the gene of interest, MDLg/pRRE, pRSV-
Rev and pMD2.G.  Retrovirus was produced in HEK293T cells that were co-transfected 
with the vector containing the gene of interest, Gag-pol and VSVG (amount ratio is 
3:2:1). Transfection was performed using Lipofactamine 2000 according to the 
manufacturer’s instructions.  Lentivirus was harvested from the medium at 48 hr 
posttransfection and applied to the target cells.  After 24 hr postinfection, target cells 
were selected in 4 µg/mL puromycin and/or 150 µg/mL zeocin for 5-7 days.  Stable cell 
lines were maintained in the appropriate medium with 0.5 µg/mL puromycin and/or 20 
µg/mL zeocin. MEFs were prepared from embryonic day 13 mouse pups as described 
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   Mitochondria play a critical role in many aspects of cell biology. Thus, dysfunction 
of this organelle is associated with many pathological conditions.  To understand the 
etiology of these human diseases, we set out to characterize the molecular function of 
evolutionarily conserved mitochondrial proteins with unknown function in both yeast and 
mammalian cells.  In this dissertation, the functions of two highly conserved 
mitochondrial proteins have been described.  The first protein is a respiratory 
superocomplex stability factor, Rcf1, which is crucial for maintaining optimal efficiency 
of mitochondrial respiration and ATP production.  The second protein, Msp1, is an 
AAA+ ATPase that possesses multiple functions including mitochondrial protein quality 
control and mitochondria-to-peroxisome communication.  Both proteins act in important 
aspects of mitochondrial biology and are potentially related to human health.	  
 Rcf1 is an evolutionarily conserved protein that is required for the normal assembly 
of respiratory supercomplexes.  We demonstrate that Rcf1 acts like glue to stabilize the 
association of Complex III and Complex IV of the electron transport chain.  In yeast, we 
demonstrate that deletion of the RCF1 gene caused impaired respiration, possibly as a 
result of destabilization of respiratory supercomplexes.  Consistent with the hypothetical 
function of these respiratory assemblies, loss of RCF1 also caused elevated mitochondrial 
oxidative stress and damage.  More importantly, we show that knockdown of HIG2A, a 
mammalian homolog of RCF1, causes impaired supercomplex formation in mammalian 
cells.  In conclusion, we hypothesize that Rcf1/HIG2A is a member of an evolutionarily 
conserved protein family that acts to promote respiratory supercomplex assembly and 
activity.  We propose that mutations on this protein family cause major impacts on 
human health as the integrity of the electron transport chain directly influences energy 
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homeostasis as well as ROS production.   
 Msp1 is an AAA+ ATPase that we have found to participate in two distinct 
functions.  The first one is mitochondrial protein quality control in patrolling 
mitochondria for mislocalized TA proteins.  ER-targeted TA proteins are inserted by the 
GET system and it has been shown that loss of GET system activity causes protein 
mislocalization to the mitochondria.  In yeast, we show that deletion of MSP1 causes two 
TA proteins, Pex15 and Gos1, to accumulate on mitochondria when the GET system is 
impaired.  Likely as a result of failing to extract mislocalized TA proteins, yeast with 
combined mutation of the MSP1 gene and the GET system exhibit strong synergistic 
growth defects and severe mitochondrial damage.  In mammalian cells, the human 
homologue of Msp1, ATAD1 limits the mitochondrial mislocalization of PEX26 and 
GOS28, orthologs of Pex15 and Gos1, respectively.  GOS28 protein level is also 
increased in multiple ATAD1-/- mouse tissues.  In conclusion, we propose that yeast Msp1 
and mammalian ATAD1 are conserved members of the mitochondrial protein quality 
control system that promote the extraction and degradation of mislocalized TA proteins 
to maintain mitochondrial integrity. 
 The additional and unexpected function of Msp1 that we identified is in 
mitochondria-to-peroxisome trafficking and perhaps peroxisome biogenesis.  In yeast, 
Msp1 first localizes to mitochondria and from there, it traffics to peroxisomes in an 
ATPase activity-dependent manner.  Probably due to failure of trafficking to 
peroxisomes, Msp1 localizes to vesicle-like puncta in the pex19Δ mutant that does not 
contain peroxisomes.  Importantly, depletion of yeast MSP1 and human ATAD1 leads to 
fragmentation of peroxisome, suggesting that they posses an evolutionarily conserved 
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peroxisomal function.  We also show that Msp1/ATAD1 might play a role in sorting 
peroxisome biogenesis factors (or peroxins) from mitochondria into vesicles.  Therefore, 
we conclude that Msp1/ATAD1 might participate in sorting peroxins from mitochondria 
to peroxisomes via a vesicle trafficking pathway. 
 Our findings regarding both Rcf1 and Msp1 directly impact our understanding of 
mitochondrial diseases.  First, mitochondrial ROS has been long known as an important 
contributor to organismal aging.  As Rcf1-mediated stabilization of the respiratory 
supercomplex is crucial to limit mitochondrial oxidative stress, we believe that the 
function of Rcf1 might be related to the aging process.  Therefore, the discovery of the 
function of the Rcf1/HIG2A protein family provides a perfect opportunity for the 
scientific community to explore the connection between respiratory supercomplexes and 
human health.  Next, both impaired mitochondria and peroxisomes have major impact on 
brain function.  We know that ATAD1-/- mice exhibit severe neurological defects and die 
at an early postnatal stage.  According to the functional characteristics of the 
Msp1/ATAD1 protein family, members of this protein family play an important role not 
only in mitochondria but also peroxisomes.  An interesting question that awaits to be 
answered is to what degree the two distinct functions of Msp1/ATAD1 contributes to the 
pathological phenotype of the ATAD1-/- mice.  In conclusion, we are hoping that the 
findings regarding both of these two protein families will provide more insight into 
mitochondrial disease biology and even have clinical implications. 
 	  
